<!DOCTYPE html>

<head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title>WAAMS - Western Australia AntiMicrobial Stewardship</title>
    <link rel="shortcut icon" type="image/ico" href="favicon.ico" />
    <link rel="apple-touch-icon" href="apple-touch-icon-precomposed.png">
    <link rel="apple-touch-icon-precomposed" href="apple-touch-icon-precomposed.png">
    <link rel="stylesheet" href="bootstrap/css/bootstrap.min.css" />
    <link rel="stylesheet" href="bootstrap/css/bootstrap-theme.min.css" />
    <link rel="stylesheet" href="bootstrap/css/basic.css" />
    <link rel="stylesheet" href="bootstrap/css/style.css" />
    <script src="bootstrap/js/jquery-1.11.1.min.js"></script>
    <script type="text/javascript" src="bootstrap/js/codecheckWA.js"></script>
    <!-- Needed for Forms Feature Detection -->
    <script src="polyfill/better-dom.min.js"></script>
    <!-- Needed for Validation -->
    <script src="polyfill/better-dateinput-polyfill.js"></script>
    <script src="polyfill/ie-array-polyfill.js"></script>
    <!-- General helpful functions -->
    <script src="bootstrap/js/kraken.js"></script>
</head>

<body>

    <!-- loading page -->
    <div data-role="page" id="load" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Loading</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Loading</span>
            </h3>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /load -->

    <!-- Start of respi. ?Type: #respi -->
    <div data-role="page" id="respi" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Respiratory Infections</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">What type of infection is suspected/confirmed?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchi">Bronchiectasis</a></li>
                <li><a href="#iecopd">Infective exacerbation of COPD</a></li>
                <li><a href="#influ">Influenza infection</a></li>
                <li><a href="#nursicap">Nursing home or aged care facility pneumonia</a></li>
                <li><a href="#empara">Parapneumonic effusion or empyema</a></li>
                <li><a href="#pneum">Pneumonia</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>


    <!-- Start of bronchiectasis, XRay Q: #bronchi -->
    <div data-role="page" id="bronchi" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <h3 class="color-primary mrgn15b">Does your patient have chest xray changes consistent with a pneumonia?</span>
        </h3>

        <div data-role="content" class="container-fluid">
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pneum">Yes, &#40;treat as per pneumonia&#41;</a></li>
                <li><a href="#bronchi2">No, not suggestive of pneumonia</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>An exacerbation of bronchiectasis is an acute deterioration of symptoms from the patient’s baseline
                    that usually develops over several days.</li>
                <li>In patients with bronchiectasis, the airways are often colonised with organisms such as
                    <i>Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Pseudomonas aeruginosa
                        and Staphylococcus aureus.</i> <b>Do not treat colonising organisms if the patient is clinically
                        stable.</b></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi -->

    <!-- Start of bronchiectasis page: #bronchi2 -->
    <div data-role="page" id="bronchi2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Has a nose and/or throat swab for viral (flu, RSV etc) NAAT been
                performed?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchi2b1">Yes</a></li>
                <li><a href="#bronchi2b2">No</a></li>
                <li><a href="#bronchi2b1a">I am treating an outpatient</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Viral testing is not indicated for outpatient management</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi -->

    <!-- #bronchi2b1 -->
    <div data-role="page" id="bronchi2b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Consider influenza treatment with oseltamivir whilst awaiting
                        results</span>
                </h4>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Oseltamivir orally, 12-hourly for 5 days</span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">75 mg </span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 1 year: &nbsp;</span>
                                </td>
                                <td><span class="color-purple"> 3 mg/kg </span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child 1 year or older and 15 to 23 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 45 mg</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child 1 year or older and 23 to 40 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 60 mg</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child 1 year or older and more than 40 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 75 mg</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn20b">Cease if flu results return not detected</p>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for oseltamivir is: </span>
                <span class="font15 bold">5<script> document.write(getCode())</script>flu</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FIVE</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if IV
                    treatment is to continue past five days. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchi2b1a">Proceed to next question</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1 -->

    <!-- Start of bronchi2b2 -->
    <div data-role="page" id="bronchi2b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <div id="backcolour">
                <p class="mrgn20b">Please perform a nose and/or throat swab for viral NAAT for respiratory viruses</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">And consider influenza treatment with oseltamivir whilst awaiting results</span>
                </h4>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Oseltamivir orally, 12-hourly for 5 days</span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">75 mg </span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 1 year: &nbsp;</span>
                                </td>
                                <td><span class="color-purple"> 3 mg/kg </span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child 1 year or older and 15 to 23 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 45 mg</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child 1 year or older and 23 to 40 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 60 mg</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child 1 year or older and more than 40 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 75 mg</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn20b">Cease if flu reults return not detected</p>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for oseltamivir is: </span>
                <span class="font15 bold">5<script> document.write(getCode())</script>flu</span>
                <div class="font15 mrgn20b text-left">This code is valid for FIVE days only, starting from the first day
                    of treatment for this condition. Infectious diseases must be contacted if IV treatment is to
                    continue past five days. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchi2b1a">Proceed to next question</a></li>
            </ul>
            <hr />
            <ul type="circle" class="line30">
                <li>Please perform a nose and/or throat swab for viral NAAT for respiratory viruses</li>
                <li>Consider influenza treatment with Tamiflu 75 mg whilst awaiting results</li>
                <li>75 mg oseltamivir orally, 12-hourly for 5 days</li>
                <li>Cease if flu results return not detected</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b2 -->

    <!-- Start of bronchi2b1a -->
    <div data-role="page" id="bronchi2b1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <h3 class="color-primary mrgn15b">Does your patient have evidence of a bacterial exacerbation? &#40;see
            below&#41;</h3>
        <div data-role="content" class="container-fluid">
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchi2b1a1a">Yes</a></li>
                <li><a href="#bronchi2b1a2">No</a></li>
            </ul>
            <hr />
            <ul type="circle" class="line30">
                <li>Antibiotics are only indicated for bacterial infection if all three of the following clinical
                    features are present::</li>
                <ul type="number" class="line30">
                    <li>increased sputum volume or change in sputum viscosity</li>
                    <li>increased sputum purulence</li>
                    <li>increased cough, which may be associated with wheeze, breathlessness or haemoptysis</li>
                </ul>
                <li><b>Do not</b> use antibiotic therapy unless the patient has clinical features suggestive of
                    bacterial infection</li>
                <li><b>Consider witholding antibiotics for patients managed in the community</b></li>
                <li>Collect a sputum sample for culture in all patients &#40;including patients managed in the
                    community&#41; before starting antibiotic therapy.</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a -->

    <!-- Start of bronchi2b1a2 -->
    <div data-role="page" id="bronchi2b1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div id="backcolour">
            <h4 class="medicine mrgn20b">
                <span class="color-purple">Antibiotics are not recommended if there is no evidence of bacterial
                    infection</span>
            </h4>
        </div>
        <hr />
        <ul type="circle" class="line30">
            <li>Exacerbations of bronchiectasis can be caused by colonising organisms or infection with a new organism.
                For this reason, a trial of narrower-spectrum antibiotic therapy is recommended despite previous
                <i>Pseudomonas aeruginosa</i> growth</li>
            <li>Optimise airway clearance, Optimise airway clearance, physical activity and, if appropriate,
                bronchodilator therapy during exacerbations of bronchiectasis.</li>
            <li>In patients with bronchiectasis, the airways are often colonised with organisms such as <i>Haemophilus
                    influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Pseudomonas aeruginosa</i> and
                <i>Staphylococcus aureus</i>. Exacerbations of bronchiectasis may be caused by colonising organisms or
                infection with a new organism, including common respiratory viruses</li>
            <li>Many patients with bronchiectasis easily expectorate sputum. Collect a sputum sample for culture in all
                patients (including patients managed in the community) before starting any antibiotic therapy.</li>
        </ul>
        <hr>
        <h4 class="mrgn20b references">
            <span class="color-purple"><b>References: </b></span><br><br>
            <span class="font15"><a
                    href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                    target="_blank">See section on bronchiectasis</a> - Antibiotic Expert Groups. Therapeutic
                guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
        </h4>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a2 -->

    <!-- Start of bronchi2b1a1 -->
    <div data-role="page" id="bronchi2b1a1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">How old is the patient?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchi2b1a1a1">Adult patient</a></li>
                <li><a href="#bronchi2b1a1a2">Child &#40;&lt; 12 years old&#41;</a></li>
            </ul>
            <hr />
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a -->

    <!-- Start of bronchi2b1a1a1 Adult ?severe -->
    <div data-role="page" id="bronchi2b1a1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">How severe is your patient/s clinical status? &#40;see below&#41;</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchi2b1a1a1a">Severe</a></li>
                <li><a href="#bronchi2b1a1a1b">Non-severe</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Worsening respiratory distress</li>
                <li>Worsening hypoxaemia from the patient’s baseline state</li>
                <li>Acute-onset confusion</li>
                <li>Signs of sepsis or septic shock</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a1 -->

    <!-- Start of bronchi2b1a1a2 Child ?severe -->
    <div data-role="page" id="bronchi2b1a1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">How severe is your patient/s clinical status? &#40;see below&#41;</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchi2b1a1a2a">Severe</a></li>
                <li><a href="#bronchi2b1a1a2b">Non-severe</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Worsening respiratory distress</li>
                <li>Worsening hypoxaemia from the patient’s baseline state</li>
                <li>Acute-onset confusion</li>
                <li>Signs of sepsis or septic shock</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a2 -->

    <!-- Start of  bronchi2b1a1a1a ADULT Severe -->
    <div data-role="page" id="bronchi2b1a1a1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchi2b1a1a1a1">No penicillin allergy</a></li>
                <li><a href="#bronchi2b1a1a1a2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#bronchi2b1a1a1a3">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a1a -->

    <!-- Start of  bronchi2b1a1a1b ADULT NOT BAD -->
    <div data-role="page" id="bronchi2b1a1a1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchi2b1a1a1b1">No penicillin allergy</a></li>
                <li><a href="#bronchi2b1a1a1b2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#bronchi2b1a1a1b2">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a1b -->


    <!-- Start of  bronchi2b1a1a1a CHILD Severe -->
    <div data-role="page" id="bronchi2b1a1a2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchi2b1a1a2a1">No penicillin allergy</a></li>
                <li><a href="#bronchi2b1a1a2a2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#bronchi2b1a1a2a3">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a2a -->

    <!-- Start of  bronchi2b1a2a1b CHILD NOT BAD -->
    <div data-role="page" id="bronchi2b1a1a2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchi2b1a1a2b1">No penicillin allergy</a></li>
                <li><a href="#bronchi2b1a1a2b2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#bronchi2b1a1a2b3">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a2b -->

    <!-- Start of bronchi2b1a1 -->
    <div data-role="page" id="bronchi2b1a1a1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Has your patient been colonised with <i>Pseudomonas aeruginosa</i> on
                <b>previous</b> microbiology? Or do they have known active <i>Pseudomonas aeruginosa</i> infection?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchi2b1a1a1b1a">Yes</a></li>
                <li><a href="#bronchi2b1a1a1b1b">No</a></li>
            </ul>
            <hr />
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1 -->


    <!-- Start of bronchi with no Penicillin Allergy adult mild, pseud yes : #bronchi2b1a1a1b1 -->
    <div data-role="page" id="bronchi2b1a1a1b1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For treatment in a patient with no penicillin allergy use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 1 g PO, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> if patient has previous resistant, or suspected resistant <i>Haemophilus
                        influenzae</i> or <i>Moraxella catarrhalis</i></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 875 mg/Clavulanic acid 125 mg PO, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <ul type="circle" class="line30">
                <li>Exacerbations of bronchiectasis can be caused by colonising organisms such as pseudomonas or
                    infection with a new organism. For this reason, a trial of narrower-spectrum antibiotic therapy is
                    recommended <b>despite previous <i>Pseudomonas aeruginosa</i> growth</b></li>
                <li>Optimise airway clearance, Optimise airway clearance, physical activity and, if appropriate,
                    bronchodilator therapy during exacerbations of bronchiectasis.</li>
                <li>In patients with bronchiectasis, the airways are often colonised with organisms such as
                    <i>Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Pseudomonas
                        aeruginosa</i> and <i>Staphylococcus aureus</i>. Exacerbations of bronchiectasis may be caused
                    by colonising organisms or infection with a new organism, including common respiratory viruses</li>
                <li>Many patients with bronchiectasis easily expectorate sputum. Collect a sputum sample for culture in
                    all patients (including patients managed in the community) before starting antibiotic therapy.</li>
                <li>Consider <i>influenza</i> treatment with Tamiflu 75 mg whilst awaiting swab results</li>
                <li>Modify regimen based on sputum culture results however, if patient improving, adjustment is not
                    required even if isolate is resistant to cultured organism. Call ID if discussion required.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bronchiectasis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a1b1a -->

    <!-- Start of bronchi with no Penicillin Allergy adult mild, pseud yes : #bronchi2b1a1a1b1 -->
    <div data-role="page" id="bronchi2b1a1a1b1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For treatment in a patient with no penicillin allergy use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 1 g PO, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> if patient has previous resistant, or suspected resistant <i>Haemophilus
                        influenzae</i> or <i>Moraxella catarrhalis</i></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 875 mg/Clavulanic acid 125 mg PO, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <ul type="circle" class="line30">
                <li>Optimise airway clearance, Optimise airway clearance, physical activity and, if appropriate,
                    bronchodilator therapy during exacerbations of bronchiectasis.</li>
                <li>In patients with bronchiectasis, the airways are often colonised with organisms such as
                    <i>Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Pseudomonas
                        aeruginosa</i> and <i>Staphylococcus aureus</i>. Exacerbations of bronchiectasis may be caused
                    by colonising organisms or infection with a new organism, including common respiratory viruses</li>
                <li>Many patients with bronchiectasis easily expectorate sputum. Collect a sputum sample for culture in
                    all patients (including patients managed in the community) before starting antibiotic therapy.</li>
                <li>Consider <i>influenza</i> treatment with Tamiflu 75 mg whilst awaiting swab results</li>
                <li>Modify regimen based on sputum culture results however, if patient improving, adjustment is not
                    required even if isolate is resistant to cultured organism. Call ID if discussion required.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bronchiectasis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a1b1b -->


    <!-- Start of bronchi2b1a1 -->
    <div data-role="page" id="bronchi2b1a1a1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Has your patient been colonised with <i>Pseudomonas aeruginosa</i> on
                <b>previous</b> microbiology? Or do they have known active <i>Pseudomonas aeruginosa</i> infection?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchi2b1a1a1b2a">Yes</a></li>
                <li><a href="#bronchi2b1a1a1b2b">No</a></li>
            </ul>
            <hr />
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1 -->


    <!-- Start of bronchi with moderate or bad Penicillin Allergy adult mild disease, pseud yes: #bronchi2b1a1a1b2a -->
    <div data-role="page" id="bronchi2b1a1a1b2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For treatment in a patient with penicillin allergy use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 100 mg PO, 12-hourly</span>
                </h4>
                <p class="mrgn20b">if there has been no improvement with the above regimen then consider this regimen
                    with anti-pseudomonal cover</p>
            </div>
            <hr />
            <ul type="circle" class="line30">
                <li>Exacerbations of bronchiectasis can be caused by colonising organisms such as pseudomonas or
                    infection with a new organism. For this reason, a trial of narrower-spectrum antibiotic therapy is
                    recommended <b>despite previous <i>Pseudomonas aeruginosa</i> growth</b></li>
                <li>If there has been <b>no improvement</b> then consider directed pseudomonas therapy</li>
                <li>Optimise airway clearance, Optimise airway clearance, physical activity and, if appropriate,
                    bronchodilator therapy during exacerbations of bronchiectasis.</li>
                <li>In patients with bronchiectasis, the airways are often colonised with organisms such as
                    <i>Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Pseudomonas
                        aeruginosa</i> and <i>Staphylococcus aureus</i>. Exacerbations of bronchiectasis may be caused
                    by colonising organisms or infection with a new organism, including common respiratory viruses</li>
                <li>Many patients with bronchiectasis easily expectorate sputum. Collect a sputum sample for culture in
                    all patients (including patients managed in the community) before starting antibiotic therapy.</li>
                <li>Consider influenza treatment with Tamiflu 75 mg whilst awaiting swab results</li>
                <li>Modify regimen based on sputum culture results however, if patient improving, adjustment is not
                    required even if isolate is resistant to cultured organism. Call ID if discussion required.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bronchiectasis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a1b2a -->

    <!-- Start of bronchi with moderate or bad Penicillin Allergy adult mild disease, pseud no: #bronchi2b1a1a1b2b -->
    <div data-role="page" id="bronchi2b1a1a1b2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For treatment in a patient with penicillin allergy use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 100 mg PO, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <ul type="circle" class="line30">
                <li>Optimise airway clearance, Optimise airway clearance, physical activity and, if appropriate,
                    bronchodilator therapy during exacerbations of bronchiectasis.</li>
                <li>In patients with bronchiectasis, the airways are often colonised with organisms such as
                    <i>Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Pseudomonas
                        aeruginosa</i> and <i>Staphylococcus aureus</i>. Exacerbations of bronchiectasis may be caused
                    by colonising organisms or infection with a new organism, including common respiratory viruses</li>
                <li>Many patients with bronchiectasis easily expectorate sputum. Collect a sputum sample for culture in
                    all patients (including patients managed in the community) before starting antibiotic therapy.</li>
                <li>Consider <i>influenza</i> treatment with Tamiflu 75 mg whilst awaiting swab results</li>
                <li>Modify regimen based on sputum culture results however, if patient improving, adjustment is not
                    required even if isolate is resistant to cultured organism. Call ID if discussion required.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bronchiectasis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a1b2b -->

    <!-- Start of bronchi2b1a1 -->
    <div data-role="page" id="bronchi2b1a1a1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Has your patient been colonised with <i>Pseudomonas aeruginosa</i> on
                <b>previous</b> microbiology? Or do they have known active <i>Pseudomonas aeruginosa</i> infection?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchi2b1a1a1a1a">Yes</a></li>
                <li><a href="#bronchi2b1a1a1a1b">No</a></li>
            </ul>
            <hr />
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1 -->

    <!-- Start of generic pseud question -->
    <div data-role="page" id="bronchi2b1a1a1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Has your patient been colonised with <i>Pseudomonas aeruginosa</i> on
                <b>previous</b> microbiology? Or do they have known active <i>Pseudomonas aeruginosa</i> infection?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchi2b1a1a1a2a">Yes</a></li>
                <li><a href="#bronchi2b1a1a1a1b">No</a></li>
            </ul>
            <hr />
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /this page -->

    <!-- Start of bronchi with NO Penicillin Allergy adult SEVERE DISEASE, pseud yes : #bronchi2b1a1a1a1a -->
    <div data-role="page" id="bronchi2b1a1a1a1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For treatment in a patient with no penicillin allergy or non-severe
                hypersensitivity and history of pseudomonas use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Piperacillin+tazobactam 4+0.5 g IV, 6-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> whilst awaiting culture results <b>ADD</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ciprofloxacin 400 mg IV,
                        8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Gentamicin IV, dosed as per nomograms
                        below or use the <a href="#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b">Step down to oral ciprofloxacin 750mg 12-hourly only if susceptible and once
                    condition improving, otherwise prolonged IV antibiotics may be required &#40;contact infectious
                    diseases&#41;</p>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for piperacillin+tazobactam, gentamicin and ciprofloxacin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>bch</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
                <li>Use the <a href="#dose7">Cockcroft gault calculator</a> to calculate renal function for adults if
                    using the nomogram, or use the <a href="#dose12">adult aminoglycoside dose calculator</a></li>
            </ul>
            <hr>
            <ul type="circle" class="line30">
                <li>If resistance to ceftazidime is proven or suspected please contact infectious diseases</li>
                <li>Exacerbations of bronchiectasis can be caused by colonising organisms or infection with a new
                    organism. For this reason, a trial of narrower-spectrum antibiotic therapy is recommended despite
                    previous <i>Pseudomonas aeruginosa</i> growth</li>
                <li>Optimise airway clearance, Optimise airway clearance, physical activity and, if appropriate,
                    bronchodilator therapy during exacerbations of bronchiectasis.</li>
                <li>In patients with bronchiectasis, the airways are often colonised with organisms such as
                    <i>Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Pseudomonas
                        aeruginosa</i> and <i>Staphylococcus aureus</i>. Exacerbations of bronchiectasis may be caused
                    by colonising organisms or infection with a new organism, including common respiratory viruses</li>
                <li>Many patients with bronchiectasis easily expectorate sputum. Collect a sputum sample for culture in
                    all patients (including patients managed in the community) before starting antibiotic therapy.</li>
                <li>Consider influenza treatment with Tamiflu 75 mg whilst awaiting swab results</li>
                <li>Modify regimen based on sputum culture results however, if patient improving, adjustment is not
                    required even if isolate is resistant to cultured organism. Call ID if discussion required.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bronchiectasis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a1a1a -->

    <!-- Start of bronchi with MILD Penicillin Allergy adult SEVERE DISEASE, pseud yes : #bronchi2b1a1a1a2a -->
    <div data-role="page" id="bronchi2b1a1a1a2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For treatment in a patient with no penicillin allergy or non-severe
                hypersensitivity and history of <i>Pseudomonas aeruginosa</i> use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftazidime 2 g IV, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> whilst awaiting culture results <b>ADD</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ciprofloxacin 400 mg IV,
                        8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Gentamicin IV, dosed as per nomograms
                        below or use the <a href="#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b">Step down to oral ciprofloxacin 750mg 12-hourly only if susceptible and once
                    condition improving, otherwise prolonged IV antibiotics may be required &#40;contact infectious
                    diseases&#41;</p>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftazidime, gentamicin and ciprofloxacin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>bch</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
                <li>Use the <a href="#dose7">Cockcroft gault calculator</a> to calculate renal function for adults if
                    using the nomogram, or use the <a href="#dose12">adult aminoglycoside dose calculator</a></li>
            </ul>
            <hr>
            <ul type="circle" class="line30">
                <li>If resistance to ceftazidime is proven or suspected please contact infectious diseases</li>
                <li>Exacerbations of bronchiectasis can be caused by colonising organisms or infection with a new
                    organism. For this reason, a trial of narrower-spectrum antibiotic therapy is recommended despite
                    previous <i>Pseudomonas aeruginosa</i> growth</li>
                <li>Optimise airway clearance, Optimise airway clearance, physical activity and, if appropriate,
                    bronchodilator therapy during exacerbations of bronchiectasis.</li>
                <li>In patients with bronchiectasis, the airways are often colonised with organisms such as
                    <i>Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Pseudomonas
                        aeruginosa</i> and <i>Staphylococcus aureus</i>. Exacerbations of bronchiectasis may be caused
                    by colonising organisms or infection with a new organism, including common respiratory viruses</li>
                <li>Many patients with bronchiectasis easily expectorate sputum. Collect a sputum sample for culture in
                    all patients (including patients managed in the community) before starting antibiotic therapy.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bronchiectasis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a1a2a -->


    <!-- Start of bronchi with no OR MILD Penicillin Allergy adult SEVERE DISEASE, pseud no : #bronchi2b1a1a1b1b -->
    <div data-role="page" id="bronchi2b1a1a1a1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For treatment in a patient with no penicillin allergy or non-severe
                hypersensitivity with no signs of pseudomonas use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2 g IV, daily</span>
                </h4>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 10<script> document.write(getCode())</script>bch</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TEN</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past ten days. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Exacerbations of bronchiectasis can be caused by colonising organisms or infection with a new
                    organism. For this reason, a trial of narrower-spectrum antibiotic therapy is recommended despite
                    previous <i>Pseudomonas aeruginosa</i> growth</li>
                <li>Optimise airway clearance, Optimise airway clearance, physical activity and, if appropriate,
                    bronchodilator therapy during exacerbations of bronchiectasis.</li>
                <li>In patients with bronchiectasis, the airways are often colonised with organisms such as
                    <i>Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Pseudomonas
                        aeruginosa</i> and <i>Staphylococcus aureus</i>. Exacerbations of bronchiectasis may be caused
                    by colonising organisms or infection with a new organism, including common respiratory viruses</li>
                <li>Many patients with bronchiectasis easily expectorate sputum. Collect a sputum sample for culture in
                    all patients (including patients managed in the community) before starting antibiotic therapy.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bronchiectasis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a1a1b -->

    <!-- Start of generic pseud question -->
    <div data-role="page" id="bronchi2b1a1a1a3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Has your patient been colonised with <i>Pseudomonas aeruginosa</i> on
                <b>previous</b> microbiology? Or do they have known active <i>Pseudomonas aeruginosa</i> infection?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchix">Yes</a></li>
                <li><a href="#bronchi2b1a1a1a3b">No</a></li>
            </ul>
            <hr />
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /this page -->

    <!-- Start of bronchi with BAD Penicillin Allergy adult SEVERE DISEASE : #bronchi2b1a1a1a3 -->
    <div data-role="page" id="bronchi2b1a1a1a3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For treatment in a patient with severe penicillin hypersensitivity and no
                evidence of <i>Pseudomonas aeruginosa</i> infection use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Moxifloxacin 400 mg IV or PO, daily</span>
                </h4>
                <p class="mrgn20b">Oral moxifloxacin is extremely bioavailable &#40;&gt;95 percent&#41; switch to oral
                    once patient starts to show signs of improvement</p>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for moxifloxacin is:</span>
                <span class="font15 bold"> 10<script> document.write(getCode())</script>bch</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TEN</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past ten days. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Exacerbations of bronchiectasis can be caused by colonising organisms or infection with a new
                    organism. For this reason, a trial of narrower-spectrum antibiotic therapy is recommended despite
                    previous <i>Pseudomonas aeruginosa</i> growth</li>
                <li>Optimise airway clearance, Optimise airway clearance, physical activity and, if appropriate,
                    bronchodilator therapy during exacerbations of bronchiectasis.</li>
                <li>In patients with bronchiectasis, the airways are often colonised with organisms such as
                    <i>Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Pseudomonas
                        aeruginosa</i> and <i>Staphylococcus aureus</i>. Exacerbations of bronchiectasis may be caused
                    by colonising organisms or infection with a new organism, including common respiratory viruses</li>
                <li>Many patients with bronchiectasis easily expectorate sputum. Collect a sputum sample for culture in
                    all patients (including patients managed in the community) before starting antibiotic therapy.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bronchiectasis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a1a3b -->


    <!-- Start of generic pseud question -->
    <div data-role="page" id="bronchi2b1a1a2b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Has your patient been colonised with <i>Pseudomonas aeruginosa</i> on
                <b>previous</b> microbiology? Or do they have known active <i>Pseudomonas aeruginosa</i> infection?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchi2b1a1a2b1a">Yes</a></li>
                <li><a href="#bronchi2b1a1a2b1b">No</a></li>
            </ul>
            <hr />
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /this page -->



    <!-- Start of bronchi with no Penicillin Allergy CHILD mild with PSEUD : #bronchi2b1a1a2b1a -->
    <div data-role="page" id="bronchi2b1a1a2b1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For treatment in a patient with evidence of <i>Pseudomonas aeruginosa</i>
                infection use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ciprofloxacin 20mg/kg &#40;up to 750mg&#41; PO, 12-hourly</span>
                </h4>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ciprofloxacin is:</span>
                <span class="font15 bold"> 10<script> document.write(getCode())</script>bch</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TEN</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past ten days. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Exacerbations of bronchiectasis can be caused by colonising organisms or infection with a new
                    organism. For this reason, a trial of narrower-spectrum antibiotic therapy is recommended despite
                    previous <i>Pseudomonas aeruginosa</i> growth</li>
                <li>Optimise airway clearance, Optimise airway clearance, physical activity and, if appropriate,
                    bronchodilator therapy during exacerbations of bronchiectasis.</li>
                <li>In patients with bronchiectasis, the airways are often colonised with organisms such as
                    <i>Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Pseudomonas
                        aeruginosa</i> and <i>Staphylococcus aureus</i>. Exacerbations of bronchiectasis may be caused
                    by colonising organisms or infection with a new organism, including common respiratory viruses</li>
                <li>Many patients with bronchiectasis easily expectorate sputum. Collect a sputum sample for culture in
                    all patients (including patients managed in the community) before starting antibiotic therapy.</li>
                <li>Ciprofloxacin is not licensed for use in children on the basis of animal studies that showed an
                    adverse effect on cartilage development with quinolone use; however, there are few data from human
                    trials to support this finding. Ciprofloxacin can be used in children when it is the drug of choice.
                </li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bronchiectasis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a2b1a -->


    <!-- Start of bronchi with no Penicillin Allergy CHILD mild NO PSEUD : #bronchi2b1a1a2b1b -->
    <div data-role="page" id="bronchi2b1a1a2b1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For treatment in a patient with no penicillin allergy use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 25 m/kg &#40;up to 1g&#41; PO, 8-hourly for 10-14 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> if patient has previous resistant, or suspected resistant <i>Haemophilus
                        influenzae</i> or <i>Moraxella catarrhalis</i></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+Clavulanic acid 22.5+3.2 mg/kg &#40; up to 875+125
                        mg&#41;&#40;for child 2 months and older&#41; PO, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <ul type="circle" class="line30">
                <li>Exacerbations of bronchiectasis can be caused by colonising organisms or infection with a new
                    organism. For this reason, a trial of narrower-spectrum antibiotic therapy is recommended despite
                    previous <i>Pseudomonas aeruginosa</i> growth</li>
                <li>Optimise airway clearance, Optimise airway clearance, physical activity and, if appropriate,
                    bronchodilator therapy during exacerbations of bronchiectasis.</li>
                <li>In patients with bronchiectasis, the airways are often colonised with organisms such as
                    <i>Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Pseudomonas
                        aeruginosa</i> and <i>Staphylococcus aureus</i>. Exacerbations of bronchiectasis may be caused
                    by colonising organisms or infection with a new organism, including common respiratory viruses</li>
                <li>Many patients with bronchiectasis easily expectorate sputum. Collect a sputum sample for culture in
                    all patients (including patients managed in the community) before starting antibiotic therapy.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bronchiectasis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a2b1b -->


    <!-- Start of generic pseud question -->
    <div data-role="page" id="bronchi2b1a1a2b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Has your patient been colonised with <i>Pseudomonas aeruginosa</i> on
                <b>previous</b> microbiology? Or do they have known active <i>Pseudomonas aeruginosa</i> infection?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchi2b1a1a2b1a">Yes</a></li>
                <li><a href="#bronchi2b1a1a2b2b">No</a></li>
            </ul>
            <hr />
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /this page -->


    <!-- Start of bronchi with moderate or bad Penicillin Allergy CHILD mild disease without PSEUD: #bronchi2b1a1a2b2b -->
    <div data-role="page" id="bronchi2b1a1a2b2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For treatment in a patient with penicillin allergy use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefuroxime 15 mg/kg &#40;up to 500mg&#41;&#40;for child 3 months and
                        older&#41; PO, 12-hourly for 10-14 days</span>
                </h4>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for cefuroxime is:</span>
                <span class="font15 bold"> 10<script> document.write(getCode())</script>bch</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TEN</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past ten days. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Exacerbations of bronchiectasis can be caused by colonising organisms or infection with a new
                    organism. For this reason, a trial of narrower-spectrum antibiotic therapy is recommended despite
                    previous <i>Pseudomonas aeruginosa</i> growth</li>
                <li>Optimise airway clearance, Optimise airway clearance, physical activity and, if appropriate,
                    bronchodilator therapy during exacerbations of bronchiectasis.</li>
                <li>In patients with bronchiectasis, the airways are often colonised with organisms such as
                    <i>Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Pseudomonas
                        aeruginosa</i> and <i>Staphylococcus aureus</i>. Exacerbations of bronchiectasis may be caused
                    by colonising organisms or infection with a new organism, including common respiratory viruses</li>
                <li>Many patients with bronchiectasis easily expectorate sputum. Collect a sputum sample for culture in
                    all patients (including patients managed in the community) before starting antibiotic therapy.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bronchiectasis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a2b2b -->

    <!-- Start of generic pseud question -->
    <div data-role="page" id="bronchi2b1a1a2b3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Has your patient been colonised with <i>Pseudomonas aeruginosa</i> on
                <b>previous</b> microbiology? Or do they have known active <i>Pseudomonas aeruginosa</i> infection?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchi2b1a1a2b1a">Yes</a></li>
                <li><a href="#bronchi2b1a1a2b3b">No</a></li>
            </ul>
            <hr />
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /this page -->

    <!-- Start of bronchi with moderate or bad Penicillin Allergy CHILD mild disease NO PSEUD: #bronchi2b1a1a2b3b -->
    <div data-role="page" id="bronchi2b1a1a2b3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For treatment in a patient with penicillin allergy use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clarithromycin 7.5 mg/kg &#40;up to 500mg&#41; PO, 12-hourly for 10-14
                        days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+sulfamethoxazole 4+20 mg/kg &#40;up to 160+800mg&#41; PO,
                        12-hourly for 10-14 days</span>
                </h4>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for clarithromycin is:</span>
                <span class="font15 bold"> 10<script> document.write(getCode())</script>bch</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TEN</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past ten days. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Exacerbations of bronchiectasis can be caused by colonising organisms or infection with a new
                    organism. For this reason, a trial of narrower-spectrum antibiotic therapy is recommended despite
                    previous <i>Pseudomonas aeruginosa</i> growth</li>
                <li>Optimise airway clearance, Optimise airway clearance, physical activity and, if appropriate,
                    bronchodilator therapy during exacerbations of bronchiectasis.</li>
                <li>In patients with bronchiectasis, the airways are often colonised with organisms such as
                    <i>Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Pseudomonas
                        aeruginosa</i> and <i>Staphylococcus aureus</i>. Exacerbations of bronchiectasis may be caused
                    by colonising organisms or infection with a new organism, including common respiratory viruses</li>
                <li>Many patients with bronchiectasis easily expectorate sputum. Collect a sputum sample for culture in
                    all patients (including patients managed in the community) before starting antibiotic therapy.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bronchiectasis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a2b3b -->


    <!-- Start of generic pseud question -->
    <div data-role="page" id="bronchi2b1a1a2a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Has your patient been colonised with <i>Pseudomonas aeruginosa</i> on
                <b>previous</b> microbiology? Or do they have known active <i>Pseudomonas aeruginosa</i> infection?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchi2b1a1a2a1a">Yes</a></li>
                <li><a href="#bronchi2b1a1a2a1b">No</a></li>
            </ul>
            <hr />
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /this page -->


    <!-- Start of bronchi with no OR MILD Penicillin Allergy CHILD SEVERE DISEASE with pseud: #bronchi2b1a1a2a1a -->
    <div data-role="page" id="bronchi2b1a1a2a1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For treatment in a patient with no penicillin allergy or delayed
                hypersensitivity and active <i>Pseudomonas</i> infection, whilst awaiting culture results use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ceftazidime 50 mg/kg &#40;up to 2
                        g&#41; IV, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Gentamicin dosed as per the nomogram
                        below</span>
                </h4>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftazidime and gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>bch</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Exacerbations of bronchiectasis can be caused by colonising organisms or infection with a new
                    organism. For this reason, a trial of narrower-spectrum antibiotic therapy is recommended despite
                    previous <i>Pseudomonas aeruginosa</i> growth</li>
                <li>Optimise airway clearance, Optimise airway clearance, physical activity and, if appropriate,
                    bronchodilator therapy during exacerbations of bronchiectasis.</li>
                <li>In patients with bronchiectasis, the airways are often colonised with organisms such as
                    <i>Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Pseudomonas
                        aeruginosa</i> and <i>Staphylococcus aureus</i>. Exacerbations of bronchiectasis may be caused
                    by colonising organisms or infection with a new organism, including common respiratory viruses</li>
                <li>Many patients with bronchiectasis easily expectorate sputum. Collect a sputum sample for culture in
                    all patients (including patients managed in the community) before starting antibiotic therapy.</li>
                <li>If resistance to ceftazidime is proven or suspected contact infectious diseases</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b text-center">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12
                years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">

                <li>It is good practice to start gentamicin therapeutic drug monitoring from the first dose if it is
                    expected to be used for more than 72 hours</li>
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
                <li>Wherever possible ensure that 2 x blood cultures are taken prior to administration of antibiotics to
                    allow directed therapy</li>
                <li>Door to needle time must be within <u>ONE HOUR</u> of recognition of septic shock</li>
                <li>Repeat fluid bolus every 15 minutes until patient is normotensive. </li>
                <li>Please contact infectious diseases within 24 hours to rationalise antibiotics once blood culture
                    results return.</li>
                <li>If patient has had a previous reaction to penicillin then contact infectious diseases immediately
                    for treatment advice</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bronchiectasis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a2a1a -->

    <!-- Start of bronchi with no OR MILD Penicillin Allergy CHILD SEVERE DISEASE : #bronchi2b1a1a2a1b -->
    <div data-role="page" id="bronchi2b1a1a2a1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For treatment in a patient with no penicillin allergy or delayed
                hypersensitivity use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin + clavulanate intravenously</span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">child younger than 3 months and less than 4kg: &nbsp;</span>
                                </td>
                                <td><span class="color-purple"> 25 + 5 mg/kg 12-hourly,</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and 4kg or more, or 3 months or
                                        older: &nbsp;</span></td>
                                <td><span class="color-purple"> 25 + 5 mg/kg (up to 1 + 0.2g) 8-hourly</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for IV amoxicillin+clavulanic acid is:</span>
                <span class="font15 bold"> 10<script> document.write(getCode())</script>bch</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TEN</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past ten days. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Exacerbations of bronchiectasis can be caused by colonising organisms or infection with a new
                    organism. For this reason, a trial of narrower-spectrum antibiotic therapy is recommended despite
                    previous <i>Pseudomonas aeruginosa</i> growth</li>
                <li>Optimise airway clearance, Optimise airway clearance, physical activity and, if appropriate,
                    bronchodilator therapy during exacerbations of bronchiectasis.</li>
                <li>In patients with bronchiectasis, the airways are often colonised with organisms such as
                    <i>Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Pseudomonas
                        aeruginosa</i> and <i>Staphylococcus aureus</i>. Exacerbations of bronchiectasis may be caused
                    by colonising organisms or infection with a new organism, including common respiratory viruses</li>
                <li>Many patients with bronchiectasis easily expectorate sputum. Collect a sputum sample for culture in
                    all patients (including patients managed in the community) before starting antibiotic therapy.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bronchiectasis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a2a1b -->

    <!-- Start of generic pseud question -->
    <div data-role="page" id="bronchi2b1a1a2a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Has your patient been colonised with <i>Pseudomonas aeruginosa</i> on
                <b>previous</b> microbiology? Or do they have known active <i>Pseudomonas aeruginosa</i> infection?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchi2b1a1a2a1a">Yes</a></li>
                <li><a href="#bronchi2b1a1a2a2b">No</a></li>
            </ul>
            <hr />
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /this page -->


    <!-- Start of bronchi with no OR MILD Penicillin Allergy CHILD SEVERE DISEASE NO PSEUD : #bronchi2b1a1a2a2b -->
    <div data-role="page" id="bronchi2b1a1a2a2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For treatment in a patient with delayed penicillin hypersensitivity use:
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 50 mg/kg &#40;up to 2 g&#41; IV, daily</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> &#40;if less than 2 months old&#41;</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefotaxime 50 mg/kg &#40;up to 2 g&#41; IV, 8-hourly</span>
                </h4>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone or cefotaxime is:</span>
                <span class="font15 bold"> 10<script> document.write(getCode())</script>bch</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TEN</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past ten days. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Exacerbations of bronchiectasis can be caused by colonising organisms or infection with a new
                    organism. For this reason, a trial of narrower-spectrum antibiotic therapy is recommended despite
                    previous <i>Pseudomonas aeruginosa</i> growth</li>
                <li>Optimise airway clearance, Optimise airway clearance, physical activity and, if appropriate,
                    bronchodilator therapy during exacerbations of bronchiectasis.</li>
                <li>In patients with bronchiectasis, the airways are often colonised with organisms such as
                    <i>Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Pseudomonas
                        aeruginosa</i> and <i>Staphylococcus aureus</i>. Exacerbations of bronchiectasis may be caused
                    by colonising organisms or infection with a new organism, including common respiratory viruses</li>
                <li>Many patients with bronchiectasis easily expectorate sputum. Collect a sputum sample for culture in
                    all patients (including patients managed in the community) before starting antibiotic therapy.</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b text-center">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12
                years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">

                <li>It is good practice to start gentamicin therapeutic drug monitoring from the first dose if it is
                    expected to be used for more than 72 hours</li>
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
                <li>Wherever possible ensure that 2 x blood cultures are taken prior to administration of antibiotics to
                    allow directed therapy</li>
                <li>Door to needle time must be within <u>ONE HOUR</u> of recognition of septic shock</li>
                <li>Repeat fluid bolus every 15 minutes until patient is normotensive. </li>
                <li>Please contact infectious diseases within 24 hours to rationalise antibiotics once blood culture
                    results return.</li>
                <li>If patient has had a previous reaction to penicillin then contact infectious diseases immediately
                    for treatment advice</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bronchiectasis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a2a2 -->

    <!-- Start of generic pseud question -->
    <div data-role="page" id="bronchi2b1a1a2a3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Bronchiectasis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Has your patient been colonised with <i>Pseudomonas aeruginosa</i> on
                <b>previous</b> microbiology? Or do they have known active <i>Pseudomonas aeruginosa</i> infection?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bronchix">Yes</a></li>
                <li><a href="#bronchi2b1a1a2a3b">No</a></li>
            </ul>
            <hr />
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /this page -->

    <!-- Start of bronchi with BAD Penicillin Allergy CHILD SEVERE DISEASE : #bronchi2b1a1a1a3b -->
    <div data-role="page" id="bronchi2b1a1a2a3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For treatment in a patient with immediate penicillin hypersensitivity use:
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Moxifloxacin 10 mg/kg &#40;up to 400 mg&#41; IV, daily</span>
                </h4>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for moxifloxacin is:</span>
                <span class="font15 bold"> 10<script>document.write(getCode())</script>bch</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TEN</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past ten days. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Exacerbations of bronchiectasis can be caused by colonising organisms or infection with a new
                    organism. For this reason, a trial of narrower-spectrum antibiotic therapy is recommended despite
                    previous <i>Pseudomonas aeruginosa</i> growth</li>
                <li>Optimise airway clearance, Optimise airway clearance, physical activity and, if appropriate,
                    bronchodilator therapy during exacerbations of bronchiectasis.</li>
                <li>In patients with bronchiectasis, the airways are often colonised with organisms such as
                    <i>Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Pseudomonas
                        aeruginosa</i> and <i>Staphylococcus aureus</i>. Exacerbations of bronchiectasis may be caused
                    by colonising organisms or infection with a new organism, including common respiratory viruses</li>
                <li>Many patients with bronchiectasis easily expectorate sputum. Collect a sputum sample for culture in
                    all patients (including patients managed in the community) before starting antibiotic therapy.</li>
                <li>Moxifloxacin is not licensed for use in children on the basis of animal studies that showed an
                    adverse effect on cartilage development with quinolone use; however, there are few data from human
                    trials to support this finding. Moxifloxacin can be used in children when it is the drug of choice.
                </li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bronchiectasis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchi2b1a1a2a3b -->

    <!-- Start of bronchi with BAD Penicillin Allergy CHILD SEVERE DISEASE : #bronchi2b1a1a1a3 -->
    <div data-role="page" id="bronchix" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For treatment in a patient with immediate severe penicillin
                hypersensitivity and pseudomonas infection:</h3>
            <div id="backcolour">
                <span class="color-danger bold">Treatment is complex, please contact infectious diseases for
                    advice</span>
            </div>
            <hr />
            <ul type="circle" class="line30">
                <li>Exacerbations of bronchiectasis can be caused by colonising organisms or infection with a new
                    organism. For this reason, a trial of narrower-spectrum antibiotic therapy is recommended despite
                    previous <i>Pseudomonas aeruginosa</i> growth</li>
                <li>Optimise airway clearance, Optimise airway clearance, physical activity and, if appropriate,
                    bronchodilator therapy during exacerbations of bronchiectasis.</li>
                <li>In patients with bronchiectasis, the airways are often colonised with organisms such as
                    <i>Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Pseudomonas
                        aeruginosa</i> and <i>Staphylococcus aureus</i>. Exacerbations of bronchiectasis may be caused
                    by colonising organisms or infection with a new organism, including common respiratory viruses</li>
                <li>Many patients with bronchiectasis easily expectorate sputum. Collect a sputum sample for culture in
                    all patients (including patients managed in the community) before starting antibiotic therapy.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bronchiectasis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bronchix -->

    <!--BRONCHIECTASIS MAZE IS OVER-->


    <!-- IECOPD Maze Begins -->
    <!-- Start of IECOPD page: #iecopd -->
    <div data-role="page" id="iecopd" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Infective Exacerbation of COPD</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Has a nose and/or throat swab for viral (flu, RSV etc) NAAT been
                performed?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#iecopd1">Yes</a></li>
                <li><a href="#iecopd2">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /iecopd -->

    <!-- Start of IECOPD swab performed question 2: #iecopd1 -->
    <div data-role="page" id="iecopd1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Infective Exacerbation of COPD</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Consider influenza treatment with oseltamivir whilst awaiting
                        results</span>
                </h4>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Oseltamivir orally, 12-hourly for 5 days</span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">75 mg </span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 1 year: &nbsp;</span>
                                </td>
                                <td><span class="color-purple"> 3 mg/kg </span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child 1 year or older and 15 to 23 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 45 mg</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child 1 year or older and 23 to 40 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 60 mg</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child 1 year or older and more than 40 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 75 mg</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn20b">Cease if flu reults return not detected</p>
                <hr />
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for oseltamivir is: </span>
                    <span class="font15 bold">5<script>document.write(getCode())</script>flu</span>
                    <div class="font15 mrgn20b text-left">This code is valid for FIVE days only, starting from the first
                        day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to
                        continue past five days. Please annotate this code on the medication chart and document when
                        infectious diseases are to be contacted in the patient notes.
                    </div>
                </h4>
            </div>
            <hr>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#iecopd1a">Proceed to next question</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /iecopd1 -->

    <!-- Start of IECOPD no swab performed question 2: #iecopd2 -->
    <div data-role="page" id="iecopd2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Infective Exacerbation of COPD</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <div id="backcolour">
                <p class="mrgn20b">Please perform a nose and/or throat swab for viral NAAT for respiratory viruses</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Consider influenza treatment with oseltamivir whilst awaiting results</span>
                </h4>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Oseltamivir orally, 12-hourly for 5 days</span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">75 mg </span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 1 year: &nbsp;</span>
                                </td>
                                <td><span class="color-purple"> 3 mg/kg </span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child 1 year or older and 15 to 23 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 45 mg</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child 1 year or older and 23 to 40 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 60 mg</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child 1 year or older and more than 40 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 75 mg</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn20b">Cease if flu reults return not detected</p>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for oseltamivir is: </span>
                <span class="font15 bold">5<script> document.write(getCode())</script>flu</span>
                <div class="font15 mrgn20b text-left">This code is valid for FIVE days only, starting from the first day
                    of treatment for this condition. Infectious diseases must be contacted if IV treatment is to
                    continue past five days. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#iecopd1a">Proceed to next question</a></li>
            </ul>
            <hr />
            <ul type="circle" class="line30">
                <li>Please perform a nose and/or throat swab for viral NAAT for respiratory viruses</li>
                <li>Consider influenza treatment with Tamiflu 75 mg whilst awaiting results</li>
                <li>75 mg oseltamivir orally, 12-hourly for 5 days</li>
                <li>Cease if flu results return not detected</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /iecopd2 -->


    <!-- Start of IECOPD question 2: #iecopd1a -->
    <div data-role="page" id="iecopd1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Infective Exacerbation of COPD</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does your patient have chest X-ray changes consistent with pneumonia?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pneum">Yes &#40;treat as pneumonia&#41;</a></li>
                <li><a href="#iecopd1a1">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /iecopd1a -->

    <!-- Start of IECOPD question 3: #iecopd1a1 -->
    <div data-role="page" id="iecopd1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Infective Exacerbation of COPD</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does your patient have evidence of a bacterial exacerbation? &#40;see
                below&#41;</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#iecopd1a1a">Yes</a></li>
                <li><a href="#iecopdx">No</a></li>
            </ul>
            <hr />
            <ul type="circle" class="line30">
                <li>Consider bacterial as a cause of COPD exacerbation if the patient has all three of three following
                    clinical features:</li>
                <ul type="number" class="line30">
                    <li>increased sputum volume</li>
                    <li>sputum purulence or a change in sputum colour</li>
                    <li>Fever</li>
                </ul>
                <li><b>Do not</b> use antibiotic therapy unless the patient has clinical features suggestive of
                    bacterial infection</li>
                <li><b>Consider witholding antibiotics for patients managed in the community</b></li>
                <li>Sputum cultures are not routinely recommended in IECOPD, Gram-negative bacteria, such as
                    Enterobacteriaceae, are sometimes identified by sputum culture in patients with COPD. These are
                    likely to be colonising organisms, reflecting trhe high levels of antibiotic use and the frequency
                    of hospitalisation in these patients. The pathology of Enterobacteriaceae in axaserbations of COPD
                    is uncertain.</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /iecopd1a1 -->

    <!-- Start of IECOPD bacterial exacerbation: #iecopdx -->
    <div data-role="page" id="iecopdx" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <div data-role="header" class="secondpage">
                <h1>Infective Exacerbation of COPD</h1>
            </div>
            <!-- /header -->
            <h3 class="color-primary mrgn15b">If no evidence of bacterial infection:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple"><b>Antibiotics are not recommended</b></span>
                </h4>
            </div>
            <hr />
            <ul type="circle" class="line30">
                <li>Antibiotics such as amoxicillin+clavulanate, macrolides and cephalosporins are not recommended for
                    initial therapy because they are not more effective than amoxicillin or doxycycline, and they expose
                    the patient to harms from unnecessary broader-spectrum treatment.</li>
                <li>If antibiotics are deemed necessary for another reason, a lack of response to initial antibiotic
                    therapy rarely requires a change to broader-spectrum therapy. Ensure the patient is receiving
                    appropriate inhaled bronchodilator and, where necessary, oral corticosteroid therapy. Viral and
                    noninfective causes of COPD exacerbations are common. Consider other diagnoses such as pneumonia,
                    influenza or heart failure.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cellulitis and erysipelas</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /iecopdx -->


    <!-- Start of IECOPD question 3: #iecopd1a1a -->
    <div data-role="page" id="iecopd1a1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Infective Exacerbation of COPD</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does your patient have severe symptoms or are they requiring ICU or HDU
                support? &#40;see COPD assessment criteria below&#41;</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pneum">Yes &#40;treat as per pneumonia&#41;</a></li>
                <li><a href="#iecopda2a">No</a></li>
            </ul>
            <hr />
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>COPD ASSESSMENT</th>
                        <th>MILD</th>
                        <th>MODERATE</th>
                        <th>SEVERE</th>
                    </tr>
                    <tr>
                        <td><i>Typical Symptoms</i></td>
                        <td>
                            <ul>
                                <li>few symptoms</li>
                                <li>breathless on moderate exertion</li>
                                <li>recurrent chest infections</li>
                                <li>little or not effect on daily activities</li>
                            </ul>
                        </td>
                        <td>
                            <ul>
                                <li>increased dyspnoea</li>
                                <li>breathless walking on level ground</li>
                                <li>increasing limitation of daily activities</li>
                                <li>cough and sputum production</li>
                                <li>exacerbations requiring corticosteroids</li>
                            </ul>
                        </td>
                        <td>
                            <ul>
                                <li>dyspnoea on minimal exertion</li>
                                <li>daily activities severely curtailed</li>
                                <li>experiencing regular sputum production</li>
                                <li>chronic cough</li>
                                <li>exacerbations requiring corticosteroids</li>
                            </ul>
                        </td>
                    </tr>
                    <tr>
                        <td><i>Lung function</i></td>
                        <td>FEV<sub>1</sub> &asymp; 60 to 80% predicted</td>
                        <td>FEV<sub>1</sub> &asymp; 40 to 59% predicted</td>
                        <td>FEV<sub>1</sub> less than 40% predicted</td>
                    </tr>
                </table>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /iecopd1a1a -->

    <!-- Start of  IECOPD question 4 pen allergy: #iecopda2a -->
    <div data-role="page" id="iecopda2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Infective Exacerbation of COPD</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#iecopda2a1">No penicillin allergy</a></li>
                <li><a href="#iecopda2a2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#iecopda2a2">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /iecopda2a -->

    <!-- Start of IECOPD with no Penicillin Allergy ?severity : #iecopda2a1 -->
    <div data-role="page" id="iecopda2a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For treatment in a patient with no penicillin allergy use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Amoxicillin 500 mg orally, 8-hourly
                        for 5 days </span>
                </h4>
                <p class="mrgn60b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Amoxicillin 1 g orally, 12-hourly for
                        5 days </span>
                </h4>
                <p class="mrgn60b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Doxycycline 100 mg, daily for 5
                        days</span>
                </h4>
            </div>
            <hr />
            <ul type="circle" class="line30">
                <li>Other antibiotics such as amoxicillin+clavulanate, macrolides and cephalosporins are not recommended
                    for initial therapy because they are not more effective than amoxicillin or doxycycline, and they
                    expose the patient to harms from unnecessary broader-spectrum treatment.</li>
                <li>Lack of response to initial antibiotic therapy rarely requires a change to broader-spectrum therapy.
                    Ensure the patient is receiving appropriate inhaled bronchodilator and, where necessary, oral
                    corticosteroid therapy. Viral and noninfective causes of COPD exacerbations are common. Consider
                    other diagnoses such as pneumonia, influenza or heart failure.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cellulitis and erysipelas</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /iecopda2a1 -->


    <!-- Start of IECOPD with BAD Penicillin Allergy ?severity : #iecopda2a2 -->
    <div data-role="page" id="iecopda2a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Infective Exacerbation of COPD</h1>
        </div>
        <!-- /header -->
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For treatment in a patient with immediate or delayed non-severe or severe
                penicillin allergy use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 100 mg daily for 5 days </span>
                </h4>
            </div>
            <hr />
            <ul type="circle" class="line30">
                <li>Other antibiotics such as amoxicillin+clavulanate, macrolides and cephalosporins are not recommended
                    for initial therapy because they are not more effective than amoxicillin or doxycycline, and they
                    expose the patient to harms from unnecessary broader-spectrum treatment.</li>
                <li>Lack of response to initial antibiotic therapy rarely requires a change to broader-spectrum therapy.
                    Ensure the patient is receiving appropriate inhaled bronchodilator and, where necessary, oral
                    corticosteroid therapy. Viral and noninfective causes of COPD exacerbations are common. Consider
                    other diagnoses such as pneumonia, influenza or heart failure.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cellulitis and erysipelas</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /iecopda2a2 -->
    <!-- END of IECOPD treatment maze -->

    <!-- Start of INFLU page, Sex NO, PregYES: ?COMPLY #influ -->
    <div data-role="page" id="influ" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Influenza</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient has signs of influenza like illness:</span>
            </h3>
            <h4 class="color-primary">Diagnostic criteria for influenza:</h4>
            <ol type="1">
                <li>Fever &ge; 38&deg;c or definite history of fever, <b>AND</b></li>
                <li>Cough and/or sore throat, in the absence of any other explanation for symptoms</li>
            </ol>
            <br>
            <h4 class="color-primary">Treat with:</h4>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Oseltamivir 75 mg &#40;child dose as per nomogram below&#41; orally,
                        12-hourly</span>
                </h4>
                <p class="mrgn20b">Continue treatment for up to <b>FIVE days</b> or until viral PCR swabs return
                    negative</p>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for oseltamivir is: </span>
                <span class="font15 bold">5<script> document.write(getCode())</script>flu</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FIVE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 5 days. Please annotate this code on the medication chart and document when infectious
                    diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Patients with proven or suspected influenza should be placed in droplet and contact precautions and
                    in a single room if possible. If single room not possible patients should be cohorted in a 2 bed
                    room &#40;&gt;1 metre apart&#41;</li>
                <ul class="circle">
                    <li>Do not cohort undiagnosed influenza with confirmed influenza</li>
                    <li>See the influenza management guideline for further details on infection control measures</li>
                </ul>
                <li>Patients are considered no longer infectious if 24 hours have elapsed since the resolution of fever,
                    provided <u>either</u>:</li>
                <ul class="circle">
                    <li>They have received 72 hours of ant-influenza medication, <b>OR</b></li>
                    <li>7 days have elapsed since onset of respiratory symptoms.</li>
                </ul>
                <li>Patients should be vaccinated prior to discharge. See the influenza management guideline for further
                    details on influenza vaccination</li>
                <li>Cease oseltamivir and remove from droplet precautions if influenza swabs return negative or another
                    respiratory virus is identified</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines</a> for dose adjustments if creatinine clearance is &lt;30 mL/min</li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Oseltamivir dosing in children 1-13 years of age</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Body weight</th>
                        <th>Dosage</th>
                    </tr>
                    <tr>
                        <td>&lt;15Kg</td>
                        <td>30 mg orally twice daily for FIVE days</td>
                    </tr>
                    <tr>
                        <td>15Kg-23Kg</td>
                        <td>45 mg orally twice daily for FIVE days</td>
                    </tr>
                    <tr>
                        <td>23Kg-40kg</td>
                        <td>60 mg orally twice daily for FIVE days</td>
                    </tr>
                    <tr>
                        <td>&gt;40kg</td>
                        <td>75 mg orally twice daily for FIVE days</td>
                    </tr>
                </table>
            </div>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">See
                        the section on Influenza</a> Antibiotic Expert Groups. Therapeutic guidelines: antibiotic.
                    Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.</span>
            </h4>
        </div>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /influenza -->

    <!-- Start of Nursing home pneumonia link page -->
    <div data-role="page" id="nursicap" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Nursing home or aged care facility associated pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For nursing home or aged care facility acquired pneumonia treat as per
                    community acquired pneumonia</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cap1">Continue to Community Acquired Pneumonia Treatment</a></li>
            </ul>
            <hr>
            <ul type="circle" class="line30">
                <li>Community-acquired pneumonia (CAP) mortality is higher in aged-care facility residents than in the
                    general community. This is largely due to comorbidities and advanced age rather than infection with
                    resistant pathogens.</li>
                <li>The spectrum of pathogens identified in aged-care facility residents with pneumonia does not vary
                    greatly from the general community. Streptococcus pneumoniae is the most common pathogen</li>
                <li>Although residents of aged-care facilities are at higher risk of being colonised with
                    multidrug-resistant Gram-negative bacteria such as extended-spectrum beta-lactamase (ESBL)-producing
                    bacteria, these organisms rarely cause CAP</li>
                <li>If sputum samples are taken for Gram stain and culture, interpret with care. The identification of
                    enteric Gram-negative bacilli (eg Klebsiella pneumoniae) in sputum usually reflects colonisation or
                    prior antibiotic use, especially in patients with low- to moderate-severity CAP</li>
                <li>Atypical bacterial pathogens such as Mycoplasma pneumoniae and Chlamydophila (Chlamydia) pneumoniae
                    are uncommon. Therefore, empirical antibiotics for atypical pathogens are not routinely required,
                    but may be considered if atypical bacterial pathogens (especially Legionella species) are suspected
                    on clinical history or risk exposures</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on CAP in residents of aged-care facilities</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /nursicap -->

    <!-- Start of Pneumonias -->
    <!-- Start of pneumonia pages: #pneum -->
    <div data-role="page" id="pneum" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pneumonia</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">What type of pneumonia is suspected?</span>

            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#asp">Aspiration Pneumonia</a></li>
                <li><a href="#cap">Community Acquired Pneumonia</a></li>
                <li><a href="#hap">Hospital Acquired Pneumonia</a></li>
                <li><a href="#tcap">Tropically Acquired Community Acquired Pneumonia</a></li>
            </ul>
            <ul class="line30">
                <li>Hospital-acquired pneumonia &#40;HAP&#41; is pneumonia that develops in a patient who has been
                    hospitalised for longer than 48 hours. Most bacterial HAP occurs by 'microaspiration' of bacteria
                    that colonise the oropharynx or upper gastrointestinal tract. Atypical pathogens &#40;eg
                    Legionella&#41; are much less common in HAP than in community-acquired pneumonia.</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pneum -->

    <div data-role="page" id="asp" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Aspiration pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Has the patient had an aspiration event &#40;ie a clear or witnessed episode
                    of aspiration&#41; <b>AND signs of pneumonia</b> &#40;tachypnoea at rest, tachycardia, persistent
                    fever, rigors, hypoxaemia or crackles on auscultation that do not clear with coughing&#41; &#40;See
                    information table below&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#asp1">Yes</a></li>
                <li><a href="#asp2">No</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Only aspiration pneumonia needs antibiotics &#40;Information taken from
                eTG 2019&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th></th>
                        <th>Definition</th>
                        <th>Is antibiotic therapy required?</th>
                    </tr>
                    <tr>
                        <td>
                            aspiration pneumonitis
                        </td>
                        <td>
                            Acute chemical injury to the lung parenchyma after aspiration of acidic stomach contents.

                            Also known as chemical pneumonitis or Mendelson syndrome.

                            Symptom onset is rapid (usually within hours of aspiration). This is the key difference
                            between aspiration pneumonitis and aspiration pneumonia.

                            Clinical features can be difficult to distinguish from aspiration pneumonia and the chest
                            X-ray can appear similar to pneumonia.

                            Severity ranges from mild symptoms such as cough or wheeze to severe acute respiratory
                            distress syndrome (ARDS).

                            In most patients, symptoms improve quickly (usually within 24 to 48 hours).
                            A bacterial infection caused by aspiration of organisms from the oropharynx.

                            It can also follow aspiration pneumonitis, particularly in patients taking gastric acid
                            suppression therapy or with bowel obstruction.

                            Symptom onset is delayed; this differentiates aspiration pneumonia from aspiration
                            pneumonitis.
                        </td>
                        <td>No. Closely monitor the patient for deterioration.

                            If unable to differentiate between aspiration pneumonitis and aspiration pneumonia, start
                            antibiotic therapy and review within 24 to 48 hours (see Initial management of aspiration
                            pneumonia). Consider stopping antibiotic therapy if the patient has significantly improved
                            and aspiration pneumonitis is a more likely diagnosis.
                        </td>
                    </tr>
                </table>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /asp -->

    <div data-role="page" id="asp1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Aspiration pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Treat the patient as:</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cap">Community Acquired Pneumonia</a></li>
                <li><a href="#hap">Hospital Acquired Pneumonia</a></li>
            </ul>
            <hr>
            <h3 class="mrgn20b">
                <span class="color-primary">Has the patient shown improvement on empirical CAP or HAP therapy at 48
                    hours?</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#capnochange">Yes</a></li>
                <li><a href="#asp1b">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /asp1 -->

    <!-- Start of CAP no change -->
    <div data-role="page" id="capnochange" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>
        <div data-role="header" class="secondpage">
            <h1>Pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient is improving on the current regimen:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Continue with the same regimen, there is no need to change
                        antibiotics</span>
                </h4>
            </div>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Aspiration Pneumonia</a> section for more information
                    on treatment of aspiration pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a1b -->


    <div data-role="page" id="asp2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Aspiration pneumonia treatment</h1>
        </div>
        <br>
        <!-- /header -->
        <div class="container-fluid">
            <h4 class="color-danger mrgn15b">
                No antibiotics required. Monitor closely </h4>
        </div>
        <hr>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /asp2 -->

    <div data-role="page" id="asp1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Aspiration pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#asp1a1">No penicillin allergy</a></li>
                <li><a href="#asp1a2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#asp1a3">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /asp1a -->

    <div data-role="page" id="asp1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Aspiration pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Has the patient been on amoxicillin+clavulanate, clindamycin, lincomycin,
                    meropenem, moxifloxacin or piperacillin+tazobactam (single doses do not count).</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#asp1b1">Yes</a></li>
                <li><a href="#asp1b2">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /asp1b -->

    <div data-role="page" id="asp1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Aspiration pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Consider the addition of anaerobic cover</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#asp1a">Click here to continue</a></li>
            </ul>
        </div>

        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /asp1b -->

    <div data-role="page" id="asp1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Aspiration pneumonia treatment</h1>
        </div>
        <br>
        <!-- /header -->
        <div class="container-fluid">
            <h4 class="color-danger mrgn15b">Please contact infectious diseases for advice</h4>
        </div>
        <hr>
        <ul class="line30">
            <li>The duration of therapy for aspiration pneumonia is guided by the setting (eg hospital- or
                community-acquired pneumonia).
                <ul>
                    <li>For community-acquired aspiration pneumonia, the total duration of therapy is 5 to 7 days
                        (intravenous + oral). If the patient has significantly improved after 2 to 3 days of antibiotic
                        therapy, treat for 5 days. If the clinical response is slow, treat for 7 days.</li>
                    <li>For hospital-acquired aspiration pneumonia, 7 days of therapy (intravenous + oral) is generally
                        adequate.</li>
                    <li>Patients with lung abscess, empyema or large parapneumonic effusion complicating aspiration
                        pneumonia require a longer duration of therapy — see <a href="#empara">Parapneumonic effusion
                            and empyema</a>.</li>
            </li>
            <li>If the patient is not improving and susceptibility results are not available, seek expert advice.</li>
            <li>Initial therapy for aspiration pneumonia is the same as empirical therapy for CAP or HAP, which treats
                most pathogens aspirated from the oropharynx, including oral anaerobes. If the response to empirical
                therapy is inadequate at 48 hours, reassess the diagnosis before adjusting the antibiotic regimen.</li>
            <li>In rare cases, pneumonia following aspiration may be due to specific anaerobes such as Bacteroides or
                Prevotella species that are not adequately treated with some empirical regimens for CAP or HAP. These
                pathogens are more likely in a patient who has severe periodontal disease or putrid sputum. Pneumonia
                involving anaerobic pathogens can be necrotising or cavitary, and the infection may progress to lung
                abscess or parapneumonic effusion and empyema. Assess the patient for these complications.</li>
            <li>Antibiotic regimens for CAP and HAP in these guidelines that include amoxicillin+clavulanate,
                clindamycin, lincomycin, meropenem, moxifloxacin or piperacillin+tazobactam are effective against a
                broader range of oral anaerobes that cause pneumonia, including Bacteroides or Prevotella species. If
                the patient is taking one of these drugs and the response is inadequate after 48 hours, seek expert
                advice.</li>
        </ul>
        <hr>
        <h4 class="mrgn20b references">
            <span class="color-purple"><b>References: </b></span><br><br>
            <span class="font15"><a
                    href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                    target="_blank">See section on aspiration pneumonia</a> - Antibiotic Expert Groups. Therapeutic
                guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
        </h4>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /asp1b1 -->

    <div data-role="page" id="asp1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Aspiration pneumonia</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Aspiration pneumonia treatment with no penicillin allergy:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 1g child: 25 mg/kg up to 1 g) orally or enterally,
                        8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally, 12 hourly
                    </span>
                </h4>
            </div>
            <hr>
            <ul class="line30">
                <li>The duration of therapy for aspiration pneumonia is guided by the setting (eg hospital- or
                    community-acquired pneumonia).
                    <ul>
                        <li>For community-acquired aspiration pneumonia, the total duration of therapy is 5 to 7 days
                            (intravenous + oral). If the patient has significantly improved after 2 to 3 days of
                            antibiotic therapy, treat for 5 days. If the clinical response is slow, treat for 7 days.
                        </li>
                        <li>For hospital-acquired aspiration pneumonia, 7 days of therapy (intravenous + oral) is
                            generally adequate.</li>
                        <li>Patients with lung abscess, empyema or large parapneumonic effusion complicating aspiration
                            pneumonia require a longer duration of therapy — see <a href="#empara">Parapneumonic
                                effusion and empyema</a>.</li>
                </li>
                <li>If the patient is not improving and susceptibility results are not available, seek expert advice.
                </li>
                <li>Initial therapy for aspiration pneumonia is the same as empirical therapy for CAP or HAP, which
                    treats most pathogens aspirated from the oropharynx, including oral anaerobes. If the response to
                    empirical therapy is inadequate at 48 hours, reassess the diagnosis before adjusting the antibiotic
                    regimen.</li>
                <li>In rare cases, pneumonia following aspiration may be due to specific anaerobes such as Bacteroides
                    or Prevotella species that are not adequately treated with some empirical regimens for CAP or HAP.
                    These pathogens are more likely in a patient who has severe periodontal disease or putrid sputum.
                    Pneumonia involving anaerobic pathogens can be necrotising or cavitary, and the infection may
                    progress to lung abscess or parapneumonic effusion and empyema. Assess the patient for these
                    complications.</li>
                <li>Antibiotic regimens for CAP and HAP in these guidelines that include amoxicillin+clavulanate,
                    clindamycin, lincomycin, meropenem, moxifloxacin or piperacillin+tazobactam are effective against a
                    broader range of oral anaerobes that cause pneumonia, including Bacteroides or Prevotella species.
                    If the patient is taking one of these drugs and the response is inadequate after 48 hours, seek
                    expert advice.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on aspiration pneumonia</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
            <!-- /content -->
            <div class="footer">
                <a href="index.html" class="btn btn-lg btn-success"><span
                        class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
    </div>
    <!-- /asp1a1 -->

    <div data-role="page" id="asp1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Aspiration pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For aspiration pneumonia treatment with immediate non-severe or delayed
                    non-severe penicillin allergy give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 450 mg (child: 10 mg/kg up to 450 mg) orally or enterally,
                        8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> If IV antibiotics are required replace the above with:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 1g (child 1 month or older: 50 mg/kg up to 1 g) IV daily
                    </span>
                    <p class="mrgn20b"><b>PLUS</b></p>
                    <span class="color-purple">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously,
                        12-hourly</span>
                </h4>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for clindamycin orally and ceftriaxone IV is:</span>
                <span class="font15 bold"> 7<script> document.write(getCode())</script>asp</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only. Starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted within 48 hours.
                    Please annotate this code on the medication chart and document when infectious diseases are to be
                    contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>The duration of therapy for aspiration pneumonia is guided by the setting (eg hospital- or
                    community-acquired pneumonia).
                    <ul>
                        <li>For community-acquired aspiration pneumonia, the total duration of therapy is 5 to 7 days
                            (intravenous + oral). If the patient has significantly improved after 2 to 3 days of
                            antibiotic therapy, treat for 5 days. If the clinical response is slow, treat for 7 days.
                        </li>
                        <li>For hospital-acquired aspiration pneumonia, 7 days of therapy (intravenous + oral) is
                            generally adequate.</li>
                        <li>Patients with lung abscess, empyema or large parapneumonic effusion complicating aspiration
                            pneumonia require a longer duration of therapy — see <a href="#empara">Parapneumonic
                                effusion and empyema</a>.</li>
                </li>
                <li>If the patient is not improving and susceptibility results are not available, seek expert advice.
                </li>
                <li>Initial therapy for aspiration pneumonia is the same as empirical therapy for CAP or HAP, which
                    treats most pathogens aspirated from the oropharynx, including oral anaerobes. If the response to
                    empirical therapy is inadequate at 48 hours, reassess the diagnosis before adjusting the antibiotic
                    regimen.</li>
                <li>In rare cases, pneumonia following aspiration may be due to specific anaerobes such as Bacteroides
                    or Prevotella species that are not adequately treated with some empirical regimens for CAP or HAP.
                    These pathogens are more likely in a patient who has severe periodontal disease or putrid sputum.
                    Pneumonia involving anaerobic pathogens can be necrotising or cavitary, and the infection may
                    progress to lung abscess or parapneumonic effusion and empyema. Assess the patient for these
                    complications.</li>
                <li>Antibiotic regimens for CAP and HAP in these guidelines that include amoxicillin+clavulanate,
                    clindamycin, lincomycin, meropenem, moxifloxacin or piperacillin+tazobactam are effective against a
                    broader range of oral anaerobes that cause pneumonia, including Bacteroides or Prevotella species.
                    If the patient is taking one of these drugs and the response is inadequate after 48 hours, seek
                    expert advice.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on aspiration pneumonia</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /asp1a2 -->

    <div data-role="page" id="asp1a3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Aspiration pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Aspiration pneumonia treatment in a patient with immediate or delayed severe
                    penicillin allergy:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600 mg (child: 15 mg/kg up to 600 mg) intravenously,
                        8-hourly</span>
                </h4>
            </div>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for clindamycin IV is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>asp</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only. Starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted within 48 hours.
                    Please annotate this code on the medication chart and document when infectious diseases are to be
                    contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>The duration of therapy for aspiration pneumonia is guided by the setting (eg hospital- or
                    community-acquired pneumonia).
                    <ul>
                        <li>For community-acquired aspiration pneumonia, the total duration of therapy is 5 to 7 days
                            (intravenous + oral). If the patient has significantly improved after 2 to 3 days of
                            antibiotic therapy, treat for 5 days. If the clinical response is slow, treat for 7 days.
                        </li>
                        <li>For hospital-acquired aspiration pneumonia, 7 days of therapy (intravenous + oral) is
                            generally adequate.</li>
                        <li>Patients with lung abscess, empyema or large parapneumonic effusion complicating aspiration
                            pneumonia require a longer duration of therapy — see <a href="#empara">Parapneumonic
                                effusion and empyema</a>.</li>
                </li>
                <li>If the patient is not improving and susceptibility results are not available, seek expert advice.
                </li>
                <li>Initial therapy for aspiration pneumonia is the same as empirical therapy for CAP or HAP, which
                    treats most pathogens aspirated from the oropharynx, including oral anaerobes. If the response to
                    empirical therapy is inadequate at 48 hours, reassess the diagnosis before adjusting the antibiotic
                    regimen.</li>
                <li>In rare cases, pneumonia following aspiration may be due to specific anaerobes such as Bacteroides
                    or Prevotella species that are not adequately treated with some empirical regimens for CAP or HAP.
                    These pathogens are more likely in a patient who has severe periodontal disease or putrid sputum.
                    Pneumonia involving anaerobic pathogens can be necrotising or cavitary, and the infection may
                    progress to lung abscess or parapneumonic effusion and empyema. Assess the patient for these
                    complications.</li>
                <li>Antibiotic regimens for CAP and HAP in these guidelines that include amoxicillin+clavulanate,
                    clindamycin, lincomycin, meropenem, moxifloxacin or piperacillin+tazobactam are effective against a
                    broader range of oral anaerobes that cause pneumonia, including Bacteroides or Prevotella species.
                    If the patient is taking one of these drugs and the response is inadequate after 48 hours, seek
                    expert advice.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on aspiration pneumonia</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /asp1a3 -->

    <!-- start of Community acquired PNEUMONIA treatment maze -->
    <!-- Start of cap page/ ?age: #cap -->
    <div data-role="page" id="cap" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired Pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">How old is the patient?</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cap1">&gt; 15 years of age</a></li>
                <li><a href="#cap3a">5 to 15 years old</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap -->

    <!-- Start of CAP page/ old: #cap1 -->
    <div data-role="page" id="cap1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>SMARTCOP:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">What is the patients SMARTCOP score?</span>
            </h3>
            <script>
                var calcsmartcopo = function () {
                    var resulto = 0;
                    var smartCopAge = 0;
                    smartCopAge = parseInt($('#smrtCopAge option:selected').val());
                    //alert("Please cmartcopage is "+smartCopAge)
                    if (smartCopAge === 50) {
                        console.log(smartCopAge);
                        //console.log('updating value');
                        //console.log($('#systolic').val());
                        var resulto = 0;
                        if (parseInt($('#systolico').val()) < 90) {
                            resulto += 2;
                        }
                        if (parseInt($('#albumino').val()) < 35) {
                            resulto += 1;
                        }
                        if (parseInt($('#respo').val()) > 29) {
                            resulto += 1;
                        }
                        if (parseInt($('#tacho').val()) > 124) {
                            resulto += 1;
                        }
                        if (parseInt($('#oxyo').val() * 100) < 9010) {
                            resulto += 2;
                        }
                        if (parseInt($('#artero').val() * 100) < 735) {
                            resulto += 2;
                        }
                        //console.log($('#multilobaro option:selected').val());
                        resulto += parseInt($('#multilobaro option:selected').val());
                        $('#smartcopresulto').text(resulto);
                        //console.log($('#confusiono option:selected').val());
                        resulto += parseInt($('#confusiono option:selected').val());
                        $('#smartcopresulto').text(resulto);
                    }
                    else if (smartCopAge === 49) {
                        console.log(smartCopAge);
                        //console.log('updating value');
                        //console.log($('#systolic').val());
                        var resulto = 0;
                        if (parseInt($('#systolico').val()) < 90) {
                            resulto += 2;
                        }
                        if (parseInt($('#albumino').val()) < 35) {
                            resulto += 1;
                        }
                        if (parseInt($('#respo').val()) > 24) {
                            resulto += 1;
                        }
                        if (parseInt($('#tacho').val()) > 124) {
                            resulto += 1;
                        }
                        if (parseInt($('#oxyo').val() * 100) < 9310) {
                            resulto += 2;
                        }
                        if (parseInt($('#artero').val() * 100) < 735) {
                            resulto += 2;
                        }
                        //console.log($('#multilobary option:selected').val());
                        resulto += parseInt($('#multilobaro option:selected').val());
                        $('#smartcopresulto').text(resulto);
                        //console.log($('#confusiony option:selected').val());
                        resulto += parseInt($('#confusiono option:selected').val());
                        $('#smartcopresulto').text(resulto);
                    }
                    $('#smartcopresulto').text(resulto);
                }
            </script>
            <form onsubmit="return false">
                <h4 class="color-primary mrgn20b">Enter the patient age and obs to calculate a <b>SMARTCOP</b> score or
                    scroll down to skip this step</h4>
                <hr />
                <div class="form-group">
                    <label for="smrtCopAge">How old is the patient?:</label>
                    <select name="smrtCopAge" id="smrtCopAge" class="form-control">
                        <option value="49">50 years old or less</option>
                        <option value="50">More than 50 years old</option>
                    </select>
                </div>
                <div class="form-group"><label for="systolic"><b>S</b>ystolic BP:</label><input type="number" min="10"
                        id="systolico" name="systolico" class="form-control"></div>
                <div class="form-group">
                    <label for="multilobaro"><b>M</b>ultilobar chest involvement?:</label>
                    <select name="multilobaro" id="multilobaro" class="form-control">
                        <option value="0">No</option>
                        <option value="1">Yes</option>
                    </select>
                </div>
                <div class="form-group"><label for="albumino"><b>A</b>lbumin:</label><input type="number" min="0"
                        id="albumino" name="albumino" class="form-control"></div>
                <div class="form-group"><label for="respo"><b>R</b>espiratory rate (RPM):</label><input type="number"
                        min="0" id="respo" name="respo" class="form-control"></div>
                <div class="form-group"><label for="tacho"><b>T</b>achyardia? - Heart rate (BPM):</label><input
                        type="number" min="0" id="tacho" name="tacho" class="form-control"></div>
                <div class="form-group">
                    <label for="confusiono"><b>C</b>onfusion? (new onset):</label>
                    <select name="confusiono" id="confusiono" class="form-control">
                        <option value="0">No</option>
                        <option value="1">Yes</option>
                    </select>
                </div>
                <div class="form-group"><label for="oxyo"><b>O</b>xygen saturation(%):</label><input type="number"
                        step="0.1" min="0" id="oxyo" name="oxyo" value="99" class="form-control" /></div>
                <div class="form-group"><label for="artero"><b>P</b>h &#40;arterial pH, this value can be left blank if
                        unknown&#41;:</label><input type="number" step="0.01" min="0" id="artero" name="artero"
                        value="7.4" onchange="calcsmartcopo();" class="form-control" /></div>
                <button onclick="calcsmartcopo();" class="btn btn-primary">Calculate Smartcop</button>
                <p class="color-primary mrgn20b"><b>SMARTCOP SCORE: </b><strong><span
                            id="smartcopresulto">0</span></strong></p>
            </form>
            <hr />
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cap1a">Continue to treatment</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>If blood lactate concentration is more than 2 mmol/L consider treating as per severe pneumonia
                    protocol</li>
            </ul>
        </div>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1 -->

    <!-- Start of cap page/ ?severity: #cap1a -->
    <div data-role="page" id="cap1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired Pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">How severe is the pneumonia?</span>

            </h3>
            <h4 class="medicine mrgn20b">
                <span class="color-purple">Grade severity based on both clinical impression and SMARTCOP score:</span>

            </h4>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cap1a1">Mild (smartcop &lt;3)</a></li>
                <li><a href="#cap1a2">Moderate (smartcop 3-4)</a></li>
                <li><a href="#cap1a3">Severe (smartcop &ge;5)</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>If clinical impression from a medical consultant is that the pneumonia is severe it should always be
                    treated as severe regardless of the SMARTCOP score</li>
                <li>Any patient which meets the criteria for severe sepsis (see infectious diseases severe sepsis
                    protocol for details) or any patients accepted into ICU or transferred to ICU should be treated as
                    severe (ICU)</li>
            </ul>
        </div>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a -->

    <!-- Start of cap page: mild ?pen all #cap1a1 -->
    <div data-role="page" id="cap1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired Pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cap1a1c2">No penicillin allergy</a></li>
                <li><a href="#cap1a1a1">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#cap1a1b">Penicillin anaphylaxis</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a1 -->

    <!-- Start of cap page: Moderate ?pen all #cap1a2 -->
    <div data-role="page" id="cap1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired Pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cap1a2c2a">No penicillin allergy</a></li>
                <li><a href="#cap1a2a1a1">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#cap1a2b1a1">Penicillin anaphylaxis</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2 -->

    <!-- Start of cap page: sev ?pen all #cap1a3 -->
    <div data-role="page" id="cap1a3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired Pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cap1a3c2a">No penicillin allergy</a></li>
                <li><a href="#cap1a3c2a">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#cap1a3b2">Penicillin anaphylaxis</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a3 -->

    <!-- Start of cap page: MILD pen OK Melioid NO #cap1a1c2 -->
    <div data-role="page" id="cap1a1c2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired Pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient likely to require atypical cover?</span>
                <span class="font15"> (See below for a summary of when to consider atypical cover)</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cap1a1c1a">Yes</a></li>
                <li><a href="#cap1a1c1b">No</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent
                    headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues &#40;contact with
                    known cases of “atypical” pneumonia, or if there is a current outbreak&#41;</li>
                <li>For more information on pneumonia in your area please see your local pneumonia guideline on the
                    intranet</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a1c2-->

    <!--TREATMENTS FOR CAP BEGIN-->
    <!-- Start of CAP Sev MILD, Pen MILD, Melioid YES, atypicals YES, : #cap1a1a1 -->
    <div data-role="page" id="cap1a1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired pneumonia:</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Mild community acquired pneumonia should be treated as an outpatient with
                    oral antibiotic therapy where possible:</span>
            </h3>
            <h4 class="medicine mrgn20b">
                <span class="color-purple">Doxycycline 100mg orally,</span>
                <span class="font15"> every 12 hours for 5-7 days</span>
            </h4>
            <p class="mrgn20b"><b>Empirical monotherpay is preffered unless there is a risk that follow up at 48 hours
                    will not occur. If so, please see eTG for combination empirical therapy recommendations</b></p>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in your area please see your local pneumonia guideline on the
                    intranet</li>
                <li>It is important to use oral agents or a penicillin rather than ceftriaxone where appropriate, as
                    overuse of third-generation cephalosporins within a hospital has been shown to lead to an increased
                    incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li>
                <li>If the patient has already been treated with doxycycline and monotherapy has failed, contact
                    infectious diseases. Combination treatment with cefuroxime or an alternative agent may be warranted
                </li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a1a1a -->

    <!-- Start of CAP Sev MILD, Pen BAD, Melioid YES, atypicals YES, : #cap1a1b -->
    <div data-role="page" id="cap1a1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>
        <div data-role="header" class="secondpage">
            <h1>Community Acquired pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Mild community acquired pneumonia should be treated as an outpatient with
                    oral antibiotic therapy where possible:</span>

            </h3>
            <h4 class="medicine mrgn20b">
                <span class="color-purple">Doxycycline 100mg orally,</span>
                <span class="font15"> every 12 hours for 5-7 days</span>
            </h4>
            <p class="mrgn20b"><b>Empirical monotherpay is preffered unless there is a risk that follow up at 48 hours
                    will not occur. If so, please see eTG for combination empirical therapy recommendations</b></p>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in your area please see your local pneumonia guideline on the
                    intranet</li>
                <li>If compliance with oral antibiotics is unlikely then consider treating as for moderate pneumonia
                </li>
                <li>It is important to use oral agents or a penicillin rather than ceftriaxone where appropriate, as
                    overuse of third-generation cephalosporins within a hospital has been shown to lead to an increased
                    incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li>
                <li>If the patient has already been treated with doxycycline and monotherapy has failed, contact
                    infectious diseases. Combination treatment with cefuroxime or an alternative agent may be warranted
                </li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a1b -->

    <!-- Start of CAP Sev MILD, Pen MILD, Melioid YES, atypicals YES, : #cap1a1c1a -->
    <div data-role="page" id="cap1a1c1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Mild community acquired pneumonia should be treated as an outpatient with
                    oral antibiotic therapy where possible:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 100mg orally,</span>
                    <span class="font15"> every 12 hours for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 1g orally,</span>
                    <span class="font15"> every 8 hours for 5-7 days</span>
                </h4>
            </div>
            <p class="mrgn20b"><b>Empirical monotherpay is preffered unless there is a risk that follow up at 48 hours
                    will not occur. If so, please see eTG for combination empirical therapy recommendations</b></p>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in your area please see your local pneumonia guideline on the
                    intranet</li>
                <li>It is important to use oral agents or a penicillin rather than ceftriaxone where appropriate, as
                    overuse of third-generation cephalosporins within a hospital has been shown to lead to an increased
                    incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a1c1a -->

    <!-- Start of CAP Sev MILD, Pen OK, Melioid YES, atypicals NO, : #cap1a1c1b -->
    <div data-role="page" id="cap1a1c1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired pneumonia:</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Mild community acquired pneumonia should be treated as an outpatient with
                    oral antibiotic therapy where possible:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 1g orally, every 8 hours for 5-7 days</span>
                </h4>
            </div>
            <p class="mrgn20b"><b>Empirical monotherpay is preffered unless there is a risk that follow up at 48 hours
                    will not occur. If so, please see eTG for combination empirical therapy recommendations</b></p>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in your area please see your local pneumonia guideline on the
                    intranet</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a1c1b -->

    <!-- Start of CAP Sev MOD, Pen MILD, Melioid YES, atypicals YES, GENT BAD : #cap1a2a1a1 -->
    <div data-role="page" id="cap1a2a1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired pneumonia:</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Community acquired pneumonia treatment:</span>

            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 100mg orally, every 12 hours for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 1g IV, daily until results of cultures available or patient
                        meets switch to oral criteria &#40;usually 2-3 days&#41;</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>THREE</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past 72 hours. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in your area please see your local pneumonia guideline on the
                    intranet</li>
                <li>It is important to use oral agents or a penicillin rather than ceftriaxone as soon as appropriate,
                    as overuse of third-generation cephalosporins within a hospital has been shown to lead to an
                    increased incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA
                </li>
                <li>Please see the switch to oral guideline on the intranet for details on when the patient can qualify
                    for the IV to oral switch</li>
                <li>Ensure blood cultures, sputum gram stain and cultures are sent to pathology for testing. Please see
                    your local pneumonia guideline on the intranet for a full list of all relevant tests required</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2a1a1 -->

    <!-- Start of CAP Severe, Pen MILD or NONE, atypicals YES: #cap1a3c2a -->
    <div data-role="page" id="cap1a3c2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community acquired pneumonia:</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Community acquired pneumonia treatment:</span>

            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Azithromycin 500mg IV,</span>
                    <span class="font15"> daily</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 1g IV, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> if rapid progression to sepsis, or gram-positive cocci in clusters on gram
                    stain, consider adding:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, with a 25-30 mg/kg loading dose, then dosed as per
                        nomogram below &#40;until culture results return&#41; or use the <a href="#dose6">vancomycin
                            empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone and azithromycin iv is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>THREE</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past 72 hours. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past 48 hours. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <hr>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in your area please see your local pneumonia guideline on the
                    intranet</li>
                <li>It is important to use oral agents or a penicillin rather than ceftriaxone as soon as appropriate,
                    as overuse of third-generation cephalosporins within a hospital has been shown to lead to an
                    increased incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA
                </li>
                <li>Please see the switch to oral guideline on the intranet for details on when the patient can qualify
                    for the IV to oral switch</li>
                <li>Ensure blood cultures, sputum gram stain and cultures are sent to pathology for testing. Please see
                    your local pneumonia guideline on the intranet for a full list of all relevant tests required</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a3c2a -->

    <!-- Start of CAP Sev MOD, Pen BAD, atypicals YES, GENT BAD : #cap1a2b1a1 -->
    <div data-role="page" id="cap1a2b1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Community acquired pneumonia treatment:</span>

            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Moxifloxacin 400mg orally, daily for 5-7 days</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for moxifloxacin orally is:</span>
                <span class="font15 bold"> 7<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>SEVEN</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past one week. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in your area please see your local pneumonia guideline on the
                    intranet</li>
                <li>Please see the switch to oral guideline on the intranet for details on when the patient can qualify
                    for the IV to oral switch</li>
                <li>Ensure blood cultures, sputum gram stain and cultures are sent to pathology for testing. Please see
                    your local pneumonia guideline on the intranet for a full list of all relevant tests required</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2b1a1 -->

    <!-- Start of CAP Sev MOD, Pen OK, Melioid NO, atypicals YES,: #cap1a2c2a -->
    <div data-role="page" id="cap1a2c2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Community acquired pneumonia treatment:</span>

            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 100mg orally, every 12 hours for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Benzylpenicillin 1.2g IV, every 6 hours until results of cultures
                        available or patient meets switch to oral criteria (usually 2-3 days)</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in your area please see your local pneumonia guideline on the
                    intranet</li>
                <li>Please see the switch to oral guideline on the intranet for details on when the patient can qualify
                    for the IV to oral switch</li>
                <li>Ensure blood cultures, sputum gram stain and cultures are sent to pathology for testing. Please see
                    your local pneumonia guideline on the intranet for a full list of all relevant tests required</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2c2a -->

    <!-- Start of CAP Sev MOD, Pen OK, Melioid NO, atypicals YES,: #cap1a2a1b1 -->
    <div data-role="page" id="cap1a2a1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Community acquired pneumonia treatment:</span>

            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Benzylpenicillin 1.2g IV, 6 hourly until results of cultures available or
                        patient meets criteria to switch to Amoxicillin 1g, 8 hourly &#40;usually after 2-3
                        days&#41;</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in your area please see your local pneumonia guideline on the
                    intranet</li>
                <li>Please see the switch to oral guideline on the intranet for details on when the patient can qualify
                    for the IV to oral switch</li>
                <li>Ensure blood cultures, sputum gram stain and cultures are sent to pathology for testing. Please see
                    your local pneumonia guideline on the intranet for a full list of all relevant tests required</li>
                <li>It is important to use oral agents or a penicillin rather than ceftriaxone where appropriate, as
                    overuse of third-generation cephalosporins within a hospital has been shown to lead to an increased
                    incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2a1b1 -->

    <!-- Start of CAP Sev MOD, Pen BAD: #cap1a3b2 -->
    <div data-role="page" id="cap1a3b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Community acquired pneumonia treatment:</span>

            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Moxifloxacin 400mg IV, daily until clinical features have improved then
                        switch to oral</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> if rapid progression to sepsis, or gram-positive cocci in clusters on gram
                    stain, consider adding:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, with a 25-30 mg/kg loading dose, then dosed as per
                        nomogram below &#40;until culture results return&#41; or use the <a href="#dose6">vancomycin
                            empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for moxifloxacin iv is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>THREE</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past 72 hours. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past 48 hours. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <hr>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in your area please see your local pneumonia guideline on the
                    intranet</li>
                <li>Ensure blood cultures, sputum gram stain and cultures are sent to pathology for testing. Please see
                    your local pneumonia guideline on the intranet for a full list of all relevant tests required</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a3b2 -->

    <!--START CAP KIDS SECTION-->
    <!-- Start of cap page/ ?severity: #cap3a -->
    <div data-role="page" id="cap3a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired Pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">How severe is the pneumonia?</span>

            </h3>
            <h4 class="medicine mrgn20b">
                <span class="color-purple">Grade severity based on clinical impression:</span>

            </h4>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cap3a1">Mild to Moderate</a></li>
                <li><a href="#cap3a2">Severe</a></li>
                <li><a href="#cap3a3">Severe (ICU)</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Any patient which meets the criteria for severe sepsis (see infectious diseases severe sepsis
                    protocol for details) or any patients accepted into ICU or transferred to ICU should be treated as
                    "Severe (ICU)"</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap3a -->

    <!-- Start of cap page: mild-mod ?pen all #cap3a1 -->
    <div data-role="page" id="cap3a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired Pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cap3a1c">No penicillin allergy</a></li>
                <li><a href="#cap3a1a">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#cap3a1a1">Penicillin anaphylaxis</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or
                    DRESS immediately after administration of a penicillin</li>
                <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin.
                    In most cases it is safe to administer a cephalosporin to a patient who has had a non-life
                    threatening reaction to penicillin</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap3a1 -->

    <!-- Start of cap page: Severe ?pen all #cap3a2 -->
    <div data-role="page" id="cap3a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired Pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cap3a2c">No penicillin allergy</a></li>
                <li><a href="#cap3a2a">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#cap3a2b">Penicillin anaphylaxis</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or
                    DRESS immediately after administration of a penicillin</li>
                <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin.
                    In most cases it is safe to administer a cephalosporin to a patient who has had a non-life
                    threatening reaction to penicillin</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap3a2 -->

    <!-- Start of cap page: sev (ICU) ?pen all #cap3a3 -->
    <div data-role="page" id="cap3a3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired Pneumonia:</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cap3a3c">No penicillin allergy</a></li>
                <li><a href="#cap3a3a1">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#cap3a3a1">Penicillin anaphylaxis</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or
                    DRESS immediately after administration of a penicillin</li>
                <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin.
                    In most cases it is safe to administer a cephalosporin to a patient who has had a non-life
                    threatening reaction to penicillin</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap3a3 -->

    <!-- Start of cap page: mild pen mild ?mycoplasma #cap3a1a -->
    <div data-role="page" id="cap3a1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired Pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is <i>Mycoplasma pneumoniae</i> infection suspected?</span>
                <span class="font15"> (See below for a summary of <i>Mycoplasma pneumoniae</i> clinical features)</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cap3a1a1">Yes</a></li>
                <li><a href="#cap3a1a2">No</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li><i>Mycoplasma</i> or other atypical cover should be considered if the patient has a prodrome of &gt;
                    1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                    &#40;contact with known cases of “atypical” pneumonia, or if there is a current outbreak&#41;</li>
                <li>Clinical features of <i>Mycoplasma pneumoniae</i> infection include: concurrent pharyngitis,
                    rhinorrhea and ear pain.</li>
                <li>Skin rash, joint involvement or symptoms indicative of gastrointestinal tract, CNS or heart disease,
                    can also indicate <i>Mycoplasma pneumoniae</i> infection.</li>
                <li><i>Mycoplasma pneumoniae</i> infection may worsen asthma symptoms and can produce wheezing in
                    children who do not have asthma</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap3a1a -->

    <!-- Start of cap page: mild pen OK ?mycoplasma #cap3a1b -->
    <div data-role="page" id="cap3a1c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired Pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is <i>Mycoplasma pneumoniae</i> infection suspected?</span>
                <span class="font15"> (See below for a summary of <i>Mycoplasma pneumoniae</i> clinical features)</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cap3a1a1">Yes</a></li>
                <li><a href="#cap3a1c2">No</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li><i>Mycoplasma</i> or other atypical cover should be considered if the patient has a prodrome of &gt;
                    1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                    &#40;contact with known cases of “atypical” pneumonia, or if there is a current outbreak&#41;</li>
                <li>Clinical features of <i>Mycoplasma pneumoniae</i> infection include: concurrent pharyngitis,
                    rhinorrhea and ear pain.</li>
                <li>Skin rash, joint involvement or symptoms indicative of gastrointestinal tract, CNS or heart disease,
                    can also indicate <i>Mycoplasma pneumoniae</i> infection.</li>
                <li><i>Mycoplasma pneumoniae</i> infection may worsen asthma symptoms and can produce wheezing in
                    children who do not have asthma</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap3a1c -->

    <!-- Start of cap page: Severe pen MILD ?mycoplasma #cap3a2a -->
    <div data-role="page" id="cap3a2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired Pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is <i>Mycoplasma pneumoniae</i> infection suspected?</span>
                <span class="font15"> (See below for a summary of <i>Mycoplasma pneumoniae</i> clinical features)</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cap3a2a1">Yes</a></li>
                <li><a href="#cap3a2a2">No</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li><i>Mycoplasma</i> or other atypical cover should be considered if the patient has a prodrome of &gt;
                    1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                    &#40;contact with known cases of “atypical” pneumonia, or if there is a current outbreak&#41;</li>
                <li>Clinical features of <i>Mycoplasma pneumoniae</i> infection include: concurrent pharyngitis,
                    rhinorrhea and ear pain.</li>
                <li>Skin rash, joint involvement or symptoms indicative of gastrointestinal tract, CNS or heart disease,
                    can also indicate <i>Mycoplasma pneumoniae</i> infection.</li>
                <li><i>Mycoplasma pneumoniae</i> infection may worsen asthma symptoms and can produce wheezing in
                    children who do not have asthma</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap3a2a -->
    <!-- Start of cap page: Severe pen BAD ?mycoplasma #cap3a2b -->
    <div data-role="page" id="cap3a2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired Pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is <i>Mycoplasma pneumoniae</i> infection suspected?</span>
                <span class="font15"> (See below for a summary of <i>Mycoplasma pneumoniae</i> clinical features)</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cap3a2b1">Yes</a></li>
                <li><a href="#cap3a2b2">No</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li><i>Mycoplasma</i> or other atypical cover should be considered if the patient has a prodrome of &gt;
                    1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                    &#40;contact with known cases of “atypical” pneumonia, or if there is a current outbreak&#41;</li>
                <li>Clinical features of <i>Mycoplasma pneumoniae</i> infection include: concurrent pharyngitis,
                    rhinorrhea and ear pain.</li>
                <li>Skin rash, joint involvement or symptoms indicative of gastrointestinal tract, CNS or heart disease,
                    can also indicate <i>Mycoplasma pneumoniae</i> infection.</li>
                <li><i>Mycoplasma pneumoniae</i> infection may worsen asthma symptoms and can produce wheezing in
                    children who do not have asthma</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap3a2b -->

    <!-- Start of cap page: Severe pen OK ?mycoplasma #cap3a2c -->
    <div data-role="page" id="cap3a2c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired Pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is <i>Mycoplasma pneumoniae</i> infection suspected?</span>
                <span class="font15"> (See below for a summary of <i>Mycoplasma pneumoniae</i> clinical features)</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cap3a2a1">Yes</a></li>
                <li><a href="#cap3a2a2">No</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li><i>Mycoplasma</i> or other atypical cover should be considered if the patient has a prodrome of &gt;
                    1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                    &#40;contact with known cases of “atypical” pneumonia, or if there is a current outbreak&#41;</li>
                <li>Clinical features of <i>Mycoplasma pneumoniae</i> infection include: concurrent pharyngitis,
                    rhinorrhea and ear pain.</li>
                <li>Skin rash, joint involvement or symptoms indicative of gastrointestinal tract, CNS or heart disease,
                    can also indicate <i>Mycoplasma pneumoniae</i> infection.</li>
                <li><i>Mycoplasma pneumoniae</i> infection may worsen asthma symptoms and can produce wheezing in
                    children who do not have asthma</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap3a2c -->

    <!--TREATMENTS FOR CAP BEGIN-->
    <!-- Start of CAP Sev MILD, Pen MILD, mycoplasma YES, : #cap3a1a1 -->
    <div data-role="page" id="cap3a1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Mild community acquired pneumonia should be treated with oral antibiotic
                    therapy where possible:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline (child 8 years or older) 2 mg/kg up to 100 mg orally, 12
                        hourly for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b> if child is younger than 8 years or doxycycline not tolerated</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Azithromycin 10mg/Kg up to 500 mg orally, daily for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b> if patient is not tolerating oral medications</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Azithromycin 10mg/Kg up to 500 mg IV, daily for 1-3 days then switch to
                        oral</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for azithromycin orally is:</span>
                <span class="font15 bold"> 5<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>FIVE</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past five days. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for azithromycin iv is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past 48 hours. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. infectious diseases
                must be contacted if IV treatment is to continue past 48 hours</div>
            <hr />
            <ul class="line30">
                <li>It is important to use oral agents rather than ceftriaxone or cefotaxime whenever appropriate, as
                    overuse of third-generation cephalosporins within a hospital has been shown to lead to an increased
                    incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://pch.health.wa.gov.au/For-health-professionals/Childrens-Antimicrobial-Management-Program/Guidelines"
                        target="_blank">See the CHAMP guidelines</a> - See local protocol for community acquired
                    pneumonia in the CHAMP guidelines</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap3a1a1a -->

    <!-- Start of CAP Sev MILD, Pen MILD, mycoplasma NO, : #cap3a1a2 -->
    <div data-role="page" id="cap3a1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Mild community acquired pneumonia should be treated with oral antibiotic
                    therapy where possible:</span>

            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Azithromycin 10mg/Kg up to 500 mg orally, daily for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b> if patient is not tolerating oral medications</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Azithromycin 10mg/Kg up to 500 mg IV, daily for 1-3 days then switch to
                        oral</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for azithromycin orally is:</span>
                <span class="font15 bold"> 5<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>FIVE</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past five days. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for azithromycin iv is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past 48 hours. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. infectious diseases
                must be contacted if IV treatment is to continue past 48 hours</div>
            <hr />
            <ul class="line30">
                <li>It is important to use oral agents rather than ceftriaxone or cefotaxime as soon as appropriate, as
                    overuse of third-generation cephalosporins within a hospital has been shown to lead to an increased
                    incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://pch.health.wa.gov.au/For-health-professionals/Childrens-Antimicrobial-Management-Program/Guidelines"
                        target="_blank">See the CHAMP guidelines</a> - See local protocol for community acquired
                    pneumonia in the CHAMP guidelines</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap3a1a1a -->

    <!-- Start of CAP Sev MILD, Pen OK, mycoplasma NO, : #cap3a1c2 -->
    <div data-role="page" id="cap3a1c2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>
        <div data-role="header" class="secondpage">
            <h1>Community Acquired pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Mild community acquired pneumonia should be treated with oral antibiotic
                    therapy where possible. Use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 25 mg/kg up to 1 g orally, 8 hourly for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b> if patient is not tolerating oral medications use:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Benzylpenicillin 50 mg/kg up to 1 g IV, 6 hourly for 1-3 days then switch
                        to oral</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>Please see the switch to oral guideline on the intranet for details on when to best make the IV to
                    oral switch</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://pch.health.wa.gov.au/For-health-professionals/Childrens-Antimicrobial-Management-Program/Guidelines"
                        target="_blank">See the CHAMP guidelines</a> - See local protocol for community acquired
                    pneumonia in the CHAMP guidelines</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap3a1c2 -->

    <!-- Start of CAP Sev SEVERE, Pen MILD, mycoplasma YES #cap3a2a1 -->
    <div data-role="page" id="cap3a2a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For severe community acquired pneumonia in a patient with non-life
                    threatening penicillin allergy empirically treat with:</span>

            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Azithromycin 10mg/Kg up to 500 mg IV, daily until patient can switch to
                        oral</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 50 mg/kg up to 1 g IV, daily until patient can switch to
                        oral</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for azithromycin iv and ceftriaxone is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past 48 hours. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Please see the switch to oral guideline on the intranet for details on when the patient can qualify
                    for the IV to oral switch</li>
                <li>Ensure blood cultures, sputum gram stain and cultures and mycoplasma serology are sent to pathology
                    for testing.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://pch.health.wa.gov.au/For-health-professionals/Childrens-Antimicrobial-Management-Program/Guidelines"
                        target="_blank">See the CHAMP guidelines</a> - See local protocol for community acquired
                    pneumonia in the CHAMP guidelines</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap3a2a1 -->

    <!-- Start of CAP SEVERE, Pen MILD, Mycoplasma NO : #cap3a2a2 -->
    <div data-role="page" id="cap3a2a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Severe community acquired pneumonia in a patient with non-life threatening
                    penicillin allergy should be treated with:</span>

            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 50 mg/kg up to 1 g IV, daily until patient can switch to
                        oral</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past 48 hours. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Please see the switch to oral guideline on the intranet for details on when the patient can qualify
                    for the IV to oral switch</li>
                <li>Ensure blood cultures, sputum gram stain and cultures and mycoplasma serology are sent to pathology
                    for testing.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://pch.health.wa.gov.au/For-health-professionals/Childrens-Antimicrobial-Management-Program/Guidelines"
                        target="_blank">See the CHAMP guidelines</a> - See local protocol for community acquired
                    pneumonia in the CHAMP guidelines</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap3a2a2 -->

    <!-- Start of CAP SEVERE, Pen BAD, Mycoplasma NO : #cap3a2b2 -->
    <div data-role="page" id="cap3a2b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Severe community acquired pneumonia in a patient with life threatening
                    penicillin allergy should be treated with:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per the nomogram below or use the <a
                            href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>THREE</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past 72 hours. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15mg/kg</td>
                        <td>18 hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15mg/kg</td>
                        <td>12 hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15mg/kg</td>
                        <td class="bluebackcolour">12 hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15mg/kg</td>
                        <td class="bluebackcolour">8 hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15mg/kg</td>
                        <td>12 hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15mg/kg</td>
                        <td>8 hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15mg/kg up to 750mg</td>
                        <td class="bluebackcolour">6 hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmentstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>

                </ul>
            </div>
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to
                    administration of antibiotics (where possible) for targeted therapy</li>
                <li>Please see the switch to oral guideline on the intranet for details on when the patient can qualify
                    for the IV to oral switch</li>
                <li>Ensure blood cultures, sputum gram stain and cultures and mycoplasma serology are sent to pathology
                    for testing.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://pch.health.wa.gov.au/For-health-professionals/Childrens-Antimicrobial-Management-Program/Guidelines"
                        target="_blank">See the CHAMP guidelines</a> - See local protocol for community acquired
                    pneumonia in the CHAMP guidelines</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap3a2b2 -->

    <!-- Start of CAP SEVERE, Pen BAD, Mycoplasma YES : #cap3a2b1 -->
    <div data-role="page" id="cap3a2b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Severe community acquired pneumonia in a patient with life threatening
                    penicillin allergy should be treated with:</span>

            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per the nomogram below or use the <a
                            href="#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND,</b> to cover <i>Mycoplasma</i>:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Azithromycin 10mg/Kg up to 500 mg IV, daily until patient can switch to
                        oral</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for azithromycin iv and vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past 48 hours. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15mg/kg</td>
                        <td>18 hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15mg/kg</td>
                        <td>12 hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15mg/kg</td>
                        <td class="bluebackcolour">12 hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15mg/kg</td>
                        <td class="bluebackcolour">8 hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15mg/kg</td>
                        <td>12 hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15mg/kg</td>
                        <td>8 hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15mg/kg up to 750mg</td>
                        <td class="bluebackcolour">6 hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmentstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>

                </ul>
            </div>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to
                    administration of antibiotics (where possible) for targeted therapy</li>
                <li>Please see the switch to oral guideline on the intranet for details on when the patient can qualify
                    for the IV to oral switch</li>
                <li>Ensure blood cultures, sputum gram stain and cultures and mycoplasma serology are sent to pathology
                    for testing.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://pch.health.wa.gov.au/For-health-professionals/Childrens-Antimicrobial-Management-Program/Guidelines"
                        target="_blank">See the CHAMP guidelines</a> - See local protocol for community acquired
                    pneumonia in the CHAMP guidelines</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap3a2b1 -->

    <!-- Start of CAP Sev ICU, Wet YES : #cap3a3a1 -->
    <div data-role="page" id="cap3a3a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Severe community acquired pneumonia for ICU admission:</span>

            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Meropenem 25mg/Kg up to 1g IV, every 8 hours</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Azithromycin 10mg/Kg up to 500mg IV, daily</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, dosed as per nomogram below or use the <a
                            href="#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin, meropenem and azithromycin iv is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past 48 hours. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <hr>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15mg/kg</td>
                        <td>18 hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15mg/kg</td>
                        <td>12 hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15mg/kg</td>
                        <td class="bluebackcolour">12 hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15mg/kg</td>
                        <td class="bluebackcolour">8 hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15mg/kg</td>
                        <td>12 hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15mg/kg</td>
                        <td>8 hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15mg/kg up to 750mg</td>
                        <td class="bluebackcolour">6 hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmentstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a
                            href="https://pch.health.wa.gov.au/For-health-professionals/Childrens-Antimicrobial-Management-Program/Guidelines"
                            target="_blank">See the CHAMP guidelines</a> - See local protocol for community acquired
                        pneumonia in the CHAMP guidelines</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>Switch to oral therapy when systemic features have improved (see switch to oral guideline on the
                    intranet for details)</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap3a3a1 -->

    <!-- Start of CAP Sev ICU, Wet NO : #cap3a3c2 -->
    <div data-role="page" id="cap3a3c2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>

        <div data-role="header" class="secondpage">
            <h1>Community Acquired pneumonia:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Severe community acquired pneumonia for ICU admission:</span>

            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Piperacillin/tazobactam 100mg/Kg up to 4g (based on piperacillin
                        component only) IV, every 6 hours</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Azithromycin 15mg/Kg up to 500mg IV, daily</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, dosed as per nomogram below or use the <a
                            href="#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for piperacillin, azithromycin iv and vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past 48 hours. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15mg/kg</td>
                        <td>18 hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15mg/kg</td>
                        <td>12 hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15mg/kg</td>
                        <td class="bluebackcolour">12 hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15mg/kg</td>
                        <td class="bluebackcolour">8 hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15mg/kg</td>
                        <td>12 hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15mg/kg</td>
                        <td>8 hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15mg/kg up to 750mg</td>
                        <td class="bluebackcolour">6 hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmentstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>

                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a
                            href="https://pch.health.wa.gov.au/For-health-professionals/Childrens-Antimicrobial-Management-Program/Guidelines"
                            target="_blank">See the CHAMP guidelines</a> - See local protocol for community acquired
                        pneumonia in the CHAMP guidelines</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>Switch to oral therapy when systemic features have improved (see switch to oral guideline on the
                    intranet for details)</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap3a3c2 -->
    <!--END CAP KIDS SECTION-->


    <!-- START of HAP treatment maze -->
    <!-- Start of HAP page: #hap -->
    <div data-role="page" id="hap" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Hospital acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <br>
        <div data-role="content" class="container-fluid">
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Hospital Acquired Pneumonia</th>
                    </tr>
                    <tr>
                        <td><b>Hospital-acquired pneumonia (HAP)</b> is pneumonia that develops in a patient who has
                            been hospitalised in acute care for longer than 48 hours. Prolonged rest and low inspiratory
                            volume (eg due to pain), which are common in hospitalised patients, can lead to basal
                            atelectasis, which predisposes the patient to pneumonia.</td>
                    </tr>
                </table>
            </div>
            <h3 class="mrgn20b">
                <span class="color-primary">How severe is the hospital acquired pneumonia?</span>
                <span class="font15"> &#40;Please see below for details on how to diagnose high severity HAP&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#hap1a">Low to moderate severity</a></li>
                <li><a href="#hap1b">High severity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">HAP severity assessment</h4>
            <span class="font15">The criteria for diagnosing high-severity HAP are not well defined. Any patient with
                any of the following features should be considered as having high-severity HAP</span>
            <ul class="line30">
                <li>septic shock</li>
                <li>respiratory failure, particularly if requiring mechanical ventilation</li>
                <li>rapid progression of infiltrates on chest X-ray</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap -->

    <!-- Start of low severity: penicillin Q? #hap1a -->
    <div data-role="page" id="hap1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Hospital acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#hap1a1">No penicillin allergy</a></li>
                <li><a href="#hap1a2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#hap1a3">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr>
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="backcolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="backcolour2">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="backcolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap1a -->

    <!-- Start of HAP, SEVERE (BOTH), Penicillin Q? #hap1b -->
    <div data-role="page" id="hap1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Hospital acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#hap1b1">No penicillin allergy</a></li>
                <li><a href="#hap1b2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#hap1b3a">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap1b -->
    <!-- Start of hap, SEVERE, no pen allergy: ?Sepsis #hap1b1 -->
    <div data-role="page" id="hap1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Hospital acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have signs of septic shock?</span>
                <span class="font15"> &#40;See below&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#hap1b1a">Yes</a></li>
                <li><a href="#hap1b1b">No</a></li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Signs of Sepsis:</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>SIRS response: &ge;2 of:</th>
                        <th>AND presence of refractory hypotension or hypoperfusion</th>
                    </tr>
                    <tr>
                        <td>
                            <p>Temp &lt;36 <b>or</b> &gt;38</p>
                            <p>Heart rate &gt; 90</p>
                            <p>Resp Rate &gt; 20</p>
                            <p>WCC &gt; 12.0 <b>or</b> &lt; 4.0</p>
                        </td>
                        <td>
                            <p align="left"><b>Hypotension:</b></p>
                            <ul type=circle>
                                <li>systolic BP&lt; 90 mmHg <b>OR</b> 40 mmHg below premorbid BP <b> AFTER</b> at least
                                    500 mL fluid challenge.</li>
                            </ul>
                            <p align="left"><b>Hypoperfusion:</b></p>
                            <ul type=circle>
                                <li>Lactate &ge;4 mmol/L <b>OR</b> Bicarbonate &lt;16mmol/L</li>
                            </ul>
                        </td>
                    </tr>
                </table>
            </div>
            <ul class="line30">
                <li>See the management of severe sepsis section in the Australian Therapeutic Guidelines for more
                    information on identifying a septic patient</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap1b1 -->

    <!-- Start of hap, SEVERE, mild pen allergy: ?Sepsis #hap1b1 -->
    <div data-role="page" id="hap1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Hospital acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have signs of septic shock?</span>
                <span class="font15"> &#40;See below&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#hap1b2a">Yes</a></li>
                <li><a href="#hap1b2b">No</a></li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Signs of Sepsis:</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>SIRS response: &ge;2 of:</th>
                        <th>AND presence of refractory hypotension or hypoperfusion</th>
                    </tr>
                    <tr>
                        <td>
                            <p>Temp &lt;36 <b>or</b> &gt;38</p>
                            <p>Heart rate &gt; 90</p>
                            <p>Resp Rate &gt; 20</p>
                            <p>WCC &gt; 12.0 <b>or</b> &lt; 4.0</p>
                        </td>
                        <td>
                            <p align="left"><b>Hypotension:</b></p>
                            <ul type=circle>
                                <li>systolic BP&lt; 90 mmHg <b>OR</b> 40 mmHg below premorbid BP <b> AFTER</b> at least
                                    500 mL fluid challenge.</li>
                            </ul>
                            <p align="left"><b>Hypoperfusion:</b></p>
                            <ul type=circle>
                                <li>Lactate &ge;4 mmol/L <b>OR</b> Bicarbonate &lt;16mmol/L</li>
                            </ul>
                        </td>
                    </tr>
                </table>
            </div>
            <ul class="line30">
                <li>See the management of severe sepsis section in the Australian Therapeutic Guidelines for more
                    information on identifying a septic patient</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap1b2 -->

    <!-- Start of hap Tx severe, no pen allergy, sepsis N: #hap1b1b -->
    <div data-role="page" id="hap1b1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>HAP treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has no penicillin allergy, as a single agent use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Piperacillin+tazobactam 4+0.5 g &#40;child: 100+12.5 mg/kg up to 4+0.5
                        g&#41; IV, 6-hourly.</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for piperacillin+tazobactam is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>THREE</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if IV treatment is to continue past 72 hours.
                    Please annotate this code on the medication chart and document when infectious diseases are to be
                    contacted in the patient notes.
                </div>
            </h4>
            <hr>
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible,
                    expectorated sputum for cultures before antibiotics are given</li>
                <li>Consider stopping antibiotic treatment after 48 to 72 hours when patients are improving and
                    culture-negative, if an alternative diagnosis is likely. Otherwise, if pneumonia is the likely
                    diagnosis, and the patient has clinically improved, and no MDR pathogens are isolated from cultures
                    by 48 to 72 hours, consider de-escalating antibiotic therapy</li>
                <li>The usual total duration of therapy is 7 days (intravenous plus oral). Patients with lung abscess,
                    empyema or large parapneumonic effusion require a longer duration of therapy</li>
                <li>Azithromycin is not required for empirical treatment of HAP or VAP unless Legionella pneumonia is
                    strongly suspected based on clinical presentation and/or risk factors. Infection with Legionella is
                    very uncommon in this setting.</li>
                <li>In overweight patients gentamicin should be dosed on ideal body weight or adjusted body weight, not
                    actual body weight</li>
            </ul>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on hospital acquired pneumonia</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap1b1b -->


    <!-- Start of hap Tx severe, no pen allergy, sepsis Y: #hap1b1a -->
    <div data-role="page" id="hap1b1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>HAP treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has no penicillin allergy and signs of sepsis use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Piperacillin+tazobactam 4+0.5 g &#40;child: 100+12.5 mg/kg up to 4+0.5
                        g&#41; IV, 6-hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin 4 to 7 mg/kg &#40;child: 7.5 mg/kg up to 320 mg&#41; IV, for
                        the first dose, then dose as per nomograms below or use the <a href="#dose12">gentamicin empiric
                            dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, with a loading dose of 25-30 mg/kg, then dosed as per the
                        nomograms below or use the <a href="#dose6">vancomycin empiric dose calculator for
                            adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for piperacillin+tazobactam is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>THREE</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if IV treatment is to continue past 72 hours.
                    Please annotate this code on the medication chart and document when infectious diseases are to be
                    contacted in the patient notes.
                </div>
            </h4>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin and gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible,
                    expectorated sputum for cultures before antibiotics are given</li>
                <li>Consider stopping antibiotic treatment after 48 to 72 hours when patients are improving and
                    culture-negative, if an alternative diagnosis is likely. Otherwise, if pneumonia is the likely
                    diagnosis, and the patient has clinically improved, and no MDR pathogens are isolated from cultures
                    by 48 to 72 hours, consider de-escalating antibiotic therapy</li>
                <li>The usual total duration of therapy is 7 days (intravenous plus oral). Patients with lung abscess,
                    empyema or large parapneumonic effusion require a longer duration of therapy</li>
                <li>Azithromycin is not required for empirical treatment of HAP or VAP unless Legionella pneumonia is
                    strongly suspected based on clinical presentation and/or risk factors. Infection with Legionella is
                    very uncommon in this setting.</li>
                <li>In overweight patients gentamicin should be dosed on ideal body weight or adjusted body weight, not
                    actual body weight</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td>1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td>1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td>2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td>2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td>3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>---</td>
                    </tr>
                    <tr>
                        <td>Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                        <td>48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td>Before the 3<sup>rd</sup> dose</td>
                        <td>Before the <br />4<sup>th</sup> dose</td>
                        <td>---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul class="line30">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>

                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>

                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing Age &gt; 12 Years</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>

                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on hospital acquired pneumonia</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap1b1a -->






    <!-- Start of hap Tx severe, mild pen allergy, sepsis Y: #hap1b2a -->
    <div data-role="page" id="hap1b2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>HAP treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has mild penicillin allergy and signs of sepsis use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefepime 2 g &#40;child: 50 mg/kg up to 2 g &#41; IV, 8-hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin 4 to 7 mg/kg &#40;child: 7.5 mg/kg up to 320 mg&#41; IV, for
                        the first dose, then dose as per nomograms below or use the <a href="#dose12">gentamicin empiric
                            dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per nomograms below or use the <a
                            href="#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for cefepime is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>THREE</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if IV treatment is to continue past 72 hours.
                    Please annotate this code on the medication chart and document when infectious diseases are to be
                    contacted in the patient notes.
                </div>
            </h4>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin and gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible,
                    expectorated sputum for cultures before antibiotics are given</li>
                <li>Consider stopping antibiotic treatment after 48 to 72 hours when patients are improving and
                    culture-negative, if an alternative diagnosis is likely. Otherwise, if pneumonia is the likely
                    diagnosis, and the patient has clinically improved, and no MDR pathogens are isolated from cultures
                    by 48 to 72 hours, consider de-escalating antibiotic therapy</li>
                <li>The usual total duration of therapy is 7 days (intravenous plus oral). Patients with lung abscess,
                    empyema or large parapneumonic effusion require a longer duration of therapy</li>
                <li>Azithromycin is not required for empirical treatment of HAP or VAP unless Legionella pneumonia is
                    strongly suspected based on clinical presentation and/or risk factors. Infection with Legionella is
                    very uncommon in this setting.</li>
                <li>In overweight patients gentamicin should be dosed on ideal body weight or adjusted body weight, not
                    actual body weight</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td>1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td>1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td>2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td>2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td>3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>---</td>
                    </tr>
                    <tr>
                        <td>Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                        <td>48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td>Before the 3<sup>rd</sup> dose</td>
                        <td>Before the <br />4<sup>th</sup> dose</td>
                        <td>---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul class="line30">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>

                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>

                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing Age &gt; 12 Years</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>

                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on hospital acquired pneumonia</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap1b2a -->



    <!-- Start of hap Tx severe, mild pen allergy, sepsis N: #hap1b2b -->
    <div data-role="page" id="hap1b2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>HAP treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has no penicillin allergy, as a single agent use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefepime 2 g &#40;child: 50 mg/kg up to 2 g &#41; IV, 8-hourly.</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for cefepime is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>THREE</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if IV treatment is to continue past 72 hours.
                    Please annotate this code on the medication chart and document when infectious diseases are to be
                    contacted in the patient notes.
                </div>
            </h4>
            <hr>
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible,
                    expectorated sputum for cultures before antibiotics are given</li>
                <li>Consider stopping antibiotic treatment after 48 to 72 hours when patients are improving and
                    culture-negative, if an alternative diagnosis is likely. Otherwise, if pneumonia is the likely
                    diagnosis, and the patient has clinically improved, and no MDR pathogens are isolated from cultures
                    by 48 to 72 hours, consider de-escalating antibiotic therapy</li>
                <li>The usual total duration of therapy is 7 days (intravenous plus oral). Patients with lung abscess,
                    empyema or large parapneumonic effusion require a longer duration of therapy</li>
                <li>Azithromycin is not required for empirical treatment of HAP or VAP unless Legionella pneumonia is
                    strongly suspected based on clinical presentation and/or risk factors. Infection with Legionella is
                    very uncommon in this setting.</li>
                <li>In overweight patients gentamicin should be dosed on ideal body weight or adjusted body weight, not
                    actual body weight</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">See
                        section on hospital acquired pneumonia</a> - Antibiotic Expert Groups. Therapeutic guidelines:
                    antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap1b2b -->

    <!-- Start of hap Tx severe, bad pen allergy, sepsis Y: #hap1b3a -->
    <div data-role="page" id="hap1b3a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>HAP treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has severe penicillin allergy use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ciprofloxacin 400 mg &#40;child: 10
                        mg/kg up to 400 mg &#41; IV, 8-hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Vancomycin IV, with a 25-30 mg/kg
                        loading dose then as per nomograms below or use the <a href="#dose6">vancomycin empiric dose
                            calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>OR</b> &#40;as a single drug&#41;</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Meropenem 1 g &#40;child: 20 mg/kg up
                        to 1 g&#41; IV, 8-hourly.</span><span class="color-danger"> Give cautiously in a critical care
                        area and monitor for reaction</span>
                </h4>
                <p class="mrgn20b"><b>NB</b> If the meropenem regimen is used, if staphylococcal pneumonia is suspected
                    or patient is severely septic then consider adding vancomycin as with ciprofloxacin above.</p>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ciprofloxacin iv and meropenem is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>THREE</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if IV treatment is to continue past 72 hours.
                    Please annotate this code on the medication chart and document when infectious diseases are to be
                    contacted in the patient notes.
                </div>
            </h4>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>If the patient only has a single IV line it is important to give the other antibiotics before
                    vancomycin as it has the longest infusion time</li>
                <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible,
                    expectorated sputum for cultures before antibiotics are given</li>
                <li>The usual total duration of therapy is 7 days (intravenous plus oral). Patients with lung abscess,
                    empyema or large parapneumonic effusion require a longer duration of therapy</li>
                <li>Azithromycin is not required for empirical treatment of HAP or VAP unless Legionella pneumonia is
                    strongly suspected based on clinical presentation and/or risk factors. Infection with Legionella is
                    very uncommon in this setting.</li>
                <li>In overweight patients gentamicin should be dosed on ideal body weight or adjusted body weight, not
                    actual body weight</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td>1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td>1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td>2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td>2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td>3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>---</td>
                    </tr>
                    <tr>
                        <td>Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                        <td>48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td>Before the 3<sup>rd</sup> dose</td>
                        <td>Before the <br />4<sup>th</sup> dose</td>
                        <td>---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul class="line30">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>

                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>

                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing Age &gt; 12 Years</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>

                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on hospital acquired pneumonia</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap1b3a -->



    <!-- Start of hap Tx MILD, PEN OK: #hap1a1 -->
    <div data-role="page" id="hap1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>HAP treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient tolerates penicillin use as a single agent:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple"> Amoxicillin+clavulanate 875+125 mg &#40;child: 22.5+3.2 mg/kg up to
                        875+125 mg&#41; orally or enterally, 12-hourly for 8 days.</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> If patient is not tolerating oral or enteral medications</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17"><span class="color-purple"> Amoxicillin + clavulanate
                            intravenously</span></span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">1 + 0.2 g 8-hourly, </span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and less than 4kg: &nbsp;</span>
                                </td>
                                <td><span class="color-purple"> 25 + 5 mg/kg 12-hourly,</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and 4kg or more, or 3 months or
                                        older: &nbsp;</span></td>
                                <td><span class="color-purple"> 25 + 5 mg/kg (up to 1 + 0.2g) 8-hourly</span></td>
                            </tr>
                        </table>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for Amoxicillin IV & Clavulanate is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Broader anaerobic cover is not normally required for mild hospital acquired pneumonia</li>
                <li>The usual total duration of therapy is 7 days (intravenous plus oral). Patients with lung abscess,
                    empyema or large parapneumonic effusion require a longer duration of therapy</li>
                <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible,
                    expectorated sputum for cultures before antibiotics are given</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on hospital acquired pneumonia</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap1a1 -->


    <!-- Start of hap Tx MILD, PEN MILD: #hap1a2 -->
    <div data-role="page" id="hap1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>HAP treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has immediate nonsevere or delayed nonsevere penicillin allergy
                    use as a single agent:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefuroxime 500 mg &#40;child: 15 mg/kg up to 500 mg&#41; orally or
                        enterally, 12-hourly for 7 days.</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> If patient is not tolerating oral or enteral medications</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 1 g &#40;child 1 month or older: 50 mg/kg up to 1 g&#41; IV,
                        daily until patient tolerating oral medications</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for cefuroxime is:</span>
                <span class="font15 bold"> 7<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 7 days. Please annotate this code on the medication chart and document when infectious
                    diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Broader anaerobic cover is not normally required for mild hospital acquired pneumonia</li>
                <li>The usual total duration of therapy is 7 days (intravenous plus oral). Patients with lung abscess,
                    empyema or large parapneumonic effusion require a longer duration of therapy</li>
                <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible,
                    expectorated sputum for cultures before antibiotics are given</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on hospital acquired pneumonia</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap1a2 -->


    <!-- Start of hap Tx MILD, PEN BAD: #hap1a3 -->
    <div data-role="page" id="hap1a3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>HAP treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has severe penicillin allergy use as a single agent:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Moxifloxacin 400 mg &#40;child: 10 mg/kg up to 400 mg&#41; orally or
                        enterally, 24-hourly for 7 days.</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> If patient is not tolerating oral or enteral medications</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Moxifloxacin 400 mg &#40;child: 10 mg/kg up to 400 mg&#41; IV, daily
                        until patient tolerating oral medications.</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for moxifloxacin orally is:</span>
                <span class="font15 bold"> 7<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 7 days. Please annotate this code on the medication chart and document when infectious
                    diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for moxifloxacin iv is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Broader anaerobic cover is not normally required for mild hospital acquired pneumonia</li>
                <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible,
                    expectorated sputum for cultures before antibiotics are given</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on hospital acquired pneumonia</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap1a3 -->

    <!-- Start of hap Tx MDR NO, MODER/SEVERE, PEN BAD, : #hap1b3 -->
    <div data-role="page" id="hap1b3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>HAP treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient is an adult immediately hypersensitive to penicillin (life
                    threatening reaction) use:</span>
            </h3>
            <hr>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Moxifloxacin 400 mg orally or
                        enterally, daily for 8 days.</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> If patient is not tolerating oral or enteral medications</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Moxifloxacin 400 mg IV, daily for 8
                        days or until tolerating oral antibiotics</span>
                </h4>
            </div>
            <h4 class="color-danger mrgn15b">Please contact infectious diseases for treatment options for a child
                immediately hypersensitive to penicillin</h4>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible,
                    expectorated sputum for cultures before antibiotics are given</li>
                <li>The usual total duration of therapy is 7 days (intravenous plus oral). Patients with lung abscess,
                    empyema or large parapneumonic effusion require a longer duration of therapy</li>
                <li>Please note that oral moxifloxacin has excellent bioavailability &#40;&gt;90% orally
                    bioavailable&#41;</li>
                <li>Consider stopping antibiotic treatment after 48 to 72 hours when patients are improving and
                    culture-negative, if an alternative diagnosis is likely.</li>
                <li>Azithromycin is not required for empirical treatment of HAP or VAP unless Legionella pneumonia is
                    strongly suspected based on clinical presentation and/or risk factors. Infection with Legionella is
                    very uncommon in this setting.</li>
            </ul>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for Moxifloxacin IV or Moxifloxacin orally is:</span>
                <span class="font15 bold"> 8<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>EIGHT</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past eight days. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on hospital acquired pneumonia</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap1b3 -->

    <!-- Start of HAP MDR YES, Penicillin BAD, ?MRSA #hap2b -->
    <div data-role="page" id="hap2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>HAP treatment</h1>
        </div>
        <br>
        <!-- /header -->
        <div class="container-fluid">
            <h4 class="color-danger mrgn15b">If patient has penicillin hypersensitivity treatment is complex, please
                contact infectious diseases for advice</h4>
        </div>
        <hr>
        <h4 class="mrgn20b references">
            <span class="color-purple"><b>References: </b></span><br><br>
            <span class="font15"><a
                    href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                    target="_blank">See section on hospital acquired pneumonia</a> - Antibiotic Expert Groups.
                Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
        </h4>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap2b -->

    <!-- Start of HAP MDR YES, PEN OK, V SEPTIC YES,: Gent question #hap2c1a -->
    <div data-role="page" id="hap2c1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Hospital acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#hap2c1a2">Gentamicin not contraindicated</a></li>
                <li><a href="#hap2c1a1">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap2c2a -->

    <!-- Start of HAP MDR YES, Penicillin MILD, MRSA YES, anaerobe YES #hap2a1 -->
    <div data-role="page" id="hap2a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>HAP treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has not had a life threatening penicillin reaction use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefepime 2 g &#40;child: 50 mg/kg up to 2 g&#41; IV, 8-hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per nomograms below or use the <a
                            href="#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <br>
            <p class="mrgn20b"><b>AND</b> for anaerobic cover</p>
            <br>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Metronidazole 400 mg &#40;child: 10
                        mg/kg up to 400 mg&#41; orally or enterally, 12-hourly for 8 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> If patient is not tolerating oral or enteral medications</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Metronidazole 500 mg &#40;child: 12.5
                        mg/kg up to 500 mg&#41; IV, 12-hourly for 8 days or until ready to switch to oral</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for cefepime is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible,
                    expectorated sputum for cultures before antibiotics are given</li>
                <li>Consider stopping antibiotic treatment after 48 to 72 hours when patients are improving and
                    culture-negative, if an alternative diagnosis is likely. Otherwise, if pneumonia is the likely
                    diagnosis, and the patient has clinically improved, and no MDR pathogens are isolated from cultures
                    by 48 to 72 hours, consider de-escalating antibiotic therapy</li>
                <li>The usual total duration of therapy is 7 days (intravenous plus oral). Patients with lung abscess,
                    empyema or large parapneumonic effusion require a longer duration of therapy</li>
                <li>Azithromycin is not required for empirical treatment of HAP or VAP unless Legionella pneumonia is
                    strongly suspected based on clinical presentation and/or risk factors. Infection with Legionella is
                    very uncommon in this setting.</li>
                <li>In patients with severe disease who have recently been treated with the above drugs meropenem may be
                    required. Please contact infectious diseases if your patient meets this criteria</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul class="line30">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on hospital acquired pneumonia</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap2a1 -->


    <!-- Start of HAP MDR YES, Penicillin MILD, MRSA YES, anaerobe NO #hap2a2 -->
    <div data-role="page" id="hap2a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>HAP treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has not had a life threatening penicillin reaction use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefepime 2 g &#40;child: 50 mg/kg up to 2 g&#41; IV, 8-hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per nomograms below or use the <a
                            href="#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for cefepime is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible,
                    expectorated sputum for cultures before antibiotics are given</li>
                <li>Consider stopping antibiotic treatment after 48 to 72 hours when patients are improving and
                    culture-negative, if an alternative diagnosis is likely. Otherwise, if pneumonia is the likely
                    diagnosis, and the patient has clinically improved, and no MDR pathogens are isolated from cultures
                    by 48 to 72 hours, consider de-escalating antibiotic therapy</li>
                <li>The usual total duration of therapy is 7 days (intravenous plus oral). Patients with lung abscess,
                    empyema or large parapneumonic effusion require a longer duration of therapy</li>
                <li>Azithromycin is not required for empirical treatment of HAP or VAP unless Legionella pneumonia is
                    strongly suspected based on clinical presentation and/or risk factors. Infection with Legionella is
                    very uncommon in this setting.</li>
                <li>In patients with severe disease who have recently been treated with the above drugs meropenem may be
                    required. Please contact infectious diseases if your patient meets this criteria</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul class="line30">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on hospital acquired pneumonia</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap2a2 -->

    <!-- Start of HAP MDR YES, Penicillin OK, Severe sepsis; NO #hap2c2 -->
    <div data-role="page" id="hap2c2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>HAP treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has not had a life threatening penicillin reaction use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Piperacillin+tazobactam 4+0.5 g &#40;child: 100+12.5 mg/kg up to 4+0.5
                        g&#41; IV, 6-hourly.</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for piperacillin+tazobactam is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>infectious diseases should be contacted as soon as possible if staphylococcal pneumonia is suspected
                    as the patient may require MRSA cover</li>
                <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible,
                    expectorated sputum for cultures before antibiotics are given</li>
                <li>Consider stopping antibiotic treatment after 48 to 72 hours when patients are improving and
                    culture-negative, if an alternative diagnosis is likely. Otherwise, if pneumonia is the likely
                    diagnosis, and the patient has clinically improved, and no MDR pathogens are isolated from cultures
                    by 48 to 72 hours, consider de-escalating antibiotic therapy</li>
                <li>Azithromycin is not required for empirical treatment of HAP or VAP unless Legionella pneumonia is
                    strongly suspected based on clinical presentation and/or risk factors. Infection with Legionella is
                    very uncommon in this setting.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on hospital acquired pneumonia</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap2c2 -->

    <!-- Start of HAP MDR YES, Penicillin OK, Severe sepsis; NO #hap2c1b -->
    <div data-role="page" id="hap2c1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>HAP treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has not had a life threatening penicillin reaction use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Piperacillin+tazobactam 4+0.5 g &#40;child: 100+12.5 mg/kg up to 4+0.5
                        g&#41; IV, 6-hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">A vancomycin loading dose of 25-30 mg/Kg IV</span>
                </h4>
                <p class="mrgn20b"><b>AND THEREAFTER,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per nomograms below or use the <a
                            href="#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for piperacillin+tazobactam is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible,
                    expectorated sputum for cultures before antibiotics are given</li>
                <li>Consider stopping antibiotic treatment after 48 to 72 hours when patients are improving and
                    culture-negative, if an alternative diagnosis is likely. Otherwise, if pneumonia is the likely
                    diagnosis, and the patient has clinically improved, and no MDR pathogens are isolated from cultures
                    by 48 to 72 hours, consider de-escalating antibiotic therapy</li>
                <li>The usual total duration of therapy is 7 days (intravenous plus oral). Patients with lung abscess,
                    empyema or large parapneumonic effusion require a longer duration of therapy</li>
                <li>Azithromycin is not required for empirical treatment of HAP or VAP unless Legionella pneumonia is
                    strongly suspected based on clinical presentation and/or risk factors. Infection with Legionella is
                    very uncommon in this setting.</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul class="line30">
                <li>If the patient only has a single IV line it is important to give piperacillin before vancomycin as
                    it has the shortest infusion time</li>
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on hospital acquired pneumonia</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap2c1b -->


    <!-- Start of HAP MDR YES, Pen OK, Severe sepsis YES, GENT NO #hap2c1a1 -->
    <div data-role="page" id="hap2c1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>HAP treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has not had a life threatening penicillin reaction use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Piperacillin+tazobactam 4+0.5 g &#40;child: 100+12.5 mg/kg up to 4+0.5
                        g&#41; IV, 6-hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per nomograms below or use the <a
                            href="#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ciprofloxacin 400 mg &#40;child: 10 mg/kg up to 400 mg&#41; IV,
                        8-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for piperacillin and ciprofloxacin iv is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible,
                    expectorated sputum for cultures before antibiotics are given</li>
                <li>Consider stopping antibiotic treatment after 48 to 72 hours when patients are improving and
                    culture-negative, if an alternative diagnosis is likely. Otherwise, if pneumonia is the likely
                    diagnosis, and the patient has clinically improved, and no MDR pathogens are isolated from cultures
                    by 48 to 72 hours, consider de-escalating antibiotic therapy</li>
                <li>The usual total duration of therapy is 7 days (intravenous plus oral). Patients with lung abscess,
                    empyema or large parapneumonic effusion require a longer duration of therapy</li>
                <li>Azithromycin is not required for empirical treatment of HAP or VAP unless Legionella pneumonia is
                    strongly suspected based on clinical presentation and/or risk factors. Infection with Legionella is
                    very uncommon in this setting.</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul class="line30">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on hospital acquired pneumonia</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap2c1a1 -->

    <!-- Start of HAP MDR YES, Pen OK, Severe YES, Gent YES #hap2c1a2 -->
    <div data-role="page" id="hap2c1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>HAP treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has not had a life threatening penicillin reaction use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Piperacillin+tazobactam 4+0.5 g &#40;child: 100+12.5 mg/kg up to 4+0.5
                        g&#41; IV, 6-hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per nomograms below or use the <a
                            href="#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin 4 to 7 mg/kg &#40;child: 7.5 mg/kg up to 320 mg&#41; IV, for
                        the first dose, then dose as per nomograms below or use the <a href="#dose12">gentamicin empiric
                            dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for piperacillin+tazobactam is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>THREE</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if IV treatment is to continue past 72 hours.
                    Please annotate this code on the medication chart and document when infectious diseases are to be
                    contacted in the patient notes.
                </div>
            </h4>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin and gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible,
                    expectorated sputum for cultures before antibiotics are given</li>
                <li>Consider stopping antibiotic treatment after 48 to 72 hours when patients are improving and
                    culture-negative, if an alternative diagnosis is likely. Otherwise, if pneumonia is the likely
                    diagnosis, and the patient has clinically improved, and no MDR pathogens are isolated from cultures
                    by 48 to 72 hours, consider de-escalating antibiotic therapy</li>
                <li>The usual total duration of therapy is 7 days (intravenous plus oral). Patients with lung abscess,
                    empyema or large parapneumonic effusion require a longer duration of therapy</li>
                <li>Azithromycin is not required for empirical treatment of HAP or VAP unless Legionella pneumonia is
                    strongly suspected based on clinical presentation and/or risk factors. Infection with Legionella is
                    very uncommon in this setting.</li>
                <li>In overweight patients gentamicin should be dosed on ideal body weight or adjusted body weight, not
                    actual body weight</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td>1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td>1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td>2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td>2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td>3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>---</td>
                    </tr>
                    <tr>
                        <td>Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                        <td>48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td>Before the 3<sup>rd</sup> dose</td>
                        <td>Before the <br />4<sup>th</sup> dose</td>
                        <td>---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul class="line30">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>

                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>

                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing Age &gt; 12 Years</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>

                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>The usual total duration of therapy is 7 days (intravenous plus oral). Patients with lung abscess,
                    empyema or large parapneumonic effusion require a longer duration of therapy</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>hap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on hospital acquired pneumonia</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /hap1b1b -->
    <!-- END of HAP treatment maze -->

    <!-- Start of parapneumonic effusion or empyema treatment maze -->

    <!-- Start of parapneum / empyema check page : #empara -->
    <div data-role="page" id="empara" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Parapneumonic effusion or empyema</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does your patient have a small effusion, large effusion or possible
                    empyema?</span>
            </h3>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Diagnosis</th>
                        <th>Definition</th>
                        <th>Management</th>
                    </tr>
                    <tr>
                        <td>Small parapneumonic effusion</td>
                        <td>incidental small effusion (eg depth less than 10 mm on lateral decubitus X-ray)</td>
                        <td>
                            <ul>
                                <li>Pleural fluid sampling and drainage <u>is not</u> required.</li>
                                <li>Hospital admission is not required, unless indicated for pneumonia.</li>
                                <li>No change to standard therapy for pneumonia is needed.</li>
                                <li>Monitor the patient to ensure the effusion does not progress.</li>
                            </ul>
                        </td>
                    </tr>
                    <tr>
                        <td>Large parapneumonic effusion</td>
                        <td>clinically significant effusion (eg depth greater than 10 mm on lateral decubitus X-ray or
                            greater than 30 mm on CT; dyspnoea attributable to effusion)</td>
                        <td>
                            <ul>
                                <li>Pleural fluid sampling and drainage is <u>often</u> required.</li>
                                <li>Admit the patient to hospital for treatment with intravenous antibiotics. The choice
                                    of regimen depends on the type of pneumonia; see here for community-acquired
                                    pneumonia in adults, here for community-acquired pneumonia in children or here for
                                    hospital-acquired pneumonia.</li>
                            </ul>
                        </td>
                    </tr>
                    <tr>
                        <td>Empyema</td>
                        <td>a collection of pus in the pleural space associated with active infection</td>
                        <td>
                            <ul>
                                <li>Pleural fluid sampling and drainage <u>is</u> required.</li>
                                <li>Admit the patient to hospital for treatment with intravenous antibiotics. The choice
                                    of regimen depends on the type of pneumonia; see here for community-acquired
                                    pneumonia in adults, here for community-acquired pneumonia in children or here for
                                    hospital-acquired pneumonia.</li>
                                <li>Intrapleural enzyme therapy may be needed when empyema is not resolving despite an
                                    adequately sited intercostal catheter for drainage.</li>
                            </ul>
                        </td>
                    </tr>
                </table>
            </div>
            <hr>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#para1">Small parapneumonic effusion</a></li>
                <li><a href="#empara2">Large parapneumonic effusion</a></li>
                <li><a href="#empara2">Empyema</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on parapneumonic effusion and empyema</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /empara -->

    <!-- Start of parapneumonic effusion, small endpoint; para1-->
    <div data-role="page" id="para1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Small parapneumonic effusion</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For a small parapneumonic effusion:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">No change to <a href="#pneum">standard pneumonia treatment</a> regimen is
                        necessary</span>
                </h4>
                <br>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Click <a href="#pneum">here</a> for pneumonia treatment regimens</span>
                </h4>
            </div>
            <hr>
            <ul class="line30">
                <li>No change is needed to standard pneumonia treatment regimens, including the timing of intravenous to
                    oral switch and duration of therapy</li>
                <li>Continue standard empirical antibiotic therapy for the applicable type and severity of pneumonia.
                    Monitor the patient to ensure the effusion does not progress.</li>
                <li>Patients with pneumonia who develop a small pleural effusion (parapneumonic effusion) do not require
                    pleural fluid sampling and drainage.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on parapneumonic effusion and empyema</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /para1 -->

    <!-- Start of parapneum severity check page : #para2 -->
    <div data-role="page" id="empara2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Parapneumonic effusion or empyema</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">How severe is the parapneumonic effusion or empyema?</span>
            </h3>
            <script>
                var calcsmartcopoe = function () {
                    var resultoe = 0;
                    var smartCopAgee = 0;
                    smartCopAgee = parseInt($('#smrtCopAgee option:selected').val());
                    //alert("Please cmartcopage is "+smartCopAge)
                    if (smartCopAgee === 50) {
                        console.log(smartCopAgee);
                        //console.log('updating value');
                        //console.log($('#systolic').val());
                        var resultoe = 0;
                        if (parseInt($('#systolicoe').val()) < 90) {
                            resultoe += 2;
                        }
                        if (parseInt($('#albuminoe').val()) < 35) {
                            resultoe += 1;
                        }
                        if (parseInt($('#respoe').val()) > 29) {
                            resultoe += 1;
                        }
                        if (parseInt($('#tachoe').val()) > 124) {
                            resultoe += 1;
                        }
                        if (parseInt($('#oxyoe').val() * 100) < 9010) {
                            resultoe += 2;
                        }
                        if (parseInt($('#arteroe').val() * 100) < 735) {
                            resultoe += 2;
                        }
                        //console.log($('#multilobaro option:selected').val());
                        resultoe += parseInt($('#multilobaroe option:selected').val());
                        $('#smartcopresultoe').text(resultoe);
                        //console.log($('#confusiono option:selected').val());
                        resultoe += parseInt($('#confusionoe option:selected').val());
                        $('#smartcopresultoe').text(resultoe);
                    }
                    else if (smartCopAgee === 49) {
                        console.log(smartCopAgee);
                        //console.log('updating value');
                        //console.log($('#systolic').val());
                        var resultoe = 0;
                        if (parseInt($('#systolicoe').val()) < 90) {
                            resultoe += 2;
                        }
                        if (parseInt($('#albuminoe').val()) < 35) {
                            resultoe += 1;
                        }
                        if (parseInt($('#respoe').val()) > 24) {
                            resultoe += 1;
                        }
                        if (parseInt($('#tachoe').val()) > 124) {
                            resultoe += 1;
                        }
                        if (parseInt($('#oxyoe').val() * 100) < 9310) {
                            resultoe += 2;
                        }
                        if (parseInt($('#arteroe').val() * 100) < 735) {
                            resultoe += 2;
                        }
                        //console.log($('#multilobary option:selected').val());
                        resultoe += parseInt($('#multilobaroe option:selected').val());
                        $('#smartcopresultoe').text(resultoe);
                        //console.log($('#confusiony option:selected').val());
                        resultoe += parseInt($('#confusionoe option:selected').val());
                        $('#smartcopresultoe').text(resultoe);
                    }
                    $('#smartcopresultoe').text(resultoe);
                }
            </script>
            <form onsubmit="return false">
                <h4 class="color-primary mrgn20b">Enter the patient age and obs to calculate a <b>SMARTCOP</b> score or
                    scroll down to skip this step</h4>
                <hr />
                <div class="form-group">
                    <label for="smrtCopAgee">How old is the patient?:</label>
                    <select name="smrtCopAgee" id="smrtCopAgee" class="form-control">
                        <option value="49">50 years old or less</option>
                        <option value="50">More than 50 years old</option>
                    </select>
                </div>
                <div class="form-group"><label for="systolicoe"><b>S</b>ystolic BP:</label><input type="number" min="10"
                        id="systolicoe" name="systolicoe" class="form-control"></div>
                <div class="form-group">
                    <label for="multilobaroe"><b>M</b>ultilobar chest involvement?:</label>
                    <select name="multilobaroe" id="multilobaroe" class="form-control">
                        <option value="0">No</option>
                        <option value="1">Yes</option>
                    </select>
                </div>
                <div class="form-group"><label for="albuminoe"><b>A</b>lbumin:</label><input type="number" min="0"
                        id="albuminoe" name="albuminoe" class="form-control"></div>
                <div class="form-group"><label for="respoe"><b>R</b>espiratory rate (RPM):</label><input type="number"
                        min="0" id="respoe" name="respoe" class="form-control"></div>
                <div class="form-group"><label for="tachoe"><b>T</b>achyardia? - Heart rate (BPM):</label><input
                        type="number" min="0" id="tachoe" name="tachoe" class="form-control"></div>
                <div class="form-group">
                    <label for="confusionoe"><b>C</b>onfusion? (new onset):</label>
                    <select name="confusionoe" id="confusionoe" class="form-control">
                        <option value="0">No</option>
                        <option value="1">Yes</option>
                    </select>
                </div>
                <div class="form-group"><label for="oxyoe"><b>O</b>xygen saturation(%):</label><input type="number"
                        step="0.1" min="0" id="oxyoe" name="oxyoe" value="99" class="form-control" /></div>
                <div class="form-group"><label for="arteroe"><b>P</b>h &#40;arterial pH, this value can be left blank if
                        unknown&#41;:</label><input type="number" step="0.01" min="0" id="arteroe" name="arteroe"
                        value="7.4" class="form-control" /></div>
                <button onclick="calcsmartcopoe();" class="btn btn-primary">Calculate Smartcop</button>
                <p class="color-primary mrgn20b"><b>SMARTCOP SCORE: </b><strong><span
                            id="smartcopresultoe">0</span></strong></p>
            </form>
            <hr>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#empara2a">Low to moderate severity disease &#40;SMARTCOP &lte; 4&#41;</a></li>
                <li><a href="#empara2b">High severity disease &#40;SMARTCOP &gte; 5&#41;</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on parapneumonic effusion and empyema</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /empara2 -->

    <!-- Start of low to moderate acuity parapneumon or empyema allergy check page: #empara2a -->
    <div data-role="page" id="empara2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Low to moderate severity empyema or parapneumonic effusion</h1>
        </div>
        <!-- /header -->
        <h3 class="color-primary mrgn15b">Does the patient have a penicillin allergy? <span
                class="font15 color-info">&#40;See below for details on penicillin allergy severity&#41;</span></h3>

        <div data-role="content" class="container-fluid">
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#empara2a1">No penicillin allergy</a></li>
                <li><a href="#empara2a2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#empara2a3">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr>
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>

        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /empara2a -->

    <!-- Start of low to moderate acuity parapneumon or empyema allergy check page: #empara2b -->
    <div data-role="page" id="empara2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Low to moderate severity empyema or parapneumonic effusion</h1>
        </div>
        <!-- /header -->
        <h3 class="color-primary mrgn15b">Does the patient have a penicillin allergy? <span
                class="font15 color-info">&#40;See below for details on penicillin allergy severity&#41;</span></h3>
        <div data-role="content" class="container-fluid">
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#empara2b2">No penicillin allergy</a></li>
                <li><a href="#empara2b2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#empara2a3">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr>
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>

        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /empara2b -->

    <!-- Start of empara2a1. large or empyema, not severe, PEN OK: #empara2a1 -->
    <div data-role="page" id="empara2a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Low severity empyema/parapneumonic effusion treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient does not have a penicillin allergy give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Benzylpenicillin 1.2 g intravenously, 6-hourly, daily</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg IV, 12-hourly</span>
                </h4>
            </div>
            <hr>
            <ul class="line30">
                <li>In adults with large parapneumonic effusion or empyema complicating CAP, the most likely pathogens
                    are:
                    <ul>
                        <li><i>Streptococcus pneumoniae</i></li>
                        <li>the <i>Streptococcus anginosus</i> (milleri) group (<i>S. anginosus, S. constellatus, S.
                                intermedius</i>)</li>
                        <li>anaerobes such as <i>Bacteroides, Veillonella</i> and <i>Peptostreptococcus</i> species
                            <ul>
                                <li>If an anerobic pathogen is identified by culture, the infection is often
                                    polymicorbial, seek ID consult</li>
                            </ul>
                        </li>
                    </ul>
                </li>
                <li>Polymicrobial infection is common. Staphylococcus species cause less than 10% of cases. Atypical
                    pathogens are unlikely to cause parapneumonic effusion or empyema</li>
                <li>Infectious disease consultation is recommended for all parapneumonic effusion and empyema cases</li>
                <li>Pleural fluid sampling is recommended in all cases</li>
                <li>Culturing pleural fluid in blood culture bottles, in addition to standard culture, can increase
                    microbial yield.</li>
                <li>If available, use the results of microbiological investigations to guide antibiotic therapy. If an
                    anaerobic pathogen is identified by culture, the infection is often polymicrobial—seek expert advice
                    on adjusting therapy.</li>
                <li>In adults with parapneumonic effusion or empyema complicating CAP, the total duration of therapy is
                    3 to 4 weeks (intravenous + oral). Consider monitoring serum C-reactive protein (CRP) for response
                    to treatment.</li>
                <li> Once the patient has improved and the pleural space is adequately drained, switch to oral therapy.
                    <span class="font15"><a
                            href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                            target="_blank">See the section on parapneumonic effusion/empyema</a> in the Therapeutic
                        Guidelines for details on when to make the IV to oral switch and suggested antibiotics</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on parapneumonic effusion/empyema</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /empara2a1 -->

    <!-- Start of empara2b1. large or empyema, not severe, PEN MILD: #empara2a2 -->
    <div data-role="page" id="empara2a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Low severity empyema/parapneumonic effusion treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient has non-severe penicillin allergy give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2 g IV, daily</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg IV, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 5<script> document.write(getCode())</script>emp</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past one week. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>In adults with large parapneumonic effusion or empyema complicating CAP, the most likely pathogens
                    are:
                    <ul>
                        <li><i>Streptococcus pneumoniae</i></li>
                        <li>the <i>Streptococcus anginosus</i> (milleri) group (<i>S. anginosus, S. constellatus, S.
                                intermedius</i>)</li>
                        <li>anaerobes such as <i>Bacteroides, Veillonella</i> and <i>Peptostreptococcus</i> species
                            <ul>
                                <li>If an anerobic pathogen is identified by culture, the infection is often
                                    polymicorbial, seek ID consult</li>
                            </ul>
                        </li>
                    </ul>
                </li>
                <li>Polymicrobial infection is common. Staphylococcus species cause less than 10% of cases. Atypical
                    pathogens are unlikely to cause parapneumonic effusion or empyema</li>
                <li>Infectious disease consultation is recommended for all parapneumonic effusion and empyema cases</li>
                <li>Pleural fluid sampling is recommended in all cases</li>
                <li>Culturing pleural fluid in blood culture bottles, in addition to standard culture, can increase
                    microbial yield.</li>
                <li>If available, use the results of microbiological investigations to guide antibiotic therapy. If an
                    anaerobic pathogen is identified by culture, the infection is often polymicrobial—seek expert advice
                    on adjusting therapy.</li>
                <li>In adults with parapneumonic effusion or empyema complicating CAP, the total duration of therapy is
                    3 to 4 weeks (intravenous + oral). Consider monitoring serum C-reactive protein (CRP) for response
                    to treatment.</li>
                <li> Once the patient has improved and the pleural space is adequately drained, switch to oral therapy.
                    <span class="font15"><a
                            href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                            target="_blank">See the section on parapneumonic effusion/empyema</a> in the Therapeutic
                        Guidelines for details on when to make the IV to oral switch and suggested antibiotics</li>
            </ul>

            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on parapneumonic effusion/empyema</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /empara2a2 -->

    <!-- Start of empara2b2. large or empyema, not severe, PEN MILD: #empara2b2 -->
    <div data-role="page" id="empara2b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>High severity empyema/parapneumonic effusion treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient has non-severe or no penicillin allergy give either:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ceftriaxone 2 g IV, daily</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b> if the patient has septic shock</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ceftriaxone 1 g IV, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b> with either of the above ceftriaxone dosing regimens <b>ADD</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg IV, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 7<script> document.write(getCode())</script>emp</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past one week. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>In adults with large parapneumonic effusion or empyema complicating CAP, the most likely pathogens
                    are:
                    <ul>
                        <li><i>Streptococcus pneumoniae</i></li>
                        <li>the <i>Streptococcus anginosus</i> (milleri) group (<i>S. anginosus, S. constellatus, S.
                                intermedius</i>)</li>
                        <li>anaerobes such as <i>Bacteroides, Veillonella</i> and <i>Peptostreptococcus</i> species
                            <ul>
                                <li>If an anerobic pathogen is identified by culture, the infection is often
                                    polymicorbial, seek ID consult</li>
                            </ul>
                        </li>
                    </ul>
                </li>
                <li>Polymicrobial infection is common. Staphylococcus species cause less than 10% of cases. Atypical
                    pathogens are unlikely to cause parapneumonic effusion or empyema</li>
                <li>Infectious disease consultation is recommended for all parapneumonic effusion and empyema cases</li>
                <li>Pleural fluid sampling is recommended in all cases</li>
                <li>Culturing pleural fluid in blood culture bottles, in addition to standard culture, can increase
                    microbial yield.</li>
                <li>If available, use the results of microbiological investigations to guide antibiotic therapy. If an
                    anaerobic pathogen is identified by culture, the infection is often polymicrobial—seek expert advice
                    on adjusting therapy.</li>
                <li>In adults with parapneumonic effusion or empyema complicating CAP, the total duration of therapy is
                    3 to 4 weeks (intravenous + oral). Consider monitoring serum C-reactive protein (CRP) for response
                    to treatment.</li>
                <li> Once the patient has improved and the pleural space is adequately drained, switch to oral therapy.
                    <span class="font15"><a
                            href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                            target="_blank">See the section on parapneumonic effusion/empyema</a> in the Therapeutic
                        Guidelines for details on when to make the IV to oral switch and suggested antibiotics</li>
            </ul>

            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on parapneumonic effusion/empyema</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /empara2b2 -->



    <!-- Start of empara2b1. large or empyema, not severe, PEN BAD: #empara2a3 -->
    <div data-role="page" id="empara2a3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empyema/parapneumonic effusion treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient has a severe reaction to penicillin give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Moxifloxacin 400 mg IV, daily</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for IV moxifloxacin is:</span>
                <span class="font15 bold"> 5<script> document.write(getCode())</script>emp</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past one week. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>In adults with large parapneumonic effusion or empyema complicating CAP, the most likely pathogens
                    are:
                    <ul>
                        <li><i>Streptococcus pneumoniae</i></li>
                        <li>the <i>Streptococcus anginosus</i> (milleri) group (<i>S. anginosus, S. constellatus, S.
                                intermedius</i>)</li>
                        <li>anaerobes such as <i>Bacteroides, Veillonella</i> and <i>Peptostreptococcus</i> species
                            <ul>
                                <li>If an anerobic pathogen is identified by culture, the infection is often
                                    polymicorbial, seek ID consult</li>
                            </ul>
                        </li>
                    </ul>
                </li>
                <li>Polymicrobial infection is common. Staphylococcus species cause less than 10% of cases. Atypical
                    pathogens are unlikely to cause parapneumonic effusion or empyema</li>
                <li>Infectious disease consultation is recommended for all parapneumonic effusion and empyema cases</li>
                <li>Pleural fluid sampling is recommended in all cases</li>
                <li>Culturing pleural fluid in blood culture bottles, in addition to standard culture, can increase
                    microbial yield.</li>
                <li>If available, use the results of microbiological investigations to guide antibiotic therapy. If an
                    anaerobic pathogen is identified by culture, the infection is often polymicrobial—seek expert advice
                    on adjusting therapy.</li>
                <li>In adults with parapneumonic effusion or empyema complicating CAP, the total duration of therapy is
                    3 to 4 weeks (intravenous + oral). Consider monitoring serum C-reactive protein (CRP) for response
                    to treatment.</li>
                <li> Once the patient has improved and the pleural space is adequately drained, switch to oral therapy.
                    <span class="font15"><a
                            href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                            target="_blank">See the section on parapneumonic effusion/empyema</a> in the Therapeutic
                        Guidelines for details on when to make the IV to oral switch and suggested antibiotics</li>
            </ul>

            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on parapneumonic effusion/empyema</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /empara2a3 -->

    <!-- END of EMPYEMA -->

    <!-- Start of TROPICAL CAP -->

    <!-- Start of cap page/ ?age: #cap -->
    <div data-role="page" id="tcap" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">How old is the patient?</span>

            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1">&gt; 50 years of age</a></li>
                <li><a href="#tcap2">15 to 50 years old</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap -->

    <!-- Start of CAP page/ old: #cap1 -->
    <div data-role="page" id="tcap1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>SMARTCOP</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">What is the patient's SMARTCOP score?</span>

            </h3>
            <script>
                var tcalcsmartcopo = function () {

                    //console.log('updating value');
                    //console.log($('#systolic').val());
                    var tresulto = 0;
                    if (parseInt($('#tsystolico').val()) < 90) {

                        tresulto += 2;
                    } else {

                    }

                    if (parseInt($('#talbumino').val()) < 35) {

                        tresulto += 1;
                    } else {

                    }

                    if (parseInt($('#trespo').val()) > 29) {

                        tresulto += 1;
                    } else {

                    }

                    if (parseInt($('#ttacho').val()) > 124) {
                        tresulto += 1;
                    } else {

                    }

                    if (parseInt($('#toxyo').val() * 100) < 9010) {
                        tresulto += 2;
                    } else {

                    }

                    if (parseInt($('#tartero').val() * 100) < 735) {
                        tresulto += 2;
                    } else {

                    }

                    //console.log($('#multilobaro option:selected').val());
                    tresulto += parseInt($('#tmultilobaro option:selected').val());
                    $('#tsmartcopresulto').text(tresulto);
                    //console.log($('#confusiono option:selected').val());
                    tresulto += parseInt($('#tconfusiono option:selected').val());
                    $('#tsmartcopresulto').text(tresulto);
                }
            </script>

            <form onsubmit="return false">
                <h4 class="color-primary mrgn20b">Enter the patient obs to calculate a <b>SMARTCOP</b> score or scroll
                    down to skip this step</h4>
                <hr />
                <div class="form-group"><label for="tsystolic"><b>S</b>ystolic BP:</label><input type="number" min="10"
                        id="tsystolico" name="tsystolico" onchange="tcalcsmartcopo();" class="form-control"></div>
                <div class="form-group">
                    <label for="tmultilobaro"><b>M</b>ultilobar chest involvement?:</label>
                    <select name="tmultilobaro" id="tmultilobaro" onchange="tcalcsmartcopo();" class="form-control">
                        <option value="0">No</option>
                        <option value="1">Yes</option>
                    </select>
                </div>
                <div class="form-group"><label for="talbumino"><b>A</b>lbumin:</label><input type="number" min="0"
                        id="talbumino" name="talbumino" onchange="tcalcsmartcopo();" class="form-control"></div>
                <div class="form-group"><label for="trespo"><b>R</b>espiratory rate (RPM):</label><input type="number"
                        min="0" id="trespo" name="trespo" onchange="tcalcsmartcopo();" class="form-control"></div>
                <div class="form-group"><label for="ttacho"><b>T</b>achyardia? - Heart rate (BPM):</label><input
                        type="number" min="0" id="ttacho" name="ttacho" onchange="tcalcsmartcopo();"
                        class="form-control"></div>
                <div class="form-group">
                    <label for="tconfusiono"><b>C</b>onfusion? (new onset):</label>
                    <select name="tconfusiono" id="tconfusiono" onchange="tcalcsmartcopo();" class="form-control">
                        <option value="0">No</option>
                        <option value="1">Yes</option>
                    </select>
                </div>
                <div class="form-group"><label for="toxyo"><b>O</b>xygen saturation(%):</label><input type="number"
                        step="0.1" min="0" id="oxyo" name="toxyo" value="99" onchange="tcalcsmartcopo();"
                        class="form-control" /></div>
                <div class="form-group"><label for="tartero"><b>P</b>h (arterial pH):</label><input type="number"
                        step="0.01" min="0" id="artero" name="tartero" value="7.4" onchange="tcalcsmartcopo();"
                        class="form-control" /></div>
                <p class="color-primary mrgn20b"><b>SMARTCOP SCORE: </b><strong><span
                            id="tsmartcopresulto">0</span></strong></p>
            </form>
            <hr />
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a">Continue to treatment</a></li>
            </ul>
        </div>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1 -->

    <!-- Start of CAP page/ young: #cap2 -->
    <div data-role="page" id="tcap2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>SMARTCOP</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">What is the patient's SMARTCOP score?</span>

            </h3>
            <script>
                var calcsmartcop = function () {

                    //console.log('updating value');
                    //console.log($('#systolic').val());
                    var resulty = 0;
                    if (parseInt($('#systolicy').val()) < 90) {

                        resulty += 2;
                    } else {

                    }

                    if (parseInt($('#albuminy').val()) < 35) {

                        resulty += 1;
                    } else {

                    }

                    if (parseInt($('#respy').val()) > 24) {

                        resulty += 1;
                    } else {

                    }

                    if (parseInt($('#tachy').val()) > 124) {
                        resulty += 1;
                    } else {

                    }

                    if (parseInt($('#oxyy').val() * 100) < 9310) {
                        resulty += 2;
                    } else {

                    }

                    if (parseInt($('#artery').val() * 100) < 735) {
                        resulty += 2;
                    } else {

                    }

                    //console.log($('#multilobary option:selected').val());
                    resulty += parseInt($('#multilobary option:selected').val());
                    $('#smartcopresulty').text(resulty);


                    //console.log($('#confusiony option:selected').val());
                    resulty += parseInt($('#confusiony option:selected').val());
                    $('#smartcopresulty').text(resulty);
                }


            </script>

            <form onsubmit="return false">
                <h4 class="color-primary mrgn20b">Enter the patient obs to calculate a <b>SMARTCOP</b> score or scroll
                    down to skip this step</h4>
                <div class="form-group"><label for="systolicy"><b>S</b>ystolic BP:</label><input type="number" min="10"
                        id="systolicy" name="systolicy" onchange="calcsmartcop();" required class="form-control"></div>
                <div class="form-group"><label for="multilobary"><b>M</b>ultilobar chest involvement?:</label>
                    <select name="multilobary" id="multilobary" onchange="calcsmartcop();" class="form-control">
                        <option value="0">No</option>
                        <option value="1">Yes</option>
                    </select>
                </div>
                <div class="form-group"><label for="albuminy"><b>A</b>lbumin:</label><input type="number" min="0"
                        id="albuminy" name="albuminy" onchange="calcsmartcop();" required class="form-control"></div>
                <div class="form-group"><label for="respy"><b>R</b>espiratory rate (RPM):</label><input type="number"
                        min="0" id="respy" name="respy" onchange="calcsmartcop();" required class="form-control"></div>
                <div class="form-group"><label for="tachy"><b>T</b>achyardia? - Heart rate (BPM):</label><input
                        type="number" min="0" id="tachy" name="tachy" onchange="calcsmartcop();" required
                        class="form-control"></div>
                <div class="form-group"><label for="confusiony"><b>C</b>onfusion? (new onset):</label>
                    <select name="confusiony" id="confusiony" onchange="calcsmartcop();" class="form-control">
                        <option value="0">No</option>
                        <option value="1">Yes</option>
                    </select>
                </div>
                <div class="form-group"><label for="oxyy"><b>O</b>xygen saturation(%):</label><input type="number"
                        step="0.1" min="0" id="oxyy" name="oxyy" onchange="calcsmartcop();" required
                        class="form-control"></div>
                <div class="form-group"><label for="artery"><b>P</b>h (arterial pH):</label><input type="number"
                        step="0.01" id="artery" name="artery" onchange="calcsmartcop();" required class="form-control">
                </div>
                <p class="color-primary"><b>SMARTCOP SCORE: </b><strong><span id="smartcopresulty">0</span></strong></p>
            </form>
            <hr />
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a">Continue to treatment</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap2 -->

    <!-- Start of cap page/ ?severity: #cap1a -->
    <div data-role="page" id="tcap1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">How severe is the pneumonia?</span>
            </h3>
            <h4 class="medicine mrgn20b">
                <span class="color-purple">Grade severity based on both clinical impression and SMARTCOP score:</span>

            </h4>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a1">Mild (&lt;3)&#9733;</a></li>
                <li><a href="#tcap1a2">Moderate (&lt;3)&#9784;</a></li>
                <li><a href="#tcap1a3">Severe (&ge;3)(non-ICU)</a></li>
                <li><a href="#tcap1a4">Severe (&ge;3)&#40;ICU&#41;</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <p>&#9733; And clinical impression is mild</p>
                <p>&#9784; And clinical impression is moderate</p>
                <li>If clinical impression from a medical consultant is that the pneumonia is severe it should always be
                    treated as severe regardless of the SMARTCOP score</li>
                <li>Any patient which meets the criteria for severe sepsis (see IFD severe sepsis protocol for details)
                    or any patients accepted into ICU or transferred to ICU should be treated as "severe &#40;ICU&#41;"
                </li>
            </ul>
        </div>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a -->

    <!-- Start of cap page: mild ?pen all #cap1a1 -->
    <div data-role="page" id="tcap1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a1c2">No penicillin allergy</a></li>
                <li><a href="#tcap1a1a1">Immediate or delayed non-severe penicillin hypersensitivity</a></li>
                <li><a href="#tcap1a1b">Immediate or delayed severe penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Immediate or delayed non-severe penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 1-2% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin &#40;except if there is a shared side chain; eg cefalexin and
                    amoxicillin&#41;, and probably even less for other types of allergies. In most cases it is safe to
                    administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Immediate or delayed severe penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; and other life-threatening reactions such as
                    Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug reaction with
                    eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a1 -->

    <!-- Start of cap page: Moderate ?pen all #cap1a2 -->
    <div data-role="page" id="tcap1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a2c">No penicillin allergy</a></li>
                <li><a href="#tcap1a2a">Immediate or delayed non-severe penicillin hypersensitivity</a></li>
                <li><a href="#tcap1a2b">Immediate or delayed severe penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Immediate or delayed non-severe penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 1-2% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin &#40;except if there is a shared side chain; eg cefalexin and
                    amoxicillin&#41;, and probably even less for other types of allergies. In most cases it is safe to
                    administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Immediate or delayed severe penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; and other life-threatening reactions such as
                    Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug reaction with
                    eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2 -->

    <!-- Start of cap page: sev ?pen all #cap1a3 -->
    <div data-role="page" id="tcap1a3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a3c1">No penicillin allergy</a></li>
                <li><a href="#tcap1a3c1">Immediate or delayed non-severe penicillin hypersensitivity</a></li>
                <li><a href="#tcap1a3b1">Immediate or delayed severe penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Immediate or delayed non-severe penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 1-2% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin &#40;except if there is a shared side chain; eg cefalexin and
                    amoxicillin&#41;, and probably even less for other types of allergies. In most cases it is safe to
                    administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Immediate or delayed severe penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; and other life-threatening reactions such as
                    Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug reaction with
                    eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a3 -->

    <!-- Start of cap page: sevICU ?pen all #cap1a4 -->
    <div data-role="page" id="tcap1a4" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a4c">No penicillin allergy</a></li>
                <li><a href="#tcap1a4a1">Immediate or delayed non-severe penicillin hypersensitivity</a></li>
                <li><a href="#tcap1a4a2">Immediate or delayed severe penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Immediate or delayed non-severe penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 1-2% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin &#40;except if there is a shared side chain; eg cefalexin and
                    amoxicillin&#41;, and probably even less for other types of allergies. In most cases it is safe to
                    administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Immediate or delayed severe penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; and other life-threatening reactions such as
                    Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug reaction with
                    eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a4 -->

    <!-- Start of cap page: mild pen OK ?melioid #cap1a1c -->
    <div data-role="page" id="tcap1a1c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have any risk factors for melioidosis?</span>
                <span class="font15"> (See below for a summary of melioid risk factors)</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a1c1">Yes</a></li>
                <li><a href="#tcap1a1c2">No</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Risk factors for melioid or <i>A. baumanii</i> include: Diabetes, hazardous alcohol use, chronic
                    lung disease (including COPD and bronchiectasis),
                    chronic renal failure (eGFR&lt;50 ml/min), steroid or other immunosuppressive therapy.</li>
                <li>Melioidosis can occur in immunocompetent individuals and should not be discounted if pneumonia
                    becomes severe</li>
                <li>For detailed information on pneumonia in the Top End of the Northern Territory please see 'Adult
                    Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC. Please see below
                    for the 1996-1998 rates of infection for the Top End</li>
            </ul>
            <h4 class="color-primary mrgn20b">See below for published bacteraemic adult community-acquired pneumonia
                rates</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th class="bg-success">Organism</th>
                        <th class="bg-success">Number of cases</th>
                        <th class="bg-success">Percentage of total admissions</th>
                        <th class="bg-success">Number of total deaths</th>
                        <th class="bg-success">Percentage of total deaths</th>
                        <th class="bg-success">Mortality rate (%)</th>
                    </tr>

                    <tr>
                        <td class="bg-success">Streptococcus pneumoniae</td>
                        <td>100</td>
                        <td>39%</td>
                        <td>17</td>
                        <td>20%</td>
                        <td>17%</td>
                    </tr>

                    <tr>
                        <td class="bg-success">Burkholderia pseudomallei</td>
                        <td>60</td>
                        <td>24%</td>
                        <td>30</td>
                        <td>36%</td>
                        <td>50%</td>
                    </tr>

                    <tr>
                        <td class="bg-success">Staphylococcus aureus</td>
                        <td>29</td>
                        <td>11%</td>
                        <td>11</td>
                        <td>13%</td>
                        <td>38%</td>
                    </tr>

                    <tr>
                        <td class="bg-success">Acinetobacter baumannii</td>
                        <td>26</td>
                        <td>10%</td>
                        <td>14</td>
                        <td>17%</td>
                        <td>54%</td>
                    </tr>
                </table>
            </div>
            <ul class="line30">
                <li>Taken from the Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline on the
                    PGC.</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a1c -->

    <!-- Start of cap page: Moderate pen mild ?melioid #cap1a2a -->
    <div data-role="page" id="tcap1a2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have any risk factors for melioidosis?</span>
                <span class="font15"> (See below for a summary of melioid risk factors)</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a2a1">Yes</a></li>
                <li><a href="#tcap1a2a2">No</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Risk factors for melioid or <i>A. baumanii</i> include: Diabetes, hazardous alcohol use, chronic
                    lung disease (including COPD and bronchiectasis), chronic renal failure (eGFR&lt;50 ml/min), steroid
                    or other immunosuppressive therapy.</li>
                <li>Melioidosis can occur in immunocompetent individuals and should not be discounted if pneumonia
                    becomes severe</li>
                <li>For detailed information on pneumonia in the Top End of the Northern Territory please see 'Adult
                    Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC. Please see below
                    for the 1996-1998 rates of infection for the Top End</li>
            </ul>
            <h4 class="color-primary mrgn20b">See below for published bacteraemic adult community-acquired pneumonia
                rates</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th class="bg-success">Organism</th>
                        <th class="bg-success">Number of cases</th>
                        <th class="bg-success">Percentage of total admissions</th>
                        <th class="bg-success">Number of total deaths</th>
                        <th class="bg-success">Percentage of total deaths</th>
                        <th class="bg-success">Mortality rate (%)</th>
                    </tr>

                    <tr>
                        <td class="bg-success">Streptococcus pneumoniae</td>
                        <td>100</td>
                        <td>39%</td>
                        <td>17</td>
                        <td>20%</td>
                        <td>17%</td>
                    </tr>

                    <tr>
                        <td class="bg-success">Burkholderia pseudomallei</td>
                        <td>60</td>
                        <td>24%</td>
                        <td>30</td>
                        <td>36%</td>
                        <td>50%</td>
                    </tr>

                    <tr>
                        <td class="bg-success">Staphylococcus aureus</td>
                        <td>29</td>
                        <td>11%</td>
                        <td>11</td>
                        <td>13%</td>
                        <td>38%</td>
                    </tr>

                    <tr>
                        <td class="bg-success">Acinetobacter baumannii</td>
                        <td>26</td>
                        <td>10%</td>
                        <td>14</td>
                        <td>17%</td>
                        <td>54%</td>
                    </tr>
                </table>
            </div>
            <ul class="line30">
                <li>Taken from the Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline on the
                    PGC.</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2a-->

    <!-- Start of cap page: Moderate pen BAD ?melioid #cap1a2b -->
    <div data-role="page" id="tcap1a2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have any risk factors for melioidosis?</span>
                <span class="font15"> (See below for a summary of melioid risk factors)</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a2b1">Yes</a></li>
                <li><a href="#tcap1a2b2">No</a></li>
            </ul>
            <ul class="line30">
                <li>Risk factors for melioid or <i>A. baumanii</i> include: Diabetes, hazardous alcohol use, chronic
                    lung disease (including COPD and bronchiectasis), chronic renal failure (eGFR&lt;50 ml/min), steroid
                    or other immunosuppressive therapy.</li>
                <li>Melioidosis can occur in immunocompetent individuals and should not be discounted if pneumonia
                    becomes severe</li>
                <li>For detailed information on pneumonia in the Top End of the Northern Territory please see 'Adult
                    Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC. Please see below
                    for the 1996-1998 rates of infection for the Top End</li>
            </ul>
            <h4 class="color-primary mrgn20b">See below for published bacteraemic adult community-acquired pneumonia
                rates</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th class="bg-success">Organism</th>
                        <th class="bg-success">Number of cases</th>
                        <th class="bg-success">Percentage of total admissions</th>
                        <th class="bg-success">Number of total deaths</th>
                        <th class="bg-success">Percentage of total deaths</th>
                        <th class="bg-success">Mortality rate (%)</th>
                    </tr>

                    <tr>
                        <td class="bg-success">Streptococcus pneumoniae</td>
                        <td>100</td>
                        <td>39%</td>
                        <td>17</td>
                        <td>20%</td>
                        <td>17%</td>
                    </tr>

                    <tr>
                        <td class="bg-success">Burkholderia pseudomallei</td>
                        <td>60</td>
                        <td>24%</td>
                        <td>30</td>
                        <td>36%</td>
                        <td>50%</td>
                    </tr>

                    <tr>
                        <td class="bg-success">Staphylococcus aureus</td>
                        <td>29</td>
                        <td>11%</td>
                        <td>11</td>
                        <td>13%</td>
                        <td>38%</td>
                    </tr>

                    <tr>
                        <td class="bg-success">Acinetobacter baumannii</td>
                        <td>26</td>
                        <td>10%</td>
                        <td>14</td>
                        <td>17%</td>
                        <td>54%</td>
                    </tr>
                </table>
            </div>
            <ul class="line30">
                <li>Taken from the Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline on the
                    PGC.</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2b-->

    <!-- Start of cap page: Moderate pen OK ?melioid #cap1a2c -->
    <div data-role="page" id="tcap1a2c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have any risk factors for melioidosis?</span>
                <span class="font15"> (See below for a summary of melioid risk factors)</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a2c1">Yes</a></li>
                <li><a href="#tcap1a2c2">No</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Risk factors for melioid or <i>A. baumanii</i> include: Diabetes, hazardous alcohol use, chronic
                    lung disease (including COPD and bronchiectasis),
                    chronic renal failure (eGFR&lt;50 ml/min), steroid or other immunosuppressive therapy.</li>
                <li>Melioidosis can occur in immunocompetent individuals and should not be discounted if pneumonia
                    becomes severe</li>
                <li>For detailed information on pneumonia in the Top End of the Northern Territory please see 'Adult
                    Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC. Please see below
                    for the 1996-1998 rates of infection for the Top End</li>
            </ul>
            <h4 class="color-primary mrgn20b">See below for published bacteraemic adult community-acquired pneumonia
                rates</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th class="bg-success">Organism</th>
                        <th class="bg-success">Number of cases</th>
                        <th class="bg-success">Percentage of total admissions</th>
                        <th class="bg-success">Number of total deaths</th>
                        <th class="bg-success">Percentage of total deaths</th>
                        <th class="bg-success">Mortality rate (%)</th>
                    </tr>

                    <tr>
                        <td class="bg-success">Streptococcus pneumoniae</td>
                        <td>100</td>
                        <td>39%</td>
                        <td>17</td>
                        <td>20%</td>
                        <td>17%</td>
                    </tr>

                    <tr>
                        <td class="bg-success">Burkholderia pseudomallei</td>
                        <td>60</td>
                        <td>24%</td>
                        <td>30</td>
                        <td>36%</td>
                        <td>50%</td>
                    </tr>

                    <tr>
                        <td class="bg-success">Staphylococcus aureus</td>
                        <td>29</td>
                        <td>11%</td>
                        <td>11</td>
                        <td>13%</td>
                        <td>38%</td>
                    </tr>

                    <tr>
                        <td class="bg-success">Acinetobacter baumannii</td>
                        <td>26</td>
                        <td>10%</td>
                        <td>14</td>
                        <td>17%</td>
                        <td>54%</td>
                    </tr>
                </table>
            </div>
            <ul class="line30">
                <li>Taken from the Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline on the
                    PGC.</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2c-->

    <!-- Start of cap page: MILD pen OK Melioid NO #cap1a1c2 -->
    <div data-role="page" id="tcap1a1c2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient likely to require atypical cover?</span>
                <span class="font15"> &#40;See below for a summary of when to consider atypical cover&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a1c1a">Yes</a></li>
                <li><a href="#tcap1a1c1b">No</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent
                    headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                    &#40;contact with known cases of “atypical” pneumonia, or if there is a current outbreak&#41;</li>
                <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients
                    admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been
                    undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or
                    L. longbeachae are diagnosed in patients admitted to RDH intensive care unit &#40;ICU&#41;, with
                    some requiring ventilation.</li>
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a1c2-->

    <!-- Start of cap page: MODERATE pen MILD Melioid YES #cap1a2a1 -->
    <div data-role="page" id="tcap1a2a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient likely to require atypical cover?</span>
                <span class="font15"> &#40;See below for a summary of when to consider atypical cover&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a2a1a">Yes</a></li>
                <li><a href="#tcap1a2a1b">No</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent
                    headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                    &#40;contact with known cases of “atypical” pneumonia, or if there is a current outbreak&#41;</li>
                <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients
                    admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been
                    undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or
                    L. longbeachae are diagnosed in patients admitted to RDH intensive care unit &#40;ICU&#41;, with
                    some requiring ventilation.</li>
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2a1-->

    <!-- Start of cap page: MODERATE pen MILD Melioid NO #cap1a2a2 -->
    <div data-role="page" id="tcap1a2a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient likely to require atypical cover?</span>
                <span class="font15"> &#40;See below for a summary of when to consider atypical cover&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a2a1a1">Yes</a></li>
                <li><a href="#tcap1a2a1b1">No</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent
                    headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                    &#40;contact with known cases of “atypical” pneumonia, or if there is a current outbreak&#41;</li>
                <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients
                    admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been
                    undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or
                    L. longbeachae are diagnosed in patients admitted to RDH intensive care unit &#40;ICU&#41;, with
                    some requiring ventilation.</li>
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2a2-->

    <!-- Start of cap page: MODERATE pen BAD Melioid YES #cap1a2b1 -->
    <div data-role="page" id="tcap1a2b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient likely to require atypical cover?</span>
                <span class="font15"> &#40;See below for a summary of when to consider atypical cover&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a2b1a">Yes</a></li>
                <li><a href="#tcap1a2b1b">No</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent
                    headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                    &#40;contact with known cases of “atypical” pneumonia, or if there is a current outbreak&#41;</li>
                <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients
                    admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been
                    undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or
                    L. longbeachae are diagnosed in patients admitted to RDH intensive care unit &#40;ICU&#41;, with
                    some requiring ventilation.</li>
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2b1-->

    <!-- Start of cap page: MODERATE pen BAD Melioid NO #cap1a2b2 -->
    <div data-role="page" id="tcap1a2b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient likely to require atypical cover?</span>
                <span class="font15"> &#40;See below for a summary of when to consider atypical cover&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a2b1a1">Yes</a></li>
                <li><a href="#tcap1a2b1b1">No</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent
                    headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                    &#40;contact with known cases of “atypical” pneumonia, or if there is a current outbreak&#41;</li>
                <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients
                    admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been
                    undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or
                    L. longbeachae are diagnosed in patients admitted to RDH intensive care unit &#40;ICU&#41;, with
                    some requiring ventilation.</li>
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2b2-->

    <!-- Start of cap page: MODERATE pen OK Melioid YES #cap1a2c1 -->
    <div data-role="page" id="tcap1a2c1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient likely to require atypical cover?</span>
                <span class="font15"> &#40;See below for a summary of when to consider atypical cover&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a2c1a">Yes</a></li>
                <li><a href="#tcap1a2c1b">No</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent
                    headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                    &#40;contact with known cases of “atypical” pneumonia, or if there is a current outbreak&#41;</li>
                <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients
                    admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been
                    undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or
                    L. longbeachae are diagnosed in patients admitted to RDH intensive care unit &#40;ICU&#41;, with
                    some requiring ventilation.</li>
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2c1-->

    <!-- Start of cap page: MODERATE pen OK Melioid NO #cap1a2c2 -->
    <div data-role="page" id="tcap1a2c2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient likely to require atypical cover?</span>
                <span class="font15"> &#40;See below for a summary of when to consider atypical cover&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a2c2a">Yes</a></li>
                <li><a href="#tcap1a2c2b">No</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent
                    headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                    &#40;contact with known cases of “atypical” pneumonia, or if there is a current outbreak&#41;</li>
                <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients
                    admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been
                    undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or
                    L. longbeachae are diagnosed in patients admitted to RDH intensive care unit &#40;ICU&#41;, with
                    some requiring ventilation.</li>
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2c2-->

    <!-- Start of cap page: SEVERE pen BAD Melioid YES #cap1a3b1 -->
    <div data-role="page" id="tcap1a3b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient likely to require atypical cover?</span>
                <span class="font15"> &#40;See below for a summary of when to consider atypical cover&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a3b1a">Yes</a></li>
                <li><a href="#tcap1a3b1b">No</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent
                    headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                    &#40;contact with known cases of “atypical” pneumonia, or if there is a current outbreak&#41;</li>
                <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients
                    admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been
                    undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or
                    L. longbeachae are diagnosed in patients admitted to RDH intensive care unit &#40;ICU&#41;, with
                    some requiring ventilation.</li>
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a3b1-->

    <!-- Start of cap page: SEVERE pen OK Melioid YES #cap1a3c1 -->
    <div data-role="page" id="tcap1a3c1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient likely to require atypical cover?</span>
                <span class="font15"> &#40;See below for a summary of when to consider atypical cover&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a3c1a">Yes</a></li>
                <li><a href="#tcap1a3c1b">No</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent
                    headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues &#40;contact with
                    known cases of “atypical” pneumonia, or if there is a current outbreak&#41;</li>
                <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients
                    admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been
                    undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or
                    L. longbeachae are diagnosed in patients admitted to RDH intensive care unit &#40;ICU&#41;, with
                    some requiring ventilation.</li>
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a3c1-->

    <!--start of CAP gent q#cap1a3b1a -->
    <div data-role="page" id="tcap1a3b1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a2b1a1">Gentamicin contraindicated</a></li>
                <li><a href="#tcap1a2b1a2">Gentamicin not contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Use of concomitant drugs that cause nephrotoxicity or ototoxicity</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a3b1a -->

    <!--start of CAP gent q#cap1a3b1b -->
    <div data-role="page" id="tcap1a3b1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a3b1b1">Gentamicin contraindicated</a></li>
                <li><a href="#tcap1a2b1b2">Gentamicin not contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Use of concomitant drugs that cause nephrotoxicity or ototoxicity</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a3b1b -->

    <!--start of CAP gent #cap1a3c1a -->
    <div data-role="page" id="tcap1a3c1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a2a1a1">Gentamicin contraindicated</a></li>
                <li><a href="#tcap1a2a1a2">Gentamicin not contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Use of concomitant drugs that cause nephrotoxicity or ototoxicity</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a3c1a -->

    <!--start of CAP gent q#cap1a3c1b -->
    <div data-role="page" id="tcap1a3c1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a2a1b1">Gentamicin contraindicated</a></li>
                <li><a href="#tcap1a2a1b2">Gentamicin not contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Use of concomitant drugs that cause nephrotoxicity or ototoxicity</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a3c1b -->

    <!--start of CAP gent q#cap1a2a1a -->
    <div data-role="page" id="tcap1a2a1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a2a1a1">Gentamicin contraindicated</a></li>
                <li><a href="#tcap1a2a1a2">Gentamicin not contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Use of concomitant drugs that cause nephrotoxicity or ototoxicity</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2a1a -->

    <!--start of CAP gent q#cap1a2b1a -->
    <div data-role="page" id="tcap1a2b1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a2b1a1">Gentamicin contraindicated</a></li>
                <li><a href="#tcap1a2b1a2">Gentamicin not contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Use of concomitant drugs that cause nephrotoxicity or ototoxicity</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2b1a -->

    <!--start of CAP gent q#cap1a2b1a -->
    <div data-role="page" id="tcap1a2c1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a2c1a1">Gentamicin contraindicated</a></li>
                <li><a href="#tcap1a2c1a2">Gentamicin not contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Use of concomitant drugs that cause nephrotoxicity or ototoxicity</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2c1a -->

    <!--start of CAP gent q#cap1a2a1b -->
    <div data-role="page" id="tcap1a2a1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a2a1b1">Gentamicin contraindicated</a></li>
                <li><a href="#tcap1a2a1b2">Gentamicin not contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Use of concomitant drugs that cause nephrotoxicity or ototoxicity</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2a1b -->

    <!--start of CAP gent q#cap1a2b1b -->
    <div data-role="page" id="tcap1a2b1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a2b1b1">Gentamicin contraindicated</a></li>
                <li><a href="#tcap1a2b1b2">Gentamicin not contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Use of concomitant drugs that cause nephrotoxicity or ototoxicity</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2b1b -->

    <!--start of CAP gent q#cap1a2c1b -->
    <div data-role="page" id="tcap1a2c1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a2a1b1">Gentamicin contraindicated</a></li>
                <li><a href="#tcap1a2a1b2">Gentamicin not contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Use of concomitant drugs that cause nephrotoxicity or ototoxicity</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2c1b -->

    <!-- Start of cap page: SEVERE pen OK ?wet #cap1a4c -->
    <div data-role="page" id="tcap1a4c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is this patient being treated in the wet season or dry season?</span>
                <span class="font15"> (See below for details)</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#tcap1a4a1">Wet season</a></li>
                <li><a href="#tcap1a4c2">Dry season</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Typically the wet season is from November 1st to April 30th, however this may vary year to year.
                </li>
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a4c-->

    <!--TREATMENTS FOR CAP BEGIN->
    <!- Start of CAP Sev MILD, Pen MILD, Melioid YES, atypicals YES, : #cap1a1a1 -->
    <div data-role="page" id="tcap1a1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Community acquired pneumonia</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Mild community acquired pneumonia should be treated as an outpatient with
                    oral antibiotic therapy where possible:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Doxycycline 200 mg orally, as a
                        single dose</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Doxycycline 100 mg orally, 12-hourly
                        for 5-7 days</span>
                </h4>
            </div>
            <br>
            <p class="mrgn20b"><b>As either monotherapy, or with addition of either</b></p>
            <br>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Cefuroxime 500 mg orally, 12-hourly
                        for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Ceftriaxone 2 g IV, daily for 1-3
                        days then switch to oral</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. IFD must be contacted if treatment is to continue past 48
                    hours. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for cefuroxime is:</span>
                <span class="font15 bold"> 7<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only &#40;starting from
                    today&#41;. IFD must be contacted if treatment is to continue past one week. Please annotate when
                    IFD are to be contacted on eMMa and in patient notes</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
                <li>It is important to use oral drugs or a penicillin rather than ceftriaxone if possible, as overuse of
                    third-generation cephalosporins within a hospital has been shown to lead to an increased incidence
                    of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li>
                <li>NB if discharging a patient home on cefuroxime only 3.5 days of 500 mg bd dosage can be supplied
                    through the PBS. For a duration any longer than three and a half days PBS will have to be contacted
                    for an authority prescription</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a1a1a -->

    <!-- Start of CAP Sev MILD, Pen BAD, Melioid YES, atypicals YES, : #cap1a1b -->
    <div data-role="page" id="tcap1a1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Mild community acquired pneumonia should be treated as an outpatient with
                    oral antibiotic therapy where possible:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 200 mg orally, as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 100 mg orally, 12-hourly for 5-7 days</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>Resistance to doxycycline in <i>Streptococcus pneumoniae</i> is rising in Australia. Advise the
                    patient to return to hospital if they are not improving after 48 hours of treatment</li>
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
                <li>If compliance with oral antibiotics is unlikely consider treating as for moderate pneumonia</li>
                <li>It is important to use oral drugs or a penicillin rather than ceftriaxone if appropriate, as overuse
                    of third-generation cephalosporins within a hospital has been shown to lead to an increased
                    incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a1b -->

    <!-- Start of CAP Sev MILD, Pen MILD, Melioid YES, atypicals YES, : #cap1a1c1a -->
    <div data-role="page" id="tcap1a1c1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Mild community acquired pneumonia should be treated as an outpatient with
                    oral antibiotic therapy where possible:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Doxycycline 200 mg orally, as a
                        single dose</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Doxycycline 100 mg orally, 12-hourly
                        for 5-7 days</span>
                </h4>
            </div>
            <p class="mrgn20b"><b>AND either</b></p>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Amoxicillin 1 g orally, 8-hourly for
                        5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Benzylpenicillin 1.2 g I.V, 6-hourly
                        for 1-3 days then switch to oral</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
                <li>It is important to use oral drugs or a penicillin rather than ceftriaxone if appropriate, as overuse
                    of third-generation cephalosporins within a hospital has been shown to lead to an increased
                    incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a1c1a -->

    <!-- Start of CAP Sev MILD, Pen OK, Melioid YES, atypicals NO, : #cap1a1c1b -->
    <div data-role="page" id="tcap1a1c1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Mild community acquired pneumonia should be treated as an outpatient with
                    oral antibiotic therapy where possible:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 1 g orally, 8-hourly for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Benzylpenicillin 1.2 g I.V, 6-hourly for 1-3 days then switch to
                        oral</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
                <li>It is important to use oral drugs or a penicillin rather than ceftriaxone if appropriate, as overuse
                    of third-generation cephalosporins within a hospital has been shown to lead to an increased
                    incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a1c1b -->

    <!-- Start of CAP Sev MOD, Pen NO/MILD, Melioid YES, atypicals YES, GENT BAD : #cap1a2c1a1 -->
    <div data-role="page" id="tcap1a2c1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Community acquired pneumonia treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 200 mg orally, as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 100 mg orally, 12-hourly for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2 g IV, daily until results of cultures available or patient
                        meets switch to oral criteria (usually 2-3 days)</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>cao</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. IFD must be contacted if treatment is to continue past 72
                    hours. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
                <li>It is important to step down to oral drugs or a penicillin rather than ceftriaxone as soon as
                    appropriate, as overuse of third-generation cephalosporins within a hospital has been shown to lead
                    to an increased incidence of infection with multi-resistant Gram negative organisms, C.difficile and
                    MRSA</li>
                <li>Ensure blood cultures, sputum Gram stain and cultures and melioid serology are sent to pathology for
                    testing. Please see the Therapeutic Guidelines Antibiotic for a full list of all relevant tests
                    required</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2c1a1 -->

    <!-- Start of CAP Sev MOD, Pen NO/MILD, Melioid YES, atypicals YES, GENT OK : #cap1a2a1a2 -->
    <div data-role="page" id="tcap1a2c1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Community acquired pneumonia treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 200 mg orally, as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 100 mg orally, 12-hourly for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2 g IV, daily until results of cultures available or patient
                        meets switch to oral criteria (usually 2-3 days)</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomograms below or use the <a
                            href="#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>cao</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. IFD must be contacted if treatment is to continue past 72
                    hours. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>cao</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. IFD must be contacted if treatment is to continue past 48
                    hours. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
                <li>It is important to step down to oral drugs or a penicillin rather than ceftriaxone as soon as
                    appropriate, as overuse of third-generation cephalosporins within a hospital has been shown to lead
                    to an increased incidence of infection with multi-resistant Gram negative organisms, C.difficile and
                    MRSA</li>
                <li>Gentamicin will require area under the curve and daily vestibular function monitoring if it is to be
                    used for more than 48 hours. Please contact IFD if required for more than 48 hours</li>
                <li>Ensure blood cultures, sputum Gram stain and cultures and melioid serology are sent to pathology for
                    testing. Please see the Therapeutic Guidelines Antibiotic for a full list of all relevant tests
                    required</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose; see the <a href="#dose12">adult aminoglycoside dose calculator</a>. For morbidly
                    obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Please contact IFD if IV therapy with gentamicin is required after 48 hours</li>
                <li>Use the <a href="#dose7">Cockcroft gault calculator</a> to calculate renal function for adults if
                    using the nomogram, or use the <a href="#dose12">adult aminoglycoside dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2c1a2 -->



    <!-- Start of CAP Sev SEVERE, Pen MILD, Melioid YES, atypicals YES, GENT BAD : #cap1a2a1a1 -->
    <div data-role="page" id="tcap1a2a1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Community acquired pneumonia treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 200 mg orally, as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 100 mg orally, 12-hourly for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2 g IV, daily until results of cultures available or patient
                        meets switch to oral criteria (usually 2-3 days)</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>cao</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. IFD must be contacted if treatment is to continue past 72
                    hours. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
                <li>It is important to step down to oral drugs or a penicillin rather than ceftriaxone as soon as
                    appropriate, as overuse of third-generation cephalosporins within a hospital has been shown to lead
                    to an increased incidence of infection with multi-resistant Gram negative organisms, C.difficile and
                    MRSA</li>
                <li>Ensure blood cultures, sputum Gram stain and cultures and melioid serology are sent to pathology for
                    testing. Please see the Therapeutic Guidelines Antibiotic for a full list of all relevant tests
                    required</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2a1a1 -->


    <!-- Start of CAP Sev MOD, Pen MILD, Melioid YES, atypicals YES, GENT OK : #cap1a2a1a2 -->
    <div data-role="page" id="tcap1a2a1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Community acquired pneumonia treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 200 mg orally, as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 100 mg orally, 12-hourly for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2 g IV, daily until results of cultures available or patient
                        meets switch to oral criteria (usually 2-3 days)</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomograms below or use the <a
                            href="#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>cao</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. IFD must be contacted if treatment is to continue past 72
                    hours. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>cao</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. IFD must be contacted if treatment is to continue past 48
                    hours. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
                <li>It is important to use oral agents or a penicillin rather than ceftriaxone as soon as appropriate,
                    as overuse of third-generation cephalosporins within a hospital has been shown to lead to an
                    increased incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA
                </li>
                <li>Gentamicin will require area under the curve and daily vestibular function monitoring if it is to be
                    used for more than 48 hours treatment. Please contact IFD if required for more than 48 hours</li>

                <li>Ensure blood cultures, sputum Gram stain and cultures and melioid serology are sent to pathology for
                    testing. Please see the Therapeutic Guidelines Antibiotic for a full list of all relevant tests
                    required</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>

                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose, see the <a href="#dose12">adult aminoglycoside dose calculator</a>. For morbidly
                    obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Please contact IFD if IV therapy with gentamicin is required after 48 hours</li>
                <li>Use the <a href="#dose7">Cockcroft gault calculator</a> to calculate renal function for adults if
                    using the nomogram, or use the <a href="#dose12">adult aminoglycoside dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2a1a2 -->

    <!-- Start of CAP Sev MOD, Pen BAD, Melioid YES, atypicals YES, GENT BAD : #cap1a2b1a1 -->
    <div data-role="page" id="tcap1a2b1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Community acquired pneumonia treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 200 mg orally, as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 100 mg orally, 12-hourly for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Moxifloxacin 400 mg orally, daily for 5-7 days</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for PO moxifloxacin is:</span>
                <span class="font15 bold"> 7<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only, starting from the
                    first day of treatment for this condition. IFD must be contacted if treatment is to continue past
                    one week. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>

                <li>Ensure blood cultures, sputum Gram stain and cultures and melioid serology are sent to pathology for
                    testing. Please see the Therapeutic Guidelines Antibiotic for a full list of all relevant tests
                    required</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2b1a1 -->

    <!-- Start of CAP Sev MOD, Pen BAD, Melioid YES, atypicals YES, GENT OK : #cap1a2b1a2 -->
    <div data-role="page" id="tcap1a2b1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Community acquired pneumonia treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 200 mg orally, as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 100 mg orally, 12-hourly for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Moxifloxacin 400 mg orally, daily for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomograms below or use the <a
                            href="#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for PO moxifloxacin is:</span>
                <span class="font15 bold"> 7<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only, starting from the
                    first day of treatment for this condition. IFD must be contacted if treatment is to continue past
                    one week. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>cao</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. IFD must be contacted if IV treatment is to continue past
                    48 hours. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
                <li>Ensure blood cultures, sputum Gram stain and cultures and melioid serology are sent to pathology for
                    testing. Please see the Therapeutic Guidelines Antibiotic for a full list of all relevant tests
                    required</li>
                <li>Gentamicin will require area under the curve and daily vestibular function monitoring if it is to be
                    used for more than 48 hours treatment. Please contact IFD if required for more than 48 hours</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose, see the <a href="#dose12">adult aminoglycoside dose calculator</a>. For morbidly
                    obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Use the <a href="#dose7">Cockcroft gault calculator</a> to calculate renal function for adults if
                    using the nomogram, or use the <a href="#dose12">adult aminoglycoside dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2b1a2 -->

    <!-- Start of CAP Sev MOD, Pen OK, Melioid NO, atypicals YES,: #cap1a2c2a -->
    <div data-role="page" id="tcap1a2c2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Community acquired pneumonia treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 200 mg orally, as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline 100 mg orally, 12-hourly for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Benzylpenicillin 1.2 g IV, 6-hourly until results of cultures available
                        or patient meets switch to oral criteria (usually 2-3 days)</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
                <li>Ensure blood cultures, sputum Gram stain and cultures and melioid serology are sent to pathology for
                    testing. Please see the Therapeutic Guidelines Antibiotic for a full list of all relevant tests
                    required</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2c2a -->

    <!-- Start of CAP Sev MOD, Pen OK, Melioid NO, atypicals NO,: #cap1a2c2b -->
    <div data-role="page" id="tcap1a2c2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Community acquired pneumonia treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Benzylpenicillin 1.2 g IV, 6-hourly until results of cultures available
                        or patient meets switch to oral criteria (usually 2-3 days)</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
                <li>Ensure blood cultures, sputum Gram stain and cultures and melioid serology are sent to pathology for
                    testing. Please see the Therapeutic Guidelines Antibiotic for a full list of all relevant tests
                    required</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2c2b -->

    <!-- Start of CAP Sev MOD, Pen OK, Melioid NO, atypicals YES,: #cap1a2a1b1 -->
    <div data-role="page" id="tcap1a2a1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Community acquired pneumonia treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2 g IV, daily until results of cultures available or patient
                        meets switch to oral criteria (usually 2-3 days)</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>cao</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. IFD must be contacted if treatment is to continue past 72
                    hours. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
            </h4>
            <hr />
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
                <li>Ensure blood cultures, sputum Gram stain and cultures and melioid serology are sent to pathology for
                    testing. Please see the Therapeutic Guidelines Antibiotic for a full list of all relevant tests
                    required</li>
                <li>It is important to use oral agents or a penicillin rather than ceftriaxone where appropriate, as
                    overuse of third-generation cephalosporins within a hospital has been shown to lead to an increased
                    incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2a1b1 -->

    <!-- Start of CAP Sev MOD, Pen BAD, Melioid YES, atypicals YES, GENT OK : #cap1a2a1b2 -->
    <div data-role="page" id="tcap1a2a1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Community acquired pneumonia treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2 g IV, daily for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomogram below or use the <a
                            href="#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>cao</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. IFD must be contacted if treatment is to continue past 72
                    hours. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>cao</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. IFD must be contacted if treatment is to continue past 48
                    hours. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
            </h4>
            <hr />
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>

                <li>Ensure blood cultures, sputum Gram stain and cultures and melioid serology are sent to pathology for
                    testing. Please see the Therapeutic Guidelines Antibiotic for a full list of all relevant tests
                    required</li>
                <li>Gentamicin will require area under the curve and daily vestibular function monitoring if it is to be
                    used for more than 48 hours treatment. Please contact IFD if required for more than 48 hours</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>

                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose, see the <a href="#dose12">adult aminoglycoside dose calculator</a>. For morbidly
                    obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Use the <a href="#dose7">Cockcroft gault calculator</a> to calculate renal function for adults if
                    using the nomogram, or use the <a href="#dose12">adult aminoglycoside dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2a1b2 -->

    <!-- Start of CAP Sev MOD, Pen BAD, Melioid NO, atypicals NO, GENT NO: #cap1a2b1b1 -->
    <div data-role="page" id="tcap1a2b1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Community acquired pneumonia treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Moxifloxacin 400 mg orally, daily for 5-7 days</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for PO moxifloxacin is:</span>
                <span class="font15 bold"> 7<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only, starting from the
                    first day of treatment for this condition. IFD must be contacted if treatment is to continue past
                    one week</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>

                <li>Ensure blood cultures, sputum Gram stain and cultures and melioid serology are sent to pathology for
                    testing. Please see the Therapeutic Guidelines Antibiotic for a full list of all relevant tests
                    required</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2b1b1 -->

    <!-- Start of CAP Sev MOD, Pen BAD, Melioid YES, atypicals NO, GENT OK : #cap1a2b1b2 -->
    <div data-role="page" id="tcap1a2b1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Community acquired pneumonia treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Moxifloxacin 400 mg Orally, daily for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomograms below or use the <a
                            href="#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for PO moxifloxacin is:</span>
                <span class="font15 bold"> 7<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only, starting from the
                    first day of treatment for this condition. IFD must be contacted if treatment is to continue past
                    one week</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. IFD must be contacted if IV treatment is to continue past
                    48 hours. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>

                <li>Ensure blood cultures, sputum Gram stain and cultures and melioid serology are sent to pathology for
                    testing. Please see the Therapeutic Guidelines Antibiotic for a full list of all relevant tests
                    required</li>
                <li>Gentamicin will require area under the curve and daily vestibular function monitoring if it is to be
                    used for more than 48 hours treatment. Please contact IFD if required for more than 48 hours</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose, see the <a href="#dose12">adult aminoglycoside dose calculator</a>. For morbidly
                    obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Use the <a href="#dose7">Cockcroft gault calculator</a> to calculate renal function for adults if
                    using the nomogram, or use the <a href="#dose12">adult aminoglycoside dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a2b1b2 -->

    <!-- Start of CAP Sev SEVERE, Pen BAD, Melioid YES, atypicals NO, GENT BAD: #cap1a3b1b1 -->
    <div data-role="page" id="tcap1a3b1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Severe community acquired pneumonia in a patient with previous anaphylaxis
                    to penicillin unable to tolerate gentamicin requires consultation with IFD. Start treatment
                    with:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Moxifloxacin 400 mg Orally or IV, as a single dose until IFD can be
                        contacted for advice.</span>
                </h4>
                <h4 class="medicine mrgn20b">
                    <h4 class="color-danger mrgn20b">Please contact IFD as soon as possible for advice on treatment in
                        this patient</h4>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for IV moxifloxacin is:</span>
                <span class="font15 bold"> 1<script> document.write(getCode())</script>cao</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>ONE</b> dose only. IFD must be contacted
                    if treatment is to continue past one dose, Please annotate when IFD are to be contacted on eMMa and
                    in patient notes</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
                <li>Ensure blood cultures, sputum Gram stain and cultures and melioid serology are sent to pathology for
                    testing. Please see the Therapeutic Guidelines Antibiotic for a full list of all relevant tests
                    required</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a3b1b1 -->

    <!-- Start of CAP Sev ICU, Pen MILD, Wet YES, MRSA YES : #cap1a4a1 -->
    <div data-role="page" id="tcap1a4a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Severe community acquired pneumonia:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Meropenem 1 g IV, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Azithromycin 500 mg IV, daily</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> if MRSA is suspected or confirmed</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per the nomogram below or use the <a
                            href="#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for meropenem, azithromycin &#40;and vancomycin if required&#41;
                    is:</span>
                <span class="font15 bold"> 1<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>ONE</b> day only. Starting from the
                    first day of treatment for this condition. IFD must be contacted within 24 hours of admission for
                    this patient. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call IFD</td>
                        <td>Call IFD</td>
                        <td>Call IFD</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call IFD</td>
                        <td>Call IFD</td>
                        <td>Call IFD</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul class="line30">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
                <br>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a4a1 -->


    <!-- Start of CAP Sev ICU, Pen MILD, Wet YES, ANAPHYLAXIS : #cap1a4a1 -->
    <div data-role="page" id="tcap1a4a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Severe community acquired pneumonia with penicillin anaphylaxis:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <h4 class="color-danger mrgn20b">Please contact IFD. A decision must be made based on the patients
                        past exposure</h4>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
                <br>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a4a2 -->

    <!-- Start of CAP Sev ICU, Pen MILD, Wet YES : #cap1a4c2 -->
    <div data-role="page" id="tcap1a4c2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Tropical community acquired pneumonia</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Severe community acquired pneumonia:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Piperacillin/tazobactam 4/0.5 g IV, 6-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Azithromycin 500 mg IV, daily</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> if MRSA is suspected or confirmed</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per the nomogram below or use the <a
                            href="#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for meropenem, azithromycin &#40;and vancomycin if required&#41;
                    is:</span>
                <span class="font15 bold"> 1<script> document.write(getCode())</script>cap</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>ONE</b> day only. Starting from the first day of treatment for this
                    condition. IFD must be contacted within 24 hours of admission with severe community acquired
                    pneumonia
                </div>
            </h4>
            <hr />
            <ul class="line30">
                <li>For more information on pneumonia in the tropics please see the Therapeutic Guidelines</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call IFD</td>
                        <td>Call IFD</td>
                        <td>Call IFD</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call IFD</td>
                        <td>Call IFD</td>
                        <td>Call IFD</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul class="line30">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>

            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Community Acquired Pneumonia </a> section for more
                    information on treatment of community acquired pneumonia</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cap1a4c2 -->

    <!-- END OF TROPICAL CAP -->

    <!-- End of Pneumonias YOOOOOOOOOO!-->


    <!--START OF LUNG ABSCESS MAZE-->


    <!-- Start of  LUNG ABSCESS, ?PEN -->
    <div data-role="page" id="luabsc" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Lung abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#luabsc1">No penicillin allergy</a></li>
                <li><a href="#luabsc2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#luabsc3">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc -->

    <!-- Start of LUNG ABSCESS, NO PEN, ?TYPE -->
    <div data-role="page" id="luabsc1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Lung abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">What is the source and severity of the lung abscess? (see below)</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#luabsc1a"><u>Nonsevere</u> lung abscess due to aspiration of oral bacteria</a></li>
                <li><a href="#luabsc1b">Community-acquired <u>severe</u> lung abscess due to aspiration of oral bacteria</a></li>
                <li><a href="#luabsc1c">Hospital-acquired <u>severe</u> lung abscess due to aspiration of oral bacteria</a></li>
                <li><a href="#luabsc1d">Lung abscess due to <u>septic jugular thrombophlebitis</u> (Lemierre syndrome)</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>A lung abscess can be classified as <u>nonsevere</u> if:</li>
                <ul>
                    <li>There is no evidence of bacteraemia or <i>Staphylococcus aureus</i> infection</li>
                    <li>The patient does not have sepsis or septic shock (see the WA Health Sepsis Management Guidelines for details on how to identify sepsis and septic shock)</li>
                </ul>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc1 -->

    <!-- Start of LUNG ABSCESS, MILD PEN, ?TYPE -->
    <div data-role="page" id="luabsc2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Lung abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">What is the source and severity of the lung abscess? (see below)</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#luabsc2a"><u>Nonsevere</u> lung abscess due to aspiration of oral bacteria</a></li>
                <li><a href="#luabsc2b">Community-acquired <u>severe</u> lung abscess due to aspiration of oral bacteria</a></li>
                <li><a href="#luabsc2c">Hospital-acquired <u>severe</u> lung abscess due to aspiration of oral bacteria</a></li>
                <li><a href="#luabsc2d">Lung abscess due to <u>septic jugular thrombophlebitis</u> (Lemierre syndrome)</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>A lung abscess can be classified as <u>nonsevere</u> if:</li>
                <ul>
                    <li>There is no evidence of bacteraemia or <i>Staphylococcus aureus</i> infection</li>
                    <li>The patient does not have sepsis or septic shock (see the WA Health Sepsis Management Guidelines for details on how to identify sepsis and septic shock)</li>
                </ul>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc2 -->

    <!-- Start of LUNG ABSCESS, BAD PEN, ?TYPE -->
    <div data-role="page" id="luabsc3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Lung abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">What is the source and severity of the lung abscess? (see below)</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#luabsc2a"><u>Nonsevere</u> lung abscess due to aspiration of oral bacteria</a></li>
                <li><a href="#luabsc3b">Community-acquired <u>severe</u> lung abscess due to aspiration of oral bacteria</a></li>
                <li><a href="#luabsc3b">Hospital-acquired <u>severe</u> lung abscess due to aspiration of oral bacteria</a></li>
                <li><a href="#luabsc3d">Lung abscess due to <u>septic jugular thrombophlebitis</u> (Lemierre syndrome)</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>A lung abscess can be classified as <u>nonsevere</u> if:</li>
                <ul>
                    <li>There is no evidence of bacteraemia or <i>Staphylococcus aureus</i> infection</li>
                    <li>The patient does not have sepsis or septic shock (see the WA Health Sepsis Management Guidelines for details on how to identify sepsis and septic shock)</li>
                </ul>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc3 -->

    <!-- Start of LUNG ABSCESS, NO PEN, NON-SEVERE, ?SYSTEMIC -->
    <div data-role="page" id="luabsc1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Lung abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the patient have any systemic features of infection or chest wall pain?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#luabsc1a1"><u>No</u>, no systemic features or chest wall pain</a></li>
                <li><a href="#luabsc1a2"><u>Yes</u>, patient has either systemic features or chest wall pain</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc1a -->

    <!-- Start of LUNG ABSCESS, MILD OR BAD PEN, NON-SEVERE, ?SYSTEMIC -->
    <div data-role="page" id="luabsc2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Lung abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the patient have any systemic features of infection or chest wall pain?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#luabsc2a1"><u>No</u>, no systemic features or chest wall pain</a></li>
                <li><a href="#luabsc2a2"><u>Yes</u>, patient has either systemic features or chest wall pain</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc2a -->

    <!-- Start of LUNG ABSCESS, NO PEN, CA-SEVERE, ?SEPTIC -->
    <div data-role="page" id="luabsc1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Lung abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the source of the abscess unknown, and is the patient displaying signs of septic shock?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#luabsc1b1"><u>No</u>, no septic shock, or source of infection is well known</a></li>
                <li><a href="#luabsc1b2"><u>Yes</u>, patient has symptoms of septic shock and source of abscess is not well known</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>An adult should be considered to have septic shock if they have sepsis and, despite adequate fluid resuscitation <b>either</b> of the following features :</li>
                <ul>
                    <li>Inability to maintain a mean arterial pressure of 65 mmHg (or a systolic blood pressure of 90 mmHg) without vasopressors
                    <li>Blood lactate concentration more than 2 mmol/L</li>
                </ul>
                <li>In <b>neonates</b>, clinical features of sepsis or septic shock may be nonspecific and include signs that are not typical of sepsis in older patients (eg apnoea, temperature instability, feeding intolerance). Consider sepsis in neonates when their clinical state is causing significant concern to family or clinical staff. Multiple Australian and international resources provide guidance on recognising and managing neonatal sepsis</li>
                <li>Because the signs of sepsis in neonates may be nonspecific, it is usual to give antibiotics initially for suspected sepsis (eg neonates born to mothers with confirmed intra-amniotic infection). Antibiotic therapy is then modified or stopped based on clinical progress, microbiology (eg blood culture results) and other laboratory investigations (eg full blood count, C-reactive protein)</li>
                <li>In <b>infants and children</b>, standard observations (eg respiratory rate, blood pressure) and signs of life-threatening organ dysfunction vary according to the patient’s age; age-appropriate standard observation charts are available in most jurisdictions. Clinical features can be nonspecific and include signs that are not typical of sepsis in older patients (eg gasping, grunting, increased irritability or lethargy, inability to feed or eat). Consider sepsis in infants and children when their clinical state is causing significant concern to family or clinical staff</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc1b -->

    <!-- Start of LUNG ABSCESS, NO PEN, CA-SEVERE, YES SEPTIC, ?GENT -->
    <div data-role="page" id="luabsc1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Lung abscess</h1>
        </div>
        <!-- /header -->
        <h3 class="color-primary mrgn20b">Is gentamicin contraindicated in this patient? <span
                class="color-info font15">&#40;See below for contraindications&#41;</span></h3>

        <div data-role="content" class="container-fluid">
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#luabsc1b2a">Gentamicin not contraindicated</a></li>
                <li><a href="#luabscx">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b text-center">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc1b2 -->

    <!-- Start of LUNG ABSCESS, MILD PEN, CA-SEVERE, YES SEPTIC, ?GENT -->
    <div data-role="page" id="luabsc2b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Lung abscess</h1>
        </div>
        <!-- /header -->
        <h3 class="color-primary mrgn20b">Is gentamicin contraindicated in this patient? <span
                class="color-info font15">&#40;See below for contraindications&#41;</span></h3>

        <div data-role="content" class="container-fluid">
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#luabsc2b2a">Gentamicin not contraindicated</a></li>
                <li><a href="#luabscx">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b text-center">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc2b2 -->

    <!-- Start of LUNG ABSCESS, NO PEN, HA-SEVERE, YES SEPTIC, ?GENT -->
    <div data-role="page" id="luabsc1c2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Lung abscess</h1>
        </div>
        <!-- /header -->
        <h3 class="color-primary mrgn20b">Is gentamicin contraindicated in this patient? <span
                class="color-info font15">&#40;See below for contraindications&#41;</span></h3>

        <div data-role="content" class="container-fluid">
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#luabsc1c2a">Gentamicin not contraindicated</a></li>
                <li><a href="#luabscx">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b text-center">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc1c2 -->

    <!-- Start of LUNG ABSCESS, NO PEN, HA-SEVERE, YES SEPTIC, ?GENT -->
    <div data-role="page" id="luabsc2c2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Lung abscess</h1>
        </div>
        <!-- /header -->
        <h3 class="color-primary mrgn20b">Is gentamicin contraindicated in this patient? <span
                class="color-info font15">&#40;See below for contraindications&#41;</span></h3>

        <div data-role="content" class="container-fluid">
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#luabsc2c2a">Gentamicin not contraindicated</a></li>
                <li><a href="#luabscx">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b text-center">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc2c2 -->

    <!-- Start of LUNG ABSCESS, NO PEN, HA-SEVERE, ?SEPTIC -->
    <div data-role="page" id="luabsc1c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Lung abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the patient displaying any signs of septic shock?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#luabsc1c1"><u>No</u>, no signs of septic shock</a></li>
                <li><a href="#luabsc1c2"><u>Yes</u>, patient has symptoms of septic shock</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>An adult should be considered to have septic shock if they have sepsis and, despite adequate fluid resuscitation <b>either</b> of the following features :</li>
                <ul>
                    <li>Inability to maintain a mean arterial pressure of 65 mmHg (or a systolic blood pressure of 90 mmHg) without vasopressors
                    <li>Blood lactate concentration more than 2 mmol/L</li>
                </ul>
                <li>In <b>neonates</b>, clinical features of sepsis or septic shock may be nonspecific and include signs that are not typical of sepsis in older patients (eg apnoea, temperature instability, feeding intolerance). Consider sepsis in neonates when their clinical state is causing significant concern to family or clinical staff. Multiple Australian and international resources provide guidance on recognising and managing neonatal sepsis</li>
                <li>Because the signs of sepsis in neonates may be nonspecific, it is usual to give antibiotics initially for suspected sepsis (eg neonates born to mothers with confirmed intra-amniotic infection). Antibiotic therapy is then modified or stopped based on clinical progress, microbiology (eg blood culture results) and other laboratory investigations (eg full blood count, C-reactive protein)</li>
                <li>In <b>infants and children</b>, standard observations (eg respiratory rate, blood pressure) and signs of life-threatening organ dysfunction vary according to the patient’s age; age-appropriate standard observation charts are available in most jurisdictions. Clinical features can be nonspecific and include signs that are not typical of sepsis in older patients (eg gasping, grunting, increased irritability or lethargy, inability to feed or eat). Consider sepsis in infants and children when their clinical state is causing significant concern to family or clinical staff</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc1c -->

    <!-- Start of LUNG ABSCESS, MILD PEN, CA-SEVERE, ?SEPTIC -->
    <div data-role="page" id="luabsc2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Lung abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the source of the abscess unknown, and is the patient displaying signs of septic shock?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#luabsc2b1"><u>No</u>, no septic shock, or source of infection is well known</a></li>
                <li><a href="#luabsc2b2"><u>Yes</u>, patient has symptoms of septic shock and source of abscess is not well known</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>An adult should be considered to have septic shock if they have sepsis and, despite adequate fluid resuscitation <b>either</b> of the following features :</li>
                <ul>
                    <li>Inability to maintain a mean arterial pressure of 65 mmHg (or a systolic blood pressure of 90 mmHg) without vasopressors
                    <li>Blood lactate concentration more than 2 mmol/L</li>
                </ul>
                <li>In <b>neonates</b>, clinical features of sepsis or septic shock may be nonspecific and include signs that are not typical of sepsis in older patients (eg apnoea, temperature instability, feeding intolerance). Consider sepsis in neonates when their clinical state is causing significant concern to family or clinical staff. Multiple Australian and international resources provide guidance on recognising and managing neonatal sepsis</li>
                <li>Because the signs of sepsis in neonates may be nonspecific, it is usual to give antibiotics initially for suspected sepsis (eg neonates born to mothers with confirmed intra-amniotic infection). Antibiotic therapy is then modified or stopped based on clinical progress, microbiology (eg blood culture results) and other laboratory investigations (eg full blood count, C-reactive protein)</li>
                <li>In <b>infants and children</b>, standard observations (eg respiratory rate, blood pressure) and signs of life-threatening organ dysfunction vary according to the patient’s age; age-appropriate standard observation charts are available in most jurisdictions. Clinical features can be nonspecific and include signs that are not typical of sepsis in older patients (eg gasping, grunting, increased irritability or lethargy, inability to feed or eat). Consider sepsis in infants and children when their clinical state is causing significant concern to family or clinical staff</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc2b -->

    <!-- Start of LUNG ABSCESS, MILD PEN, HA-SEVERE, ?SEPTIC -->
    <div data-role="page" id="luabsc2c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Lung abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the patient displaying any signs of septic shock?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#luabsc2c1"><u>No</u>, no signs of septic shock</a></li>
                <li><a href="#luabsc2c2"><u>Yes</u>, patient has symptoms of septic shock</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>An adult should be considered to have septic shock if they have sepsis and, despite adequate fluid resuscitation <b>either</b> of the following features :</li>
                <ul>
                    <li>Inability to maintain a mean arterial pressure of 65 mmHg (or a systolic blood pressure of 90 mmHg) without vasopressors
                    <li>Blood lactate concentration more than 2 mmol/L</li>
                </ul>
                <li>In <b>neonates</b>, clinical features of sepsis or septic shock may be nonspecific and include signs that are not typical of sepsis in older patients (eg apnoea, temperature instability, feeding intolerance). Consider sepsis in neonates when their clinical state is causing significant concern to family or clinical staff. Multiple Australian and international resources provide guidance on recognising and managing neonatal sepsis</li>
                <li>Because the signs of sepsis in neonates may be nonspecific, it is usual to give antibiotics initially for suspected sepsis (eg neonates born to mothers with confirmed intra-amniotic infection). Antibiotic therapy is then modified or stopped based on clinical progress, microbiology (eg blood culture results) and other laboratory investigations (eg full blood count, C-reactive protein)</li>
                <li>In <b>infants and children</b>, standard observations (eg respiratory rate, blood pressure) and signs of life-threatening organ dysfunction vary according to the patient’s age; age-appropriate standard observation charts are available in most jurisdictions. Clinical features can be nonspecific and include signs that are not typical of sepsis in older patients (eg gasping, grunting, increased irritability or lethargy, inability to feed or eat). Consider sepsis in infants and children when their clinical state is causing significant concern to family or clinical staff</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc2c -->

    <!-- Start of LUNG ABSCESS, NO PEN, JUGULAR, ?SEPTIC -->
    <div data-role="page" id="luabsc1d" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Lung abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the patient displaying any signs of septic shock?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#luabsc1d1"><u>No</u>, no signs of septic shock</a></li>
                <li><a href="#luabsc1d2"><u>Yes</u>, patient has symptoms of septic shock</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>An adult should be considered to have septic shock if they have sepsis and, despite adequate fluid resuscitation <b>either</b> of the following features :</li>
                <ul>
                    <li>Inability to maintain a mean arterial pressure of 65 mmHg (or a systolic blood pressure of 90 mmHg) without vasopressors
                    <li>Blood lactate concentration more than 2 mmol/L</li>
                </ul>
                <li>In <b>neonates</b>, clinical features of sepsis or septic shock may be nonspecific and include signs that are not typical of sepsis in older patients (eg apnoea, temperature instability, feeding intolerance). Consider sepsis in neonates when their clinical state is causing significant concern to family or clinical staff. Multiple Australian and international resources provide guidance on recognising and managing neonatal sepsis</li>
                <li>Because the signs of sepsis in neonates may be nonspecific, it is usual to give antibiotics initially for suspected sepsis (eg neonates born to mothers with confirmed intra-amniotic infection). Antibiotic therapy is then modified or stopped based on clinical progress, microbiology (eg blood culture results) and other laboratory investigations (eg full blood count, C-reactive protein)</li>
                <li>In <b>infants and children</b>, standard observations (eg respiratory rate, blood pressure) and signs of life-threatening organ dysfunction vary according to the patient’s age; age-appropriate standard observation charts are available in most jurisdictions. Clinical features can be nonspecific and include signs that are not typical of sepsis in older patients (eg gasping, grunting, increased irritability or lethargy, inability to feed or eat). Consider sepsis in infants and children when their clinical state is causing significant concern to family or clinical staff</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc1d -->

    <!-- Start of LUNG ABSCESS, BAD PEN, JUGULAR, ?SEPTIC -->
    <div data-role="page" id="luabsc2d" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Lung abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the patient displaying any signs of septic shock?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#luabsc2b1"><u>No</u>, no signs of septic shock</a></li>
                <li><a href="#luabsc2d2"><u>Yes</u>, patient has symptoms of septic shock</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>An adult should be considered to have septic shock if they have sepsis and, despite adequate fluid resuscitation <b>either</b> of the following features :</li>
                <ul>
                    <li>Inability to maintain a mean arterial pressure of 65 mmHg (or a systolic blood pressure of 90 mmHg) without vasopressors
                    <li>Blood lactate concentration more than 2 mmol/L</li>
                </ul>
                <li>In <b>neonates</b>, clinical features of sepsis or septic shock may be nonspecific and include signs that are not typical of sepsis in older patients (eg apnoea, temperature instability, feeding intolerance). Consider sepsis in neonates when their clinical state is causing significant concern to family or clinical staff. Multiple Australian and international resources provide guidance on recognising and managing neonatal sepsis</li>
                <li>Because the signs of sepsis in neonates may be nonspecific, it is usual to give antibiotics initially for suspected sepsis (eg neonates born to mothers with confirmed intra-amniotic infection). Antibiotic therapy is then modified or stopped based on clinical progress, microbiology (eg blood culture results) and other laboratory investigations (eg full blood count, C-reactive protein)</li>
                <li>In <b>infants and children</b>, standard observations (eg respiratory rate, blood pressure) and signs of life-threatening organ dysfunction vary according to the patient’s age; age-appropriate standard observation charts are available in most jurisdictions. Clinical features can be nonspecific and include signs that are not typical of sepsis in older patients (eg gasping, grunting, increased irritability or lethargy, inability to feed or eat). Consider sepsis in infants and children when their clinical state is causing significant concern to family or clinical staff</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc2d -->

    <!-- Start of LUNG ABSCESS, BAD PEN, JUGULAR, ?SEPTIC -->
    <div data-role="page" id="luabsc3d" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Lung abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the patient displaying any signs of septic shock?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#luabsc3d1"><u>No</u>, no signs of septic shock</a></li>
                <li><a href="#luabsc3b"><u>Yes</u>, patient has symptoms of septic shock</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>An adult should be considered to have septic shock if they have sepsis and, despite adequate fluid resuscitation <b>either</b> of the following features :</li>
                <ul>
                    <li>Inability to maintain a mean arterial pressure of 65 mmHg (or a systolic blood pressure of 90 mmHg) without vasopressors
                    <li>Blood lactate concentration more than 2 mmol/L</li>
                </ul>
                <li>In <b>neonates</b>, clinical features of sepsis or septic shock may be nonspecific and include signs that are not typical of sepsis in older patients (eg apnoea, temperature instability, feeding intolerance). Consider sepsis in neonates when their clinical state is causing significant concern to family or clinical staff. Multiple Australian and international resources provide guidance on recognising and managing neonatal sepsis</li>
                <li>Because the signs of sepsis in neonates may be nonspecific, it is usual to give antibiotics initially for suspected sepsis (eg neonates born to mothers with confirmed intra-amniotic infection). Antibiotic therapy is then modified or stopped based on clinical progress, microbiology (eg blood culture results) and other laboratory investigations (eg full blood count, C-reactive protein)</li>
                <li>In <b>infants and children</b>, standard observations (eg respiratory rate, blood pressure) and signs of life-threatening organ dysfunction vary according to the patient’s age; age-appropriate standard observation charts are available in most jurisdictions. Clinical features can be nonspecific and include signs that are not typical of sepsis in older patients (eg gasping, grunting, increased irritability or lethargy, inability to feed or eat). Consider sepsis in infants and children when their clinical state is causing significant concern to family or clinical staff</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc3d -->

    <!-- Start of LUNG ABSCESS, NO PEN, Non-SEVERE, Non-Systemic -->
    <div data-role="page" id="luabsc1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For lung abscess treatment in a patient with no penicillin allergy, and no systemic symptoms use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 1 g (child: 25 mg/kg up to 1 g) orally or enterally, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally or enterally, 12-hourly</span>
                </h4>
            </div>
            <br>
            <div id="backcolour">
                <p class="mrgn20b"><b>OR,</b> if a single-drug regimen is preferred use:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg (child 2 months or older: 22.5+3.2 mg/kg up to 875+125 mg) orally or enterally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <ul type="circle" class="line30">
                <li>Lung abscesses are usually identified on chest X-ray imaging. For patients with suspected lung abscess, consider differential diagnoses. Peripheral lung abscesses should be differentiated from loculated parapneumonic effusions or empyema (see the Therapeutic Guideline's Investigations for lung abscess). In patients with a solitary cavitary pulmonary lesion, differential diagnoses include:</li>
                <ul>
                    <li>consolidation surrounding pre-existing bullae in patients with emphysema</li>
                    <li>tumours</li>
                    <li>vasculitis</li>
                    <li>tuberculosis</li>
                </ul>
                <li>Patients requiring hospital assessment or admission because of lung abscess may require the following investigations:</li>
                <ul>
                    <li>blood culture—if haematogenous spread from Staphylococcus aureus bacteraemia or septic jugular thrombophlebitis is suspected, or the patient has sepsis or septic shock, collect three sets of blood samples for culture before starting antibiotic therapy</li>
                    <li>sputum Gram stain and culture—collect a sputum sample for Gram stain and culture before starting antibiotic therapy. Ensure a good quality sample (eg presence of polymorphs, but few or no squamous epithelial cells on microscopy) is collected</li>
                    <li>pleural ultrasound—if loculated parapneumonic effusion is a differential diagnosis, perform a pleural ultrasound. This test is usually superior to computed tomography (CT) in determining loculation</li>
                    <li>CT of the chest—if the diagnosis is uncertain, perform CT of the chest to distinguish between a peripheral lung abscess and empyema</li>
                    <li>echocardiogram—if bacteraemia is suspected in an adult, perform a transthoracic echocardiogram (TTE) or transoesophageal echocardiogram (TOE) to exclude endocarditis</li>
                    <li>bronchoscopy—if an obstructing tumour or aspirated foreign body (eg tooth, peanut) is suspected, perform bronchoscopy. In immunocompromised patients, bronchoscopy may be indicated to obtain samples for extensive microbiological testing, because infection with unusual pathogens is possible (see Approach to pneumonia in immunocompromised patients in the Therapeutic Guidelines)</li>
                </ul>
                <li>Oral therapy is recommended for patients with nonsevere lung abscess who do not have systemic features of infection (eg tachypnoea, hypoxaemia) or chest wall pain. Patients with systemic features of infection or chest wall pain need hospital admission and, unless an antibiotic with good bioavailability is available, initial intravenous therapy</li>
                <li>The total duration of therapy is usually 3 to 4 weeks (intravenous + oral). For large abscesses with persistent fluid, a longer duration of therapy may be required—seek expert advice. Consider monitoring serum C-reactive protein (CRP) for the response to therapy</li>
                <li>If the patient is not improving with antibiotic therapy, review the diagnosis and antibiotic choice. If lung abscess remains the likely diagnosis, seek expert advice from a respiratory physician or thoracic surgeon on the appropriateness of surgery or percutaneous drainage. These interventions are not routinely performed because of the potential for bronchopleural fistula formation when an intercostal catheter is inserted into the abscess; antibiotic therapy alone is often sufficient</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on lung abscess</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc1a1 -->

    <!-- Start of LUNG ABSCESS, NO PEN, Non-SEVERE, YES Systemic -->
    <div data-role="page" id="luabsc1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For lung abscess treatment in a patient with no penicillin allergy, and systemic symptoms of infection use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Benzylpenicillin 1.2 g (child: 50 mg/kg up to 1.2 g) intravenously, 6-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND, either</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally or enterally, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b> if oral or enteral metronidazole is not tolerated</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, 12-hourly</span>
                </h4>
            </div>
            <br/>
            <div id="backcolour">
                <p class="mrgn20b"><b>THEN,</b> when patient has improved and is ready for IV to oral switch (see below) a suitable step down (depending on microbiology) may be:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 1 g (child: 25 mg/kg up to 1 g) orally or enterally, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally or enterally, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b> as a single agent</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg (child 2 months or older: 22.5+3.2 mg/kg up to 875+125 mg) orally or enterally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <ul type="circle" class="line30">
                <li>Lung abscesses are usually identified on chest X-ray imaging. For patients with suspected lung abscess, consider differential diagnoses. Peripheral lung abscesses should be differentiated from loculated parapneumonic effusions or empyema (see the Therapeutic Guideline's Investigations for lung abscess). In patients with a solitary cavitary pulmonary lesion, differential diagnoses include:</li>
                <ul>
                    <li>consolidation surrounding pre-existing bullae in patients with emphysema</li>
                    <li>tumours</li>
                    <li>vasculitis</li>
                    <li>tuberculosis</li>
                </ul>
                <li>Patients requiring hospital assessment or admission because of lung abscess may require the following investigations:</li>
                <ul>
                    <li>blood culture—if haematogenous spread from Staphylococcus aureus bacteraemia or septic jugular thrombophlebitis is suspected, or the patient has sepsis or septic shock, collect three sets of blood samples for culture before starting antibiotic therapy</li>
                    <li>sputum Gram stain and culture—collect a sputum sample for Gram stain and culture before starting antibiotic therapy. Ensure a good quality sample (eg presence of polymorphs, but few or no squamous epithelial cells on microscopy) is collected</li>
                    <li>pleural ultrasound—if loculated parapneumonic effusion is a differential diagnosis, perform a pleural ultrasound. This test is usually superior to computed tomography (CT) in determining loculation</li>
                    <li>CT of the chest—if the diagnosis is uncertain, perform CT of the chest to distinguish between a peripheral lung abscess and empyema</li>
                    <li>echocardiogram—if bacteraemia is suspected in an adult, perform a transthoracic echocardiogram (TTE) or transoesophageal echocardiogram (TOE) to exclude endocarditis</li>
                    <li>bronchoscopy—if an obstructing tumour or aspirated foreign body (eg tooth, peanut) is suspected, perform bronchoscopy. In immunocompromised patients, bronchoscopy may be indicated to obtain samples for extensive microbiological testing, because infection with unusual pathogens is possible (see Approach to pneumonia in immunocompromised patients in the Therapeutic Guidelines)</li>
                </ul>
                <li>Oral therapy is recommended for patients with nonsevere lung abscess who do not have systemic features of infection (eg tachypnoea, hypoxaemia) or chest wall pain. Patients with systemic features of infection or chest wall pain need hospital admission and, unless an antibiotic with good bioavailability is available, initial intravenous therapy</li>
                <li>The total duration of therapy is usually 3 to 4 weeks (intravenous + oral). For large abscesses with persistent fluid, a longer duration of therapy may be required—seek expert advice. Consider monitoring serum C-reactive protein (CRP) for the response to therapy</li>
                <li>If the patient is not improving with antibiotic therapy, review the diagnosis and antibiotic choice. If lung abscess remains the likely diagnosis, seek expert advice from a respiratory physician or thoracic surgeon on the appropriateness of surgery or percutaneous drainage. These interventions are not routinely performed because of the potential for bronchopleural fistula formation when an intercostal catheter is inserted into the abscess; antibiotic therapy alone is often sufficient</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on lung abscess</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc1a2 -->

    <!-- Start of LUNG ABSCESS, NO PEN, CA-SEVERE, NO Sepsis/known source -->
    <div data-role="page" id="luabsc1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For community acquired severe lung abscess treatment in a patient with no penicillin allergy, without signs of septic shock use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple"> Amoxicillin + clavulanate intravenously</span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">1 + 0.2 g 6-hourly</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child 3 months or
                                        older: &nbsp;</span></td>
                                <td><span class="color-purple"> 25 + 5 mg/kg (up to 1 + 0.2g) 6-hourly</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn20b"><b>OR,</b> alternatively, as a two drug regimen:</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Ceftriaxone 2 g (child 1 month or older: 50 mg/kg up to 2 g) intravenously, daily; for patients with septic shock or requiring intensive care support, use ceftriaxone 1 g (child 1 month or older: 50 mg/kg up to 1 g) intravenously, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Cefotaxime 2 g (child: 50 mg/kg up to 2 g) intravenously, 8-hourly; for patients with septic shock or requiring intensive care support, use cefotaxime 2 g (child: 50 mg/kg up to 2 g) intravenously, 6-hourly</span>
                </h4>
            </div>
            <br/>
            <div id="backcolour">
                <p class="mrgn20b"><b>THEN,</b> when patient has improved and is ready for IV to oral switch (see below) a suitable step down (depending on microbiology) may be:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 1 g (child: 25 mg/kg up to 1 g) orally or enterally, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally or enterally, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b> as a single agent</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg (child 2 months or older: 22.5+3.2 mg/kg up to 875+125 mg) orally or enterally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for IV amoxicillin+clavulanate or ceftriaxone or cefotaxime is: </span>
                <span class="font15 bold">4<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FOUR</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if IV
                    treatment is to continue past four days. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Lung abscesses are usually identified on chest X-ray imaging. For patients with suspected lung abscess, consider differential diagnoses. Peripheral lung abscesses should be differentiated from loculated parapneumonic effusions or empyema (see the Therapeutic Guideline's Investigations for lung abscess). In patients with a solitary cavitary pulmonary lesion, differential diagnoses include:</li>
                <ul>
                    <li>consolidation surrounding pre-existing bullae in patients with emphysema</li>
                    <li>tumours</li>
                    <li>vasculitis</li>
                    <li>tuberculosis</li>
                </ul>
                <li>Patients requiring hospital assessment or admission because of lung abscess may require the following investigations:</li>
                <ul>
                    <li>blood culture—if haematogenous spread from Staphylococcus aureus bacteraemia or septic jugular thrombophlebitis is suspected, or the patient has sepsis or septic shock, collect three sets of blood samples for culture before starting antibiotic therapy</li>
                    <li>sputum Gram stain and culture—collect a sputum sample for Gram stain and culture before starting antibiotic therapy. Ensure a good quality sample (eg presence of polymorphs, but few or no squamous epithelial cells on microscopy) is collected</li>
                    <li>pleural ultrasound—if loculated parapneumonic effusion is a differential diagnosis, perform a pleural ultrasound. This test is usually superior to computed tomography (CT) in determining loculation</li>
                    <li>CT of the chest—if the diagnosis is uncertain, perform CT of the chest to distinguish between a peripheral lung abscess and empyema</li>
                    <li>echocardiogram—if bacteraemia is suspected in an adult, perform a transthoracic echocardiogram (TTE) or transoesophageal echocardiogram (TOE) to exclude endocarditis</li>
                    <li>bronchoscopy—if an obstructing tumour or aspirated foreign body (eg tooth, peanut) is suspected, perform bronchoscopy. In immunocompromised patients, bronchoscopy may be indicated to obtain samples for extensive microbiological testing, because infection with unusual pathogens is possible (see Approach to pneumonia in immunocompromised patients in the Therapeutic Guidelines)</li>
                </ul>
                <li>Oral therapy is recommended for patients with nonsevere lung abscess who do not have systemic features of infection (eg tachypnoea, hypoxaemia) or chest wall pain. Patients with systemic features of infection or chest wall pain need hospital admission and, unless an antibiotic with good bioavailability is available, initial intravenous therapy</li>
                <li>The total duration of therapy is usually 3 to 4 weeks (intravenous + oral). For large abscesses with persistent fluid, a longer duration of therapy may be required—seek expert advice. Consider monitoring serum C-reactive protein (CRP) for the response to therapy</li>
                <li>If the patient is not improving with antibiotic therapy, review the diagnosis and antibiotic choice. If lung abscess remains the likely diagnosis, seek expert advice from a respiratory physician or thoracic surgeon on the appropriateness of surgery or percutaneous drainage. These interventions are not routinely performed because of the potential for bronchopleural fistula formation when an intercostal catheter is inserted into the abscess; antibiotic therapy alone is often sufficient</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on lung abscess</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc1b1 -->

    <!-- Start of LUNG ABSCESS, NO PEN, CA-SEVERE, YES Sepsis/unknown source, GENT OK -->
    <div data-role="page" id="luabsc1b2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For community acquired severe lung abscess treatment in a patient with no penicillin allergy, with signs of septic shock use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple"> Amoxicillin + clavulanate intravenously</span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">1 + 0.2 g 6-hourly</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child 3 months or
                                        older: &nbsp;</span></td>
                                <td><span class="color-purple"> 25 + 5 mg/kg (up to 1 + 0.2g) 6-hourly</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17"><span class="color-purple">Gentamicin given over 3-5 minutes intravenously</span></span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">Adults without known or likely pre-existing kidney impairment: :&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Adults with known or likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Child younger than 10 years:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7.5 mg/kg, for the first dose, then use the nomogram below</span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Child 10 years or older:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7 mg/kg, for the first dose, then use the nomogram below</span><br><br></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">A vancomycin loading dose of 25-30 mg/Kg IV</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per nomograms below or use the <a
                            href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <br/>
            <div id="backcolour">
                <p class="mrgn20b"><b>OR,</b> alternatively, as a four drug regimen:</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Ceftriaxone 2 g (child 1 month or older: 50 mg/kg up to 2 g) intravenously, daily; for patients with septic shock or requiring intensive care support, use ceftriaxone 1 g (child 1 month or older: 50 mg/kg up to 1 g) intravenously, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Cefotaxime 2 g (child: 50 mg/kg up to 2 g) intravenously, 8-hourly; for patients with septic shock or requiring intensive care support, use cefotaxime 2 g (child: 50 mg/kg up to 2 g) intravenously, 6-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9314;</span><span class="font17"><span class="color-purple"> Gentamicin given over 3-5 minutes intravenously</span></span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">Adults without known or likely pre-existing kidney impairment: :&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Adults with known or likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Child younger than 10 years:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7.5 mg/kg, for the first dose, then use the nomogram below</span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Child 10 years or older:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7 mg/kg, for the first dose, then use the nomogram below</span><br><br></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9315;</span><span class="color-purple"> A vancomycin loading dose of 25-30 mg/Kg IV (adult and child)</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per nomograms below or use the <a
                            href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <br/>
            <div id="backcolour">
                <p class="mrgn20b"><b>THEN,</b> when patient has improved and is ready for IV to oral switch (see below) a suitable step down (depending on microbiology) may be:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 1 g (child: 25 mg/kg up to 1 g) orally or enterally, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally or enterally, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b> as a single agent</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg (child 2 months or older: 22.5+3.2 mg/kg up to 875+125 mg) orally or enterally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for IV amoxicillin+clavulanate or ceftriaxone or cefotaxime is: </span>
                <span class="font15 bold">4<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FOUR</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if IV
                    treatment is to continue past four days. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin and gentamicin is: </span>
                <span class="font15 bold">2<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if IV
                    treatment is to continue past 48 hours. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Lung abscesses are usually identified on chest X-ray imaging. For patients with suspected lung abscess, consider differential diagnoses. Peripheral lung abscesses should be differentiated from loculated parapneumonic effusions or empyema (see the Therapeutic Guideline's Investigations for lung abscess). In patients with a solitary cavitary pulmonary lesion, differential diagnoses include:</li>
                <ul>
                    <li>consolidation surrounding pre-existing bullae in patients with emphysema</li>
                    <li>tumours</li>
                    <li>vasculitis</li>
                    <li>tuberculosis</li>
                </ul>
                <li>Patients requiring hospital assessment or admission because of lung abscess may require the following investigations:</li>
                <ul>
                    <li>blood culture—if haematogenous spread from Staphylococcus aureus bacteraemia or septic jugular thrombophlebitis is suspected, or the patient has sepsis or septic shock, collect three sets of blood samples for culture before starting antibiotic therapy</li>
                    <li>sputum Gram stain and culture—collect a sputum sample for Gram stain and culture before starting antibiotic therapy. Ensure a good quality sample (eg presence of polymorphs, but few or no squamous epithelial cells on microscopy) is collected</li>
                    <li>pleural ultrasound—if loculated parapneumonic effusion is a differential diagnosis, perform a pleural ultrasound. This test is usually superior to computed tomography (CT) in determining loculation</li>
                    <li>CT of the chest—if the diagnosis is uncertain, perform CT of the chest to distinguish between a peripheral lung abscess and empyema</li>
                    <li>echocardiogram—if bacteraemia is suspected in an adult, perform a transthoracic echocardiogram (TTE) or transoesophageal echocardiogram (TOE) to exclude endocarditis</li>
                    <li>bronchoscopy—if an obstructing tumour or aspirated foreign body (eg tooth, peanut) is suspected, perform bronchoscopy. In immunocompromised patients, bronchoscopy may be indicated to obtain samples for extensive microbiological testing, because infection with unusual pathogens is possible (see Approach to pneumonia in immunocompromised patients in the Therapeutic Guidelines)</li>
                </ul>
                <li>Oral therapy is recommended for patients with nonsevere lung abscess who do not have systemic features of infection (eg tachypnoea, hypoxaemia) or chest wall pain. Patients with systemic features of infection or chest wall pain need hospital admission and, unless an antibiotic with good bioavailability is available, initial intravenous therapy</li>
                <li>The total duration of therapy is usually 3 to 4 weeks (intravenous + oral). For large abscesses with persistent fluid, a longer duration of therapy may be required—seek expert advice. Consider monitoring serum C-reactive protein (CRP) for the response to therapy</li>
                <li>If the patient is not improving with antibiotic therapy, review the diagnosis and antibiotic choice. If lung abscess remains the likely diagnosis, seek expert advice from a respiratory physician or thoracic surgeon on the appropriateness of surgery or percutaneous drainage. These interventions are not routinely performed because of the potential for bronchopleural fistula formation when an intercostal catheter is inserted into the abscess; antibiotic therapy alone is often sufficient</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr>
            <h4 class="color-primary mrgn20">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="bold color-danger">Red Man</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr>
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on lung abscess</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc1b2a -->

    <!-- Start of LUNG ABSCESS, NO PEN, HA-SEVERE, NO Sepsis/known source -->
    <div data-role="page" id="luabsc1c1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For hospital acquired severe lung abscess treatment in a patient with no penicillin allergy, without signs of septic shock use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Piperacillin+tazobactam 4+0.5 g (child: 100+12.5 mg/kg up to 4+0.5 g) intravenously, 6-hourly</span>
                </h4>
            </div>
            <br/>
            <div id="backcolour">
                <p class="mrgn20b"><b>THEN,</b> when patient has improved and is ready for IV to oral switch (see below) a suitable step down (depending on microbiology) may be:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg (child 2 months or older: 22.5+3.2 mg/kg up to 875+125 mg) orally or enterally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for piperacillin and tazobactam is: </span>
                <span class="font15 bold">4<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FOUR</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if IV
                    treatment is to continue past four days. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Lung abscesses are usually identified on chest X-ray imaging. For patients with suspected lung abscess, consider differential diagnoses. Peripheral lung abscesses should be differentiated from loculated parapneumonic effusions or empyema (see the Therapeutic Guideline's Investigations for lung abscess). In patients with a solitary cavitary pulmonary lesion, differential diagnoses include:</li>
                <ul>
                    <li>consolidation surrounding pre-existing bullae in patients with emphysema</li>
                    <li>tumours</li>
                    <li>vasculitis</li>
                    <li>tuberculosis</li>
                </ul>
                <li>Patients requiring hospital assessment or admission because of lung abscess may require the following investigations:</li>
                <ul>
                    <li>blood culture—if haematogenous spread from Staphylococcus aureus bacteraemia or septic jugular thrombophlebitis is suspected, or the patient has sepsis or septic shock, collect three sets of blood samples for culture before starting antibiotic therapy</li>
                    <li>sputum Gram stain and culture—collect a sputum sample for Gram stain and culture before starting antibiotic therapy. Ensure a good quality sample (eg presence of polymorphs, but few or no squamous epithelial cells on microscopy) is collected</li>
                    <li>pleural ultrasound—if loculated parapneumonic effusion is a differential diagnosis, perform a pleural ultrasound. This test is usually superior to computed tomography (CT) in determining loculation</li>
                    <li>CT of the chest—if the diagnosis is uncertain, perform CT of the chest to distinguish between a peripheral lung abscess and empyema</li>
                    <li>echocardiogram—if bacteraemia is suspected in an adult, perform a transthoracic echocardiogram (TTE) or transoesophageal echocardiogram (TOE) to exclude endocarditis</li>
                    <li>bronchoscopy—if an obstructing tumour or aspirated foreign body (eg tooth, peanut) is suspected, perform bronchoscopy. In immunocompromised patients, bronchoscopy may be indicated to obtain samples for extensive microbiological testing, because infection with unusual pathogens is possible (see Approach to pneumonia in immunocompromised patients in the Therapeutic Guidelines)</li>
                </ul>
                <li>Oral therapy is recommended for patients with nonsevere lung abscess who do not have systemic features of infection (eg tachypnoea, hypoxaemia) or chest wall pain. Patients with systemic features of infection or chest wall pain need hospital admission and, unless an antibiotic with good bioavailability is available, initial intravenous therapy</li>
                <li>The total duration of therapy is usually 3 to 4 weeks (intravenous + oral). For large abscesses with persistent fluid, a longer duration of therapy may be required—seek expert advice. Consider monitoring serum C-reactive protein (CRP) for the response to therapy</li>
                <li>If the patient is not improving with antibiotic therapy, review the diagnosis and antibiotic choice. If lung abscess remains the likely diagnosis, seek expert advice from a respiratory physician or thoracic surgeon on the appropriateness of surgery or percutaneous drainage. These interventions are not routinely performed because of the potential for bronchopleural fistula formation when an intercostal catheter is inserted into the abscess; antibiotic therapy alone is often sufficient</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on lung abscess</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc1c1 -->

    <!-- Start of LUNG ABSCESS, NO PEN, HA-SEVERE, YES Sepsis/unknown source, GENT OK -->
    <div data-role="page" id="luabsc1c2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For hospital acquired severe lung abscess treatment in a patient with no penicillin allergy, with signs of septic shock use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Piperacillin+tazobactam 4+0.5 g (child: 100+12.5 mg/kg up to 4+0.5 g) intravenously, 6-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17"><span class="color-purple">Gentamicin given over 3-5 minutes intravenously</span></span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">Adults without known or likely pre-existing kidney impairment: :&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Adults with known or likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Child younger than 10 years:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7.5 mg/kg, for the first dose, then use the nomogram below</span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Child 10 years or older:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7 mg/kg, for the first dose, then use the nomogram below</span><br><br></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">A vancomycin loading dose of 25-30 mg/Kg IV (adult and child)</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per nomograms below or use the <a
                            href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <br/>
            <div id="backcolour">
                <p class="mrgn20b"><b>THEN,</b> when patient has improved and is ready for IV to oral switch (see below) a suitable step down (depending on microbiology) may be:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg (child 2 months or older: 22.5+3.2 mg/kg up to 875+125 mg) orally or enterally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for piperacillin+tazobactam is: </span>
                <span class="font15 bold">4<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FOUR</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if IV
                    treatment is to continue past four days. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin and gentamicin is: </span>
                <span class="font15 bold">2<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if IV
                    treatment is to continue past 48 hours. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Lung abscesses are usually identified on chest X-ray imaging. For patients with suspected lung abscess, consider differential diagnoses. Peripheral lung abscesses should be differentiated from loculated parapneumonic effusions or empyema (see the Therapeutic Guideline's Investigations for lung abscess). In patients with a solitary cavitary pulmonary lesion, differential diagnoses include:</li>
                <ul>
                    <li>consolidation surrounding pre-existing bullae in patients with emphysema</li>
                    <li>tumours</li>
                    <li>vasculitis</li>
                    <li>tuberculosis</li>
                </ul>
                <li>Patients requiring hospital assessment or admission because of lung abscess may require the following investigations:</li>
                <ul>
                    <li>blood culture—if haematogenous spread from Staphylococcus aureus bacteraemia or septic jugular thrombophlebitis is suspected, or the patient has sepsis or septic shock, collect three sets of blood samples for culture before starting antibiotic therapy</li>
                    <li>sputum Gram stain and culture—collect a sputum sample for Gram stain and culture before starting antibiotic therapy. Ensure a good quality sample (eg presence of polymorphs, but few or no squamous epithelial cells on microscopy) is collected</li>
                    <li>pleural ultrasound—if loculated parapneumonic effusion is a differential diagnosis, perform a pleural ultrasound. This test is usually superior to computed tomography (CT) in determining loculation</li>
                    <li>CT of the chest—if the diagnosis is uncertain, perform CT of the chest to distinguish between a peripheral lung abscess and empyema</li>
                    <li>echocardiogram—if bacteraemia is suspected in an adult, perform a transthoracic echocardiogram (TTE) or transoesophageal echocardiogram (TOE) to exclude endocarditis</li>
                    <li>bronchoscopy—if an obstructing tumour or aspirated foreign body (eg tooth, peanut) is suspected, perform bronchoscopy. In immunocompromised patients, bronchoscopy may be indicated to obtain samples for extensive microbiological testing, because infection with unusual pathogens is possible (see Approach to pneumonia in immunocompromised patients in the Therapeutic Guidelines)</li>
                </ul>
                <li>Oral therapy is recommended for patients with nonsevere lung abscess who do not have systemic features of infection (eg tachypnoea, hypoxaemia) or chest wall pain. Patients with systemic features of infection or chest wall pain need hospital admission and, unless an antibiotic with good bioavailability is available, initial intravenous therapy</li>
                <li>The total duration of therapy is usually 3 to 4 weeks (intravenous + oral). For large abscesses with persistent fluid, a longer duration of therapy may be required—seek expert advice. Consider monitoring serum C-reactive protein (CRP) for the response to therapy</li>
                <li>If the patient is not improving with antibiotic therapy, review the diagnosis and antibiotic choice. If lung abscess remains the likely diagnosis, seek expert advice from a respiratory physician or thoracic surgeon on the appropriateness of surgery or percutaneous drainage. These interventions are not routinely performed because of the potential for bronchopleural fistula formation when an intercostal catheter is inserted into the abscess; antibiotic therapy alone is often sufficient</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr>
            <h4 class="color-primary mrgn20">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="bold color-danger">Red Man</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr>
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on lung abscess</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc1c2a -->

    <!-- Start of LUNG ABSCESS, NO PEN, JUGULAR, NO Sepsis/unknown source -->
    <div data-role="page" id="luabsc1d1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For community acquired severe lung abscess treatment in a patient with no penicillin allergy, with signs of septic shock use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple"> Amoxicillin + clavulanate intravenously</span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">1+0.2 g 8-hourly. If the patient has an abscess, or has septic shock or requires intensive care support, use a dose of 1+0.2 g 6-hourly</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child 3 months or
                                        older: &nbsp;</span></td>
                                <td><span class="color-purple"> 25+5 mg/kg up to 1+0.2 g 8-hourly. If the child has an abscess, or has septic shock or requires intensive care support, use a dose of 25+5 mg/kg up to 1+0.2 g 6-hourly</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
            </div>
            <br/>
            <div id="backcolour">
                <p class="mrgn20b"><b>OR,</b> alternatively, as a two drug regimen:</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b> either</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Ceftriaxone 2 g (child 1 month or older: 50 mg/kg up to 2 g) intravenously, daily; for patients with septic shock or requiring intensive care support, use ceftriaxone 1 g (child 1 month or older: 50 mg/kg up to 1 g) intravenously, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Cefotaxime 2 g (child: 50 mg/kg up to 2 g) intravenously, 8-hourly; for patients with septic shock or requiring intensive care support, use cefotaxime 2 g (child: 50 mg/kg up to 2 g) intravenously, 6-hourly</span>
                </h4>
            </div>
            <br/>
            <div id="backcolour">
                <p class="mrgn20b"><b>THEN,</b> when patient has improved and is ready for IV to oral switch (see below) a suitable step down (depending on microbiology) may be:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 1 g (child: 25 mg/kg up to 1 g) orally or enterally, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally or enterally, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b> as a single agent</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg (child 2 months or older: 22.5+3.2 mg/kg up to 875+125 mg) orally or enterally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for IV amoxicillin+clavulanate or ceftriaxone or cefotaxime is: </span>
                <span class="font15 bold">4<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FOUR</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if IV
                    treatment is to continue past four days. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Lung abscesses are usually identified on chest X-ray imaging. For patients with suspected lung abscess, consider differential diagnoses. Peripheral lung abscesses should be differentiated from loculated parapneumonic effusions or empyema (see the Therapeutic Guideline's Investigations for lung abscess). In patients with a solitary cavitary pulmonary lesion, differential diagnoses include:</li>
                <ul>
                    <li>consolidation surrounding pre-existing bullae in patients with emphysema</li>
                    <li>tumours</li>
                    <li>vasculitis</li>
                    <li>tuberculosis</li>
                </ul>
                <li>Patients requiring hospital assessment or admission because of lung abscess may require the following investigations:</li>
                <ul>
                    <li>blood culture—if haematogenous spread from Staphylococcus aureus bacteraemia or septic jugular thrombophlebitis is suspected, or the patient has sepsis or septic shock, collect three sets of blood samples for culture before starting antibiotic therapy</li>
                    <li>sputum Gram stain and culture—collect a sputum sample for Gram stain and culture before starting antibiotic therapy. Ensure a good quality sample (eg presence of polymorphs, but few or no squamous epithelial cells on microscopy) is collected</li>
                    <li>pleural ultrasound—if loculated parapneumonic effusion is a differential diagnosis, perform a pleural ultrasound. This test is usually superior to computed tomography (CT) in determining loculation</li>
                    <li>CT of the chest—if the diagnosis is uncertain, perform CT of the chest to distinguish between a peripheral lung abscess and empyema</li>
                    <li>echocardiogram—if bacteraemia is suspected in an adult, perform a transthoracic echocardiogram (TTE) or transoesophageal echocardiogram (TOE) to exclude endocarditis</li>
                    <li>bronchoscopy—if an obstructing tumour or aspirated foreign body (eg tooth, peanut) is suspected, perform bronchoscopy. In immunocompromised patients, bronchoscopy may be indicated to obtain samples for extensive microbiological testing, because infection with unusual pathogens is possible (see Approach to pneumonia in immunocompromised patients in the Therapeutic Guidelines)</li>
                </ul>
                <li>Oral therapy is recommended for patients with nonsevere lung abscess who do not have systemic features of infection (eg tachypnoea, hypoxaemia) or chest wall pain. Patients with systemic features of infection or chest wall pain need hospital admission and, unless an antibiotic with good bioavailability is available, initial intravenous therapy</li>
                <li>The total duration of therapy is usually 3 to 4 weeks (intravenous + oral). For large abscesses with persistent fluid, a longer duration of therapy may be required—seek expert advice. Consider monitoring serum C-reactive protein (CRP) for the response to therapy</li>
                <li>If the patient is not improving with antibiotic therapy, review the diagnosis and antibiotic choice. If lung abscess remains the likely diagnosis, seek expert advice from a respiratory physician or thoracic surgeon on the appropriateness of surgery or percutaneous drainage. These interventions are not routinely performed because of the potential for bronchopleural fistula formation when an intercostal catheter is inserted into the abscess; antibiotic therapy alone is often sufficient</li>
                <li>Lung abscess can be a complication of septic jugular thrombophlebitis (Lemierre syndrome). The abscess develops because of haematogenous spread of anaerobic bacteria (eg Fusobacterium necrophorum), but the infection is usually polymicrobial. Staphylococcus aureus (including methicillin-resistant S. aureus [MRSA]) can also cause septic jugular thrombophlebitis</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on lung abscess</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc1d1 -->


    <!-- Start of LUNG ABSCESS, NO PEN, JUGULAR, YES Sepsis/unknown source -->
    <div data-role="page" id="luabsc1d2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For community acquired severe lung abscess treatment in a patient with no penicillin allergy, with signs of septic shock use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple"> Amoxicillin + clavulanate intravenously</span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">1+0.2 g 8-hourly. If the patient has an abscess, or has septic shock or requires intensive care support, use a dose of 1+0.2 g 6-hourly</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child 3 months or
                                        older: &nbsp;</span></td>
                                <td><span class="color-purple"> 25+5 mg/kg up to 1+0.2 g 8-hourly. If the child has an abscess, or has septic shock or requires intensive care support, use a dose of 25+5 mg/kg up to 1+0.2 g 6-hourly</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">A vancomycin loading dose of 25-30 mg/Kg IV (adult and child)</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per nomograms below or use the <a
                            href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <br/>
            <div id="backcolour">
                <p class="mrgn20b"><b>OR,</b> alternatively, as a three drug regimen:</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b> either</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Ceftriaxone 2 g (child 1 month or older: 50 mg/kg up to 2 g) intravenously, daily; for patients with septic shock or requiring intensive care support, use ceftriaxone 1 g (child 1 month or older: 50 mg/kg up to 1 g) intravenously, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Cefotaxime 2 g (child: 50 mg/kg up to 2 g) intravenously, 8-hourly; for patients with septic shock or requiring intensive care support, use cefotaxime 2 g (child: 50 mg/kg up to 2 g) intravenously, 6-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9314;</span><span class="color-purple"> A vancomycin loading dose of 25-30 mg/Kg IV (adult and child)</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per nomograms below or use the <a
                            href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <br/>
            <div id="backcolour">
                <p class="mrgn20b"><b>THEN,</b> when patient has improved and is ready for IV to oral switch (see below) a suitable step down (depending on microbiology) may be:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 1 g (child: 25 mg/kg up to 1 g) orally or enterally, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally or enterally, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b> as a single agent</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg (child 2 months or older: 22.5+3.2 mg/kg up to 875+125 mg) orally or enterally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for IV amoxicillin+clavulanate or ceftriaxone or cefotaxime is: </span>
                <span class="font15 bold">4<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FOUR</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if IV
                    treatment is to continue past four days. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is: </span>
                <span class="font15 bold">2<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if IV
                    treatment is to continue past 48 hours. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Lung abscesses are usually identified on chest X-ray imaging. For patients with suspected lung abscess, consider differential diagnoses. Peripheral lung abscesses should be differentiated from loculated parapneumonic effusions or empyema (see the Therapeutic Guideline's Investigations for lung abscess). In patients with a solitary cavitary pulmonary lesion, differential diagnoses include:</li>
                <ul>
                    <li>consolidation surrounding pre-existing bullae in patients with emphysema</li>
                    <li>tumours</li>
                    <li>vasculitis</li>
                    <li>tuberculosis</li>
                </ul>
                <li>Patients requiring hospital assessment or admission because of lung abscess may require the following investigations:</li>
                <ul>
                    <li>blood culture—if haematogenous spread from Staphylococcus aureus bacteraemia or septic jugular thrombophlebitis is suspected, or the patient has sepsis or septic shock, collect three sets of blood samples for culture before starting antibiotic therapy</li>
                    <li>sputum Gram stain and culture—collect a sputum sample for Gram stain and culture before starting antibiotic therapy. Ensure a good quality sample (eg presence of polymorphs, but few or no squamous epithelial cells on microscopy) is collected</li>
                    <li>pleural ultrasound—if loculated parapneumonic effusion is a differential diagnosis, perform a pleural ultrasound. This test is usually superior to computed tomography (CT) in determining loculation</li>
                    <li>CT of the chest—if the diagnosis is uncertain, perform CT of the chest to distinguish between a peripheral lung abscess and empyema</li>
                    <li>echocardiogram—if bacteraemia is suspected in an adult, perform a transthoracic echocardiogram (TTE) or transoesophageal echocardiogram (TOE) to exclude endocarditis</li>
                    <li>bronchoscopy—if an obstructing tumour or aspirated foreign body (eg tooth, peanut) is suspected, perform bronchoscopy. In immunocompromised patients, bronchoscopy may be indicated to obtain samples for extensive microbiological testing, because infection with unusual pathogens is possible (see Approach to pneumonia in immunocompromised patients in the Therapeutic Guidelines)</li>
                </ul>
                <li>Oral therapy is recommended for patients with nonsevere lung abscess who do not have systemic features of infection (eg tachypnoea, hypoxaemia) or chest wall pain. Patients with systemic features of infection or chest wall pain need hospital admission and, unless an antibiotic with good bioavailability is available, initial intravenous therapy</li>
                <li>The total duration of therapy is usually 3 to 4 weeks (intravenous + oral). For large abscesses with persistent fluid, a longer duration of therapy may be required—seek expert advice. Consider monitoring serum C-reactive protein (CRP) for the response to therapy</li>
                <li>If the patient is not improving with antibiotic therapy, review the diagnosis and antibiotic choice. If lung abscess remains the likely diagnosis, seek expert advice from a respiratory physician or thoracic surgeon on the appropriateness of surgery or percutaneous drainage. These interventions are not routinely performed because of the potential for bronchopleural fistula formation when an intercostal catheter is inserted into the abscess; antibiotic therapy alone is often sufficient</li>
                <li>Lung abscess can be a complication of septic jugular thrombophlebitis (Lemierre syndrome). The abscess develops because of haematogenous spread of anaerobic bacteria (eg Fusobacterium necrophorum), but the infection is usually polymicrobial. Staphylococcus aureus (including methicillin-resistant S. aureus [MRSA]) can also cause septic jugular thrombophlebitis</li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr>
            <h4 class="color-primary mrgn20">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="bold color-danger">Red Man</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr>
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr/>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on lung abscess</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc1d2 -->

    <!-- Start of LUNG ABSCESS bail out page -->
    <div data-role="page" id="luabscx" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Liver abscess treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h4 class="color-primary mrgn15b">Treatment requires infectious diseases input:</h4>
            <h4 class="color-danger mrgn15b">Treatment options are limited. Please contact infectious diseases for advice</h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Lung abscesses are usually identified on chest X-ray imaging. For patients with suspected lung abscess, consider differential diagnoses. Peripheral lung abscesses should be differentiated from loculated parapneumonic effusions or empyema (see the Therapeutic Guideline's Investigations for lung abscess). In patients with a solitary cavitary pulmonary lesion, differential diagnoses include:</li>
                <ul>
                    <li>consolidation surrounding pre-existing bullae in patients with emphysema</li>
                    <li>tumours</li>
                    <li>vasculitis</li>
                    <li>tuberculosis</li>
                </ul>
                <li>Patients requiring hospital assessment or admission because of lung abscess may require the following investigations:</li>
                <ul>
                    <li>blood culture—if haematogenous spread from Staphylococcus aureus bacteraemia or septic jugular thrombophlebitis is suspected, or the patient has sepsis or septic shock, collect three sets of blood samples for culture before starting antibiotic therapy</li>
                    <li>sputum Gram stain and culture—collect a sputum sample for Gram stain and culture before starting antibiotic therapy. Ensure a good quality sample (eg presence of polymorphs, but few or no squamous epithelial cells on microscopy) is collected</li>
                    <li>pleural ultrasound—if loculated parapneumonic effusion is a differential diagnosis, perform a pleural ultrasound. This test is usually superior to computed tomography (CT) in determining loculation</li>
                    <li>CT of the chest—if the diagnosis is uncertain, perform CT of the chest to distinguish between a peripheral lung abscess and empyema</li>
                    <li>echocardiogram—if bacteraemia is suspected in an adult, perform a transthoracic echocardiogram (TTE) or transoesophageal echocardiogram (TOE) to exclude endocarditis</li>
                    <li>bronchoscopy—if an obstructing tumour or aspirated foreign body (eg tooth, peanut) is suspected, perform bronchoscopy. In immunocompromised patients, bronchoscopy may be indicated to obtain samples for extensive microbiological testing, because infection with unusual pathogens is possible (see Approach to pneumonia in immunocompromised patients in the Therapeutic Guidelines)</li>
                </ul>
                <li>Oral therapy is recommended for patients with nonsevere lung abscess who do not have systemic features of infection (eg tachypnoea, hypoxaemia) or chest wall pain. Patients with systemic features of infection or chest wall pain need hospital admission and, unless an antibiotic with good bioavailability is available, initial intravenous therapy</li>
                <li>The total duration of therapy is usually 3 to 4 weeks (intravenous + oral). For large abscesses with persistent fluid, a longer duration of therapy may be required—seek expert advice. Consider monitoring serum C-reactive protein (CRP) for the response to therapy</li>
                <li>If the patient is not improving with antibiotic therapy, review the diagnosis and antibiotic choice. If lung abscess remains the likely diagnosis, seek expert advice from a respiratory physician or thoracic surgeon on the appropriateness of surgery or percutaneous drainage. These interventions are not routinely performed because of the potential for bronchopleural fistula formation when an intercostal catheter is inserted into the abscess; antibiotic therapy alone is often sufficient</li>
                <li>Lung abscess can be a complication of septic jugular thrombophlebitis (Lemierre syndrome). The abscess develops because of haematogenous spread of anaerobic bacteria (eg Fusobacterium necrophorum), but the infection is usually polymicrobial. Staphylococcus aureus (including methicillin-resistant S. aureus [MRSA]) can also cause septic jugular thrombophlebitis</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on lung abscess</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabscx -->


    <!-- Start of LUNG ABSCESS, ANY PEN, Non-SEVERE, Non-Systemic -->
    <div data-role="page" id="luabsc2a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For lung abscess treatment in a patient with a penicillin allergy, and no systemic symptoms use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 450 mg (child: 10 mg/kg up to 450 mg) orally or enterally, 8-hourly; see below for advice on modification and duration of therapy</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for oral clindamycin is: </span>
                <span class="font15 bold">7<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if
                    treatment is to continue past one week. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Lung abscesses are usually identified on chest X-ray imaging. For patients with suspected lung abscess, consider differential diagnoses. Peripheral lung abscesses should be differentiated from loculated parapneumonic effusions or empyema (see the Therapeutic Guideline's Investigations for lung abscess). In patients with a solitary cavitary pulmonary lesion, differential diagnoses include:</li>
                <ul>
                    <li>consolidation surrounding pre-existing bullae in patients with emphysema</li>
                    <li>tumours</li>
                    <li>vasculitis</li>
                    <li>tuberculosis</li>
                </ul>
                <li>Patients requiring hospital assessment or admission because of lung abscess may require the following investigations:</li>
                <ul>
                    <li>blood culture—if haematogenous spread from Staphylococcus aureus bacteraemia or septic jugular thrombophlebitis is suspected, or the patient has sepsis or septic shock, collect three sets of blood samples for culture before starting antibiotic therapy</li>
                    <li>sputum Gram stain and culture—collect a sputum sample for Gram stain and culture before starting antibiotic therapy. Ensure a good quality sample (eg presence of polymorphs, but few or no squamous epithelial cells on microscopy) is collected</li>
                    <li>pleural ultrasound—if loculated parapneumonic effusion is a differential diagnosis, perform a pleural ultrasound. This test is usually superior to computed tomography (CT) in determining loculation</li>
                    <li>CT of the chest—if the diagnosis is uncertain, perform CT of the chest to distinguish between a peripheral lung abscess and empyema</li>
                    <li>echocardiogram—if bacteraemia is suspected in an adult, perform a transthoracic echocardiogram (TTE) or transoesophageal echocardiogram (TOE) to exclude endocarditis</li>
                    <li>bronchoscopy—if an obstructing tumour or aspirated foreign body (eg tooth, peanut) is suspected, perform bronchoscopy. In immunocompromised patients, bronchoscopy may be indicated to obtain samples for extensive microbiological testing, because infection with unusual pathogens is possible (see Approach to pneumonia in immunocompromised patients in the Therapeutic Guidelines)</li>
                </ul>
                <li>Oral therapy is recommended for patients with nonsevere lung abscess who do not have systemic features of infection (eg tachypnoea, hypoxaemia) or chest wall pain. Patients with systemic features of infection or chest wall pain need hospital admission and, unless an antibiotic with good bioavailability is available, initial intravenous therapy</li>
                <li>The total duration of therapy is usually 3 to 4 weeks (intravenous + oral). For large abscesses with persistent fluid, a longer duration of therapy may be required—seek expert advice. Consider monitoring serum C-reactive protein (CRP) for the response to therapy</li>
                <li>If the patient is not improving with antibiotic therapy, review the diagnosis and antibiotic choice. If lung abscess remains the likely diagnosis, seek expert advice from a respiratory physician or thoracic surgeon on the appropriateness of surgery or percutaneous drainage. These interventions are not routinely performed because of the potential for bronchopleural fistula formation when an intercostal catheter is inserted into the abscess; antibiotic therapy alone is often sufficient</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on lung abscess</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc2a1 -->

    <!-- Start of LUNG ABSCESS, ANY PEN, Non-SEVERE, YES-Systemic -->
    <div data-role="page" id="luabsc2a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For lung abscess treatment in a patient with a penicillin allergy, and systemic symptoms of infection use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 450 mg (child: 10 mg/kg up to 450 mg) orally or enterally, 8-hourly; see below for advice on modification and duration of therapy</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b> if patient is not tolerating oral medications give</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600 mg (child: 15 mg/kg up to 600 mg) intravenously, 8-hourly until patient is ready to switch to oral (see below)</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for oral clindamycin is: </span>
                <span class="font15 bold">7<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if
                    treatment is to continue past one week. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for IV clindamycin is: </span>
                <span class="font15 bold">2<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if
                    treatment is to continue past 48 hours. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Oral clindamycin is highly bioavailable (~90% bioavailable)</li>
                <li>Lung abscesses are usually identified on chest X-ray imaging. For patients with suspected lung abscess, consider differential diagnoses. Peripheral lung abscesses should be differentiated from loculated parapneumonic effusions or empyema (see the Therapeutic Guideline's Investigations for lung abscess). In patients with a solitary cavitary pulmonary lesion, differential diagnoses include:</li>
                <ul>
                    <li>consolidation surrounding pre-existing bullae in patients with emphysema</li>
                    <li>tumours</li>
                    <li>vasculitis</li>
                    <li>tuberculosis</li>
                </ul>
                <li>Patients requiring hospital assessment or admission because of lung abscess may require the following investigations:</li>
                <ul>
                    <li>blood culture—if haematogenous spread from Staphylococcus aureus bacteraemia or septic jugular thrombophlebitis is suspected, or the patient has sepsis or septic shock, collect three sets of blood samples for culture before starting antibiotic therapy</li>
                    <li>sputum Gram stain and culture—collect a sputum sample for Gram stain and culture before starting antibiotic therapy. Ensure a good quality sample (eg presence of polymorphs, but few or no squamous epithelial cells on microscopy) is collected</li>
                    <li>pleural ultrasound—if loculated parapneumonic effusion is a differential diagnosis, perform a pleural ultrasound. This test is usually superior to computed tomography (CT) in determining loculation</li>
                    <li>CT of the chest—if the diagnosis is uncertain, perform CT of the chest to distinguish between a peripheral lung abscess and empyema</li>
                    <li>echocardiogram—if bacteraemia is suspected in an adult, perform a transthoracic echocardiogram (TTE) or transoesophageal echocardiogram (TOE) to exclude endocarditis</li>
                    <li>bronchoscopy—if an obstructing tumour or aspirated foreign body (eg tooth, peanut) is suspected, perform bronchoscopy. In immunocompromised patients, bronchoscopy may be indicated to obtain samples for extensive microbiological testing, because infection with unusual pathogens is possible (see Approach to pneumonia in immunocompromised patients in the Therapeutic Guidelines)</li>
                </ul>
                <li>Oral therapy is recommended for patients with nonsevere lung abscess who do not have systemic features of infection (eg tachypnoea, hypoxaemia) or chest wall pain. Patients with systemic features of infection or chest wall pain need hospital admission and, unless an antibiotic with good bioavailability is available, initial intravenous therapy</li>
                <li>The total duration of therapy is usually 3 to 4 weeks (intravenous + oral). For large abscesses with persistent fluid, a longer duration of therapy may be required—seek expert advice. Consider monitoring serum C-reactive protein (CRP) for the response to therapy</li>
                <li>If the patient is not improving with antibiotic therapy, review the diagnosis and antibiotic choice. If lung abscess remains the likely diagnosis, seek expert advice from a respiratory physician or thoracic surgeon on the appropriateness of surgery or percutaneous drainage. These interventions are not routinely performed because of the potential for bronchopleural fistula formation when an intercostal catheter is inserted into the abscess; antibiotic therapy alone is often sufficient</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on lung abscess</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc2a2 -->

    <!-- Start of LUNG ABSCESS, MILD PEN, CA-SEVERE/JUGULAR, NO Sepsis/known source -->
    <div data-role="page" id="luabsc2b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For jugular thrombophlebitis or community acquired severe lung abscess treatment in a patient with non-severe penicillin allergy, without signs of septic shock use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ceftriaxone 2 g (child 1 month or older: 50 mg/kg up to 2 g) intravenously, daily; for patients with septic shock or requiring intensive care support, use ceftriaxone 1 g (child 1 month or older: 50 mg/kg up to 1 g) intravenously, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Cefotaxime 2 g (child: 50 mg/kg up to 2 g) intravenously, 8-hourly; for patients with septic shock or requiring intensive care support, use cefotaxime 2 g (child: 50 mg/kg up to 2 g) intravenously, 6-hourly</span>
                </h4>
            </div>
            <br/>
            <div id="backcolour">
                <p class="mrgn20b"><b>THEN,</b> when patient has improved and is ready for IV to oral switch (see below) a suitable step down (depending on microbiology) may be:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefuroxime 500 mg (child 3 months or older: 15 mg/kg up to 500 mg) orally or enterally</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally or enterally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone or cefotaxime is: </span>
                <span class="font15 bold">4<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FOUR</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if IV
                    treatment is to continue past four days. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Lung abscesses are usually identified on chest X-ray imaging. For patients with suspected lung abscess, consider differential diagnoses. Peripheral lung abscesses should be differentiated from loculated parapneumonic effusions or empyema (see the Therapeutic Guideline's Investigations for lung abscess). In patients with a solitary cavitary pulmonary lesion, differential diagnoses include:</li>
                <ul>
                    <li>consolidation surrounding pre-existing bullae in patients with emphysema</li>
                    <li>tumours</li>
                    <li>vasculitis</li>
                    <li>tuberculosis</li>
                </ul>
                <li>Patients requiring hospital assessment or admission because of lung abscess may require the following investigations:</li>
                <ul>
                    <li>blood culture—if haematogenous spread from Staphylococcus aureus bacteraemia or septic jugular thrombophlebitis is suspected, or the patient has sepsis or septic shock, collect three sets of blood samples for culture before starting antibiotic therapy</li>
                    <li>sputum Gram stain and culture—collect a sputum sample for Gram stain and culture before starting antibiotic therapy. Ensure a good quality sample (eg presence of polymorphs, but few or no squamous epithelial cells on microscopy) is collected</li>
                    <li>pleural ultrasound—if loculated parapneumonic effusion is a differential diagnosis, perform a pleural ultrasound. This test is usually superior to computed tomography (CT) in determining loculation</li>
                    <li>CT of the chest—if the diagnosis is uncertain, perform CT of the chest to distinguish between a peripheral lung abscess and empyema</li>
                    <li>echocardiogram—if bacteraemia is suspected in an adult, perform a transthoracic echocardiogram (TTE) or transoesophageal echocardiogram (TOE) to exclude endocarditis</li>
                    <li>bronchoscopy—if an obstructing tumour or aspirated foreign body (eg tooth, peanut) is suspected, perform bronchoscopy. In immunocompromised patients, bronchoscopy may be indicated to obtain samples for extensive microbiological testing, because infection with unusual pathogens is possible (see Approach to pneumonia in immunocompromised patients in the Therapeutic Guidelines)</li>
                </ul>
                <li>Oral therapy is recommended for patients with nonsevere lung abscess who do not have systemic features of infection (eg tachypnoea, hypoxaemia) or chest wall pain. Patients with systemic features of infection or chest wall pain need hospital admission and, unless an antibiotic with good bioavailability is available, initial intravenous therapy</li>
                <li>The total duration of therapy is usually 3 to 4 weeks (intravenous + oral). For large abscesses with persistent fluid, a longer duration of therapy may be required—seek expert advice. Consider monitoring serum C-reactive protein (CRP) for the response to therapy</li>
                <li>If the patient is not improving with antibiotic therapy, review the diagnosis and antibiotic choice. If lung abscess remains the likely diagnosis, seek expert advice from a respiratory physician or thoracic surgeon on the appropriateness of surgery or percutaneous drainage. These interventions are not routinely performed because of the potential for bronchopleural fistula formation when an intercostal catheter is inserted into the abscess; antibiotic therapy alone is often sufficient</li>
                <li>Lung abscess can be a complication of septic jugular thrombophlebitis (Lemierre syndrome). The abscess develops because of haematogenous spread of anaerobic bacteria (eg Fusobacterium necrophorum), but the infection is usually polymicrobial. Staphylococcus aureus (including methicillin-resistant S. aureus [MRSA]) can also cause septic jugular thrombophlebitis</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on lung abscess</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc2b1 -->

    <!-- Start of LUNG ABSCESS, MILD PEN, CA-SEVERE, YES Sepsis/unknown source, GENT OK -->
    <div data-role="page" id="luabsc2b2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For community acquired severe lung abscess treatment in a patient with no penicillin allergy, with signs of septic shock use:</h3>
            <div id="backcolour">
                <p class="mrgn20b">as a four drug regimen:</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Ceftriaxone 2 g (child 1 month or older: 50 mg/kg up to 2 g) intravenously, daily; for patients with septic shock or requiring intensive care support, use ceftriaxone 1 g (child 1 month or older: 50 mg/kg up to 1 g) intravenously, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Cefotaxime 2 g (child: 50 mg/kg up to 2 g) intravenously, 8-hourly; for patients with septic shock or requiring intensive care support, use cefotaxime 2 g (child: 50 mg/kg up to 2 g) intravenously, 6-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9314;</span><span class="font17"><span class="color-purple"> Gentamicin given over 3-5 minutes intravenously</span></span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">Adults without known or likely pre-existing kidney impairment: :&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Adults with known or likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Child younger than 10 years:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7.5 mg/kg, for the first dose, then use the nomogram below</span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Child 10 years or older:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7 mg/kg, for the first dose, then use the nomogram below</span><br><br></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9315;</span><span class="color-purple"> A vancomycin loading dose of 25-30 mg/Kg IV (adult and child)</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per nomograms below or use the <a
                            href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <br/>
            <div id="backcolour">
                <p class="mrgn20b"><b>THEN,</b> when patient has improved and is ready for IV to oral switch (see below) a suitable step down (depending on microbiology) may be:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefuroxime 500 mg (child 3 months or older: 15 mg/kg up to 500 mg) orally or enterally</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally or enterally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone or cefotaxime is: </span>
                <span class="font15 bold">4<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FOUR</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if IV
                    treatment is to continue past four days. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin and gentamicin is: </span>
                <span class="font15 bold">2<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if IV
                    treatment is to continue past 48 hours. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Lung abscesses are usually identified on chest X-ray imaging. For patients with suspected lung abscess, consider differential diagnoses. Peripheral lung abscesses should be differentiated from loculated parapneumonic effusions or empyema (see the Therapeutic Guideline's Investigations for lung abscess). In patients with a solitary cavitary pulmonary lesion, differential diagnoses include:</li>
                <ul>
                    <li>consolidation surrounding pre-existing bullae in patients with emphysema</li>
                    <li>tumours</li>
                    <li>vasculitis</li>
                    <li>tuberculosis</li>
                </ul>
                <li>Patients requiring hospital assessment or admission because of lung abscess may require the following investigations:</li>
                <ul>
                    <li>blood culture—if haematogenous spread from Staphylococcus aureus bacteraemia or septic jugular thrombophlebitis is suspected, or the patient has sepsis or septic shock, collect three sets of blood samples for culture before starting antibiotic therapy</li>
                    <li>sputum Gram stain and culture—collect a sputum sample for Gram stain and culture before starting antibiotic therapy. Ensure a good quality sample (eg presence of polymorphs, but few or no squamous epithelial cells on microscopy) is collected</li>
                    <li>pleural ultrasound—if loculated parapneumonic effusion is a differential diagnosis, perform a pleural ultrasound. This test is usually superior to computed tomography (CT) in determining loculation</li>
                    <li>CT of the chest—if the diagnosis is uncertain, perform CT of the chest to distinguish between a peripheral lung abscess and empyema</li>
                    <li>echocardiogram—if bacteraemia is suspected in an adult, perform a transthoracic echocardiogram (TTE) or transoesophageal echocardiogram (TOE) to exclude endocarditis</li>
                    <li>bronchoscopy—if an obstructing tumour or aspirated foreign body (eg tooth, peanut) is suspected, perform bronchoscopy. In immunocompromised patients, bronchoscopy may be indicated to obtain samples for extensive microbiological testing, because infection with unusual pathogens is possible (see Approach to pneumonia in immunocompromised patients in the Therapeutic Guidelines)</li>
                </ul>
                <li>Oral therapy is recommended for patients with nonsevere lung abscess who do not have systemic features of infection (eg tachypnoea, hypoxaemia) or chest wall pain. Patients with systemic features of infection or chest wall pain need hospital admission and, unless an antibiotic with good bioavailability is available, initial intravenous therapy</li>
                <li>The total duration of therapy is usually 3 to 4 weeks (intravenous + oral). For large abscesses with persistent fluid, a longer duration of therapy may be required—seek expert advice. Consider monitoring serum C-reactive protein (CRP) for the response to therapy</li>
                <li>If the patient is not improving with antibiotic therapy, review the diagnosis and antibiotic choice. If lung abscess remains the likely diagnosis, seek expert advice from a respiratory physician or thoracic surgeon on the appropriateness of surgery or percutaneous drainage. These interventions are not routinely performed because of the potential for bronchopleural fistula formation when an intercostal catheter is inserted into the abscess; antibiotic therapy alone is often sufficient</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr>
            <h4 class="color-primary mrgn20">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="bold color-danger">Red Man</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr>
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on lung abscess</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc2b2a -->

    <!-- Start of LUNG ABSCESS, MILD PEN, HA-SEVERE, NO Sepsis/known source -->
    <div data-role="page" id="luabsc2c1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For hospital acquired severe lung abscess treatment in a patient with no penicillin allergy, without signs of septic shock use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefepime 2 g (child: 50 mg/kg up to 2 g) intravenously, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, 12-hourly</span>
                </h4>
            </div>
            <br/>
            <div id="backcolour">
                <p class="mrgn20b"><b>THEN,</b> when patient has improved and is ready for IV to oral switch (see below) a suitable step down (depending on microbiology) may be:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefuroxime 500 mg (child 3 months or older: 15 mg/kg up to 500 mg) orally or enterally</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally or enterally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for cefepime is: </span>
                <span class="font15 bold">4<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FOUR</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if IV
                    treatment is to continue past four days. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Lung abscesses are usually identified on chest X-ray imaging. For patients with suspected lung abscess, consider differential diagnoses. Peripheral lung abscesses should be differentiated from loculated parapneumonic effusions or empyema (see the Therapeutic Guideline's Investigations for lung abscess). In patients with a solitary cavitary pulmonary lesion, differential diagnoses include:</li>
                <ul>
                    <li>consolidation surrounding pre-existing bullae in patients with emphysema</li>
                    <li>tumours</li>
                    <li>vasculitis</li>
                    <li>tuberculosis</li>
                </ul>
                <li>Patients requiring hospital assessment or admission because of lung abscess may require the following investigations:</li>
                <ul>
                    <li>blood culture—if haematogenous spread from Staphylococcus aureus bacteraemia or septic jugular thrombophlebitis is suspected, or the patient has sepsis or septic shock, collect three sets of blood samples for culture before starting antibiotic therapy</li>
                    <li>sputum Gram stain and culture—collect a sputum sample for Gram stain and culture before starting antibiotic therapy. Ensure a good quality sample (eg presence of polymorphs, but few or no squamous epithelial cells on microscopy) is collected</li>
                    <li>pleural ultrasound—if loculated parapneumonic effusion is a differential diagnosis, perform a pleural ultrasound. This test is usually superior to computed tomography (CT) in determining loculation</li>
                    <li>CT of the chest—if the diagnosis is uncertain, perform CT of the chest to distinguish between a peripheral lung abscess and empyema</li>
                    <li>echocardiogram—if bacteraemia is suspected in an adult, perform a transthoracic echocardiogram (TTE) or transoesophageal echocardiogram (TOE) to exclude endocarditis</li>
                    <li>bronchoscopy—if an obstructing tumour or aspirated foreign body (eg tooth, peanut) is suspected, perform bronchoscopy. In immunocompromised patients, bronchoscopy may be indicated to obtain samples for extensive microbiological testing, because infection with unusual pathogens is possible (see Approach to pneumonia in immunocompromised patients in the Therapeutic Guidelines)</li>
                </ul>
                <li>Oral therapy is recommended for patients with nonsevere lung abscess who do not have systemic features of infection (eg tachypnoea, hypoxaemia) or chest wall pain. Patients with systemic features of infection or chest wall pain need hospital admission and, unless an antibiotic with good bioavailability is available, initial intravenous therapy</li>
                <li>The total duration of therapy is usually 3 to 4 weeks (intravenous + oral). For large abscesses with persistent fluid, a longer duration of therapy may be required—seek expert advice. Consider monitoring serum C-reactive protein (CRP) for the response to therapy</li>
                <li>If the patient is not improving with antibiotic therapy, review the diagnosis and antibiotic choice. If lung abscess remains the likely diagnosis, seek expert advice from a respiratory physician or thoracic surgeon on the appropriateness of surgery or percutaneous drainage. These interventions are not routinely performed because of the potential for bronchopleural fistula formation when an intercostal catheter is inserted into the abscess; antibiotic therapy alone is often sufficient</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on lung abscess</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc2c1 -->

    <!-- Start of LUNG ABSCESS, MILD PEN, HA-SEVERE, YES Sepsis/unknown source, GENT OK -->
    <div data-role="page" id="luabsc2c2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For hospital acquired severe lung abscess treatment in a patient with no penicillin allergy, with signs of septic shock use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefepime 2 g (child: 50 mg/kg up to 2 g) intravenously, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17"><span class="color-purple">Gentamicin given over 3-5 minutes intravenously</span></span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">Adults without known or likely pre-existing kidney impairment: :&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Adults with known or likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Child younger than 10 years:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7.5 mg/kg, for the first dose, then use the nomogram below</span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Child 10 years or older:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7 mg/kg, for the first dose, then use the nomogram below</span><br><br></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">A vancomycin loading dose of 25-30 mg/Kg IV (adult and child)</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per nomograms below or use the <a
                            href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <br/>
            <div id="backcolour">
                <p class="mrgn20b"><b>THEN,</b> when patient has improved and is ready for IV to oral switch (see below) a suitable step down (depending on microbiology) may be:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefuroxime 500 mg (child 3 months or older: 15 mg/kg up to 500 mg) orally or enterally</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally or enterally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for cefepime is: </span>
                <span class="font15 bold">4<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FOUR</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if IV
                    treatment is to continue past four days. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin and gentamicin is: </span>
                <span class="font15 bold">2<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if IV
                    treatment is to continue past 48 hours. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Lung abscesses are usually identified on chest X-ray imaging. For patients with suspected lung abscess, consider differential diagnoses. Peripheral lung abscesses should be differentiated from loculated parapneumonic effusions or empyema (see the Therapeutic Guideline's Investigations for lung abscess). In patients with a solitary cavitary pulmonary lesion, differential diagnoses include:</li>
                <ul>
                    <li>consolidation surrounding pre-existing bullae in patients with emphysema</li>
                    <li>tumours</li>
                    <li>vasculitis</li>
                    <li>tuberculosis</li>
                </ul>
                <li>Patients requiring hospital assessment or admission because of lung abscess may require the following investigations:</li>
                <ul>
                    <li>blood culture—if haematogenous spread from Staphylococcus aureus bacteraemia or septic jugular thrombophlebitis is suspected, or the patient has sepsis or septic shock, collect three sets of blood samples for culture before starting antibiotic therapy</li>
                    <li>sputum Gram stain and culture—collect a sputum sample for Gram stain and culture before starting antibiotic therapy. Ensure a good quality sample (eg presence of polymorphs, but few or no squamous epithelial cells on microscopy) is collected</li>
                    <li>pleural ultrasound—if loculated parapneumonic effusion is a differential diagnosis, perform a pleural ultrasound. This test is usually superior to computed tomography (CT) in determining loculation</li>
                    <li>CT of the chest—if the diagnosis is uncertain, perform CT of the chest to distinguish between a peripheral lung abscess and empyema</li>
                    <li>echocardiogram—if bacteraemia is suspected in an adult, perform a transthoracic echocardiogram (TTE) or transoesophageal echocardiogram (TOE) to exclude endocarditis</li>
                    <li>bronchoscopy—if an obstructing tumour or aspirated foreign body (eg tooth, peanut) is suspected, perform bronchoscopy. In immunocompromised patients, bronchoscopy may be indicated to obtain samples for extensive microbiological testing, because infection with unusual pathogens is possible (see Approach to pneumonia in immunocompromised patients in the Therapeutic Guidelines)</li>
                </ul>
                <li>Oral therapy is recommended for patients with nonsevere lung abscess who do not have systemic features of infection (eg tachypnoea, hypoxaemia) or chest wall pain. Patients with systemic features of infection or chest wall pain need hospital admission and, unless an antibiotic with good bioavailability is available, initial intravenous therapy</li>
                <li>The total duration of therapy is usually 3 to 4 weeks (intravenous + oral). For large abscesses with persistent fluid, a longer duration of therapy may be required—seek expert advice. Consider monitoring serum C-reactive protein (CRP) for the response to therapy</li>
                <li>If the patient is not improving with antibiotic therapy, review the diagnosis and antibiotic choice. If lung abscess remains the likely diagnosis, seek expert advice from a respiratory physician or thoracic surgeon on the appropriateness of surgery or percutaneous drainage. These interventions are not routinely performed because of the potential for bronchopleural fistula formation when an intercostal catheter is inserted into the abscess; antibiotic therapy alone is often sufficient</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr>
            <h4 class="color-primary mrgn20">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="bold color-danger">Red Man</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr>
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on lung abscess</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc2c2a -->

    <!-- Start of LUNG ABSCESS, MILD PEN, JUGULAR, YES Sepsis/known source -->
    <div data-role="page" id="luabsc2d2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For jugular thrombophlebitis acquired lung abscess treatment in a patient with non-severe penicillin allergy, without signs of septic shock use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ceftriaxone 2 g (child 1 month or older: 50 mg/kg up to 2 g) intravenously, daily; for patients with septic shock or requiring intensive care support, use ceftriaxone 1 g (child 1 month or older: 50 mg/kg up to 1 g) intravenously, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Cefotaxime 2 g (child: 50 mg/kg up to 2 g) intravenously, 8-hourly; for patients with septic shock or requiring intensive care support, use cefotaxime 2 g (child: 50 mg/kg up to 2 g) intravenously, 6-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">A vancomycin loading dose of 25-30 mg/Kg IV (adult and child)</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per nomograms below or use the <a
                            href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <br/>
            <div id="backcolour">
                <p class="mrgn20b"><b>THEN,</b> when patient has improved and is ready for IV to oral switch (see below) a suitable step down (depending on microbiology) may be:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefuroxime 500 mg (child 3 months or older: 15 mg/kg up to 500 mg) orally or enterally</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally or enterally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone or cefotaxime is: </span>
                <span class="font15 bold">4<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FOUR</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if IV
                    treatment is to continue past four days. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is: </span>
                <span class="font15 bold">2<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if IV
                    treatment is to continue past 48 hours. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Lung abscesses are usually identified on chest X-ray imaging. For patients with suspected lung abscess, consider differential diagnoses. Peripheral lung abscesses should be differentiated from loculated parapneumonic effusions or empyema (see the Therapeutic Guideline's Investigations for lung abscess). In patients with a solitary cavitary pulmonary lesion, differential diagnoses include:</li>
                <ul>
                    <li>consolidation surrounding pre-existing bullae in patients with emphysema</li>
                    <li>tumours</li>
                    <li>vasculitis</li>
                    <li>tuberculosis</li>
                </ul>
                <li>Patients requiring hospital assessment or admission because of lung abscess may require the following investigations:</li>
                <ul>
                    <li>blood culture—if haematogenous spread from Staphylococcus aureus bacteraemia or septic jugular thrombophlebitis is suspected, or the patient has sepsis or septic shock, collect three sets of blood samples for culture before starting antibiotic therapy</li>
                    <li>sputum Gram stain and culture—collect a sputum sample for Gram stain and culture before starting antibiotic therapy. Ensure a good quality sample (eg presence of polymorphs, but few or no squamous epithelial cells on microscopy) is collected</li>
                    <li>pleural ultrasound—if loculated parapneumonic effusion is a differential diagnosis, perform a pleural ultrasound. This test is usually superior to computed tomography (CT) in determining loculation</li>
                    <li>CT of the chest—if the diagnosis is uncertain, perform CT of the chest to distinguish between a peripheral lung abscess and empyema</li>
                    <li>echocardiogram—if bacteraemia is suspected in an adult, perform a transthoracic echocardiogram (TTE) or transoesophageal echocardiogram (TOE) to exclude endocarditis</li>
                    <li>bronchoscopy—if an obstructing tumour or aspirated foreign body (eg tooth, peanut) is suspected, perform bronchoscopy. In immunocompromised patients, bronchoscopy may be indicated to obtain samples for extensive microbiological testing, because infection with unusual pathogens is possible (see Approach to pneumonia in immunocompromised patients in the Therapeutic Guidelines)</li>
                </ul>
                <li>Oral therapy is recommended for patients with nonsevere lung abscess who do not have systemic features of infection (eg tachypnoea, hypoxaemia) or chest wall pain. Patients with systemic features of infection or chest wall pain need hospital admission and, unless an antibiotic with good bioavailability is available, initial intravenous therapy</li>
                <li>The total duration of therapy is usually 3 to 4 weeks (intravenous + oral). For large abscesses with persistent fluid, a longer duration of therapy may be required—seek expert advice. Consider monitoring serum C-reactive protein (CRP) for the response to therapy</li>
                <li>If the patient is not improving with antibiotic therapy, review the diagnosis and antibiotic choice. If lung abscess remains the likely diagnosis, seek expert advice from a respiratory physician or thoracic surgeon on the appropriateness of surgery or percutaneous drainage. These interventions are not routinely performed because of the potential for bronchopleural fistula formation when an intercostal catheter is inserted into the abscess; antibiotic therapy alone is often sufficient</li>
                <li>Lung abscess can be a complication of septic jugular thrombophlebitis (Lemierre syndrome). The abscess develops because of haematogenous spread of anaerobic bacteria (eg Fusobacterium necrophorum), but the infection is usually polymicrobial. Staphylococcus aureus (including methicillin-resistant S. aureus [MRSA]) can also cause septic jugular thrombophlebitis</li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr>
            <h4 class="color-primary mrgn20">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="bold color-danger">Red Man</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr>
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on lung abscess</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc2d2 -->

    <!-- Start of LUNG ABSCESS, BAD PEN, HA/CA-SEVERE (No need for systemic/sepsis question as meropenem only option)-->
    <div data-role="page" id="luabsc3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For hospital or community acquired severe lung abscess treatment (including from jugular thrombophlebitis) in a patient with severe penicillin allergy use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Meropenem 1 g (child: 20 mg/kg up to 1 g) intravenously, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">A vancomycin loading dose of 25-30 mg/Kg IV</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per nomograms below or use the <a
                            href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for meropenem is: </span>
                <span class="font15 bold">4<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FOUR</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if IV
                    treatment is to continue past four days. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is: </span>
                <span class="font15 bold">2<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if IV
                    treatment is to continue past 48 hours. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Lung abscesses are usually identified on chest X-ray imaging. For patients with suspected lung abscess, consider differential diagnoses. Peripheral lung abscesses should be differentiated from loculated parapneumonic effusions or empyema (see the Therapeutic Guideline's Investigations for lung abscess). In patients with a solitary cavitary pulmonary lesion, differential diagnoses include:</li>
                <ul>
                    <li>consolidation surrounding pre-existing bullae in patients with emphysema</li>
                    <li>tumours</li>
                    <li>vasculitis</li>
                    <li>tuberculosis</li>
                </ul>
                <li>Patients requiring hospital assessment or admission because of lung abscess may require the following investigations:</li>
                <ul>
                    <li>blood culture—if haematogenous spread from Staphylococcus aureus bacteraemia or septic jugular thrombophlebitis is suspected, or the patient has sepsis or septic shock, collect three sets of blood samples for culture before starting antibiotic therapy</li>
                    <li>sputum Gram stain and culture—collect a sputum sample for Gram stain and culture before starting antibiotic therapy. Ensure a good quality sample (eg presence of polymorphs, but few or no squamous epithelial cells on microscopy) is collected</li>
                    <li>pleural ultrasound—if loculated parapneumonic effusion is a differential diagnosis, perform a pleural ultrasound. This test is usually superior to computed tomography (CT) in determining loculation</li>
                    <li>CT of the chest—if the diagnosis is uncertain, perform CT of the chest to distinguish between a peripheral lung abscess and empyema</li>
                    <li>echocardiogram—if bacteraemia is suspected in an adult, perform a transthoracic echocardiogram (TTE) or transoesophageal echocardiogram (TOE) to exclude endocarditis</li>
                    <li>bronchoscopy—if an obstructing tumour or aspirated foreign body (eg tooth, peanut) is suspected, perform bronchoscopy. In immunocompromised patients, bronchoscopy may be indicated to obtain samples for extensive microbiological testing, because infection with unusual pathogens is possible (see Approach to pneumonia in immunocompromised patients in the Therapeutic Guidelines)</li>
                </ul>
                <li>Oral therapy is recommended for patients with nonsevere lung abscess who do not have systemic features of infection (eg tachypnoea, hypoxaemia) or chest wall pain. Patients with systemic features of infection or chest wall pain need hospital admission and, unless an antibiotic with good bioavailability is available, initial intravenous therapy</li>
                <li>The total duration of therapy is usually 3 to 4 weeks (intravenous + oral). For large abscesses with persistent fluid, a longer duration of therapy may be required—seek expert advice. Consider monitoring serum C-reactive protein (CRP) for the response to therapy</li>
                <li>If the patient is not improving with antibiotic therapy, review the diagnosis and antibiotic choice. If lung abscess remains the likely diagnosis, seek expert advice from a respiratory physician or thoracic surgeon on the appropriateness of surgery or percutaneous drainage. These interventions are not routinely performed because of the potential for bronchopleural fistula formation when an intercostal catheter is inserted into the abscess; antibiotic therapy alone is often sufficient</li>
                <li>Lung abscess can be a complication of septic jugular thrombophlebitis (Lemierre syndrome). The abscess develops because of haematogenous spread of anaerobic bacteria (eg Fusobacterium necrophorum), but the infection is usually polymicrobial. Staphylococcus aureus (including methicillin-resistant S. aureus [MRSA]) can also cause septic jugular thrombophlebitis</li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr>
            <h4 class="color-primary mrgn20">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="bold color-danger">Red Man</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr>
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on lung abscess</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc3b -->

    <!-- Start of LUNG ABSCESS, BAD PEN, JUGULAR, NO Sepsis -->
    <div data-role="page" id="luabsc3d1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For jugular thrombophlebitis associated lung abscess treatment in a patient with a severe penicillin allergy, without signs of septic shock use as a single agent:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600 mg (child: 15 mg/kg up to 600 mg) intravenously, 8-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for IV clindamycin is: </span>
                <span class="font15 bold">2<script> document.write(getCode())</script>lab</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from
                    the first day of treatment for this condition. Infectious diseases must be contacted if IV
                    treatment is to continue past 48 hours. Please annotate this code on the medication chart and
                    document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Clindamycin has excellent oral bioavailability (~90%) orally bioavailable</li>
                <li>Lung abscesses are usually identified on chest X-ray imaging. For patients with suspected lung abscess, consider differential diagnoses. Peripheral lung abscesses should be differentiated from loculated parapneumonic effusions or empyema (see the Therapeutic Guideline's Investigations for lung abscess). In patients with a solitary cavitary pulmonary lesion, differential diagnoses include:</li>
                <ul>
                    <li>consolidation surrounding pre-existing bullae in patients with emphysema</li>
                    <li>tumours</li>
                    <li>vasculitis</li>
                    <li>tuberculosis</li>
                </ul>
                <li>Patients requiring hospital assessment or admission because of lung abscess may require the following investigations:</li>
                <ul>
                    <li>blood culture—if haematogenous spread from Staphylococcus aureus bacteraemia or septic jugular thrombophlebitis is suspected, or the patient has sepsis or septic shock, collect three sets of blood samples for culture before starting antibiotic therapy</li>
                    <li>sputum Gram stain and culture—collect a sputum sample for Gram stain and culture before starting antibiotic therapy. Ensure a good quality sample (eg presence of polymorphs, but few or no squamous epithelial cells on microscopy) is collected</li>
                    <li>pleural ultrasound—if loculated parapneumonic effusion is a differential diagnosis, perform a pleural ultrasound. This test is usually superior to computed tomography (CT) in determining loculation</li>
                    <li>CT of the chest—if the diagnosis is uncertain, perform CT of the chest to distinguish between a peripheral lung abscess and empyema</li>
                    <li>echocardiogram—if bacteraemia is suspected in an adult, perform a transthoracic echocardiogram (TTE) or transoesophageal echocardiogram (TOE) to exclude endocarditis</li>
                    <li>bronchoscopy—if an obstructing tumour or aspirated foreign body (eg tooth, peanut) is suspected, perform bronchoscopy. In immunocompromised patients, bronchoscopy may be indicated to obtain samples for extensive microbiological testing, because infection with unusual pathogens is possible (see Approach to pneumonia in immunocompromised patients in the Therapeutic Guidelines)</li>
                </ul>
                <li>Oral therapy is recommended for patients with nonsevere lung abscess who do not have systemic features of infection (eg tachypnoea, hypoxaemia) or chest wall pain. Patients with systemic features of infection or chest wall pain need hospital admission and, unless an antibiotic with good bioavailability is available, initial intravenous therapy</li>
                <li>The total duration of therapy is usually 3 to 4 weeks (intravenous + oral). For large abscesses with persistent fluid, a longer duration of therapy may be required—seek expert advice. Consider monitoring serum C-reactive protein (CRP) for the response to therapy</li>
                <li>If the patient is not improving with antibiotic therapy, review the diagnosis and antibiotic choice. If lung abscess remains the likely diagnosis, seek expert advice from a respiratory physician or thoracic surgeon on the appropriateness of surgery or percutaneous drainage. These interventions are not routinely performed because of the potential for bronchopleural fistula formation when an intercostal catheter is inserted into the abscess; antibiotic therapy alone is often sufficient</li>
                <li>Lung abscess can be a complication of septic jugular thrombophlebitis (Lemierre syndrome). The abscess develops because of haematogenous spread of anaerobic bacteria (eg Fusobacterium necrophorum), but the infection is usually polymicrobial. Staphylococcus aureus (including methicillin-resistant S. aureus [MRSA]) can also cause septic jugular thrombophlebitis</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on lung abscess</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /luabsc3d1 -->

    <!--END OF LUNG ABSCESS MAZE-->

</body>
<script src="bootstrap/js/script.js"></script>
<script src="bootstrap/js/test.js"></script>
<script src="bootstrap/js/email.js"></script>

</html>